Algorithmic methods for systems biology of Herpes-viral microRNAs by Erhard, Florian
Algorithmic Methods for Systems
Biology of Herpes-viral microRNAs
Florian Erhard
Mu¨nchen 2013
Algorithmic Methods for Systems
Biology of Herpes-viral microRNAs
Florian Erhard
Dissertation
an der Fakulta¨t fu¨r Mathematik, Informatik und Statistik
der Ludwig–Maximilians–Universita¨t
Mu¨nchen
vorgelegt von
Florian Erhard
geboren in Schongau
Mu¨nchen, den 18.10.2013
Erstgutachter: Prof. Dr. Ralf Zimmer
Zweitgutachter: Prof. Dr. Rolf Backofen
Tag der mu¨ndlichen Pru¨fung: 27.03.2014
vFormular 3.2
Name, Vorname
Erhard, Florian
Eidesstattliche Versicherung
(Siehe Promotionsordnung vom 12.07.11, § 8, Abs. 2 Pkt. .5.)
Hiermit erkläre ich an Eidesstatt, dass die Dissertation von mir
selbstständig, ohne unerlaubte Beihilfe angefertigt ist.
München, 18.10.2013
Ort, Datum Unterschrift Doktorand/in
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
vi
Contents
Summary xv
Zusammenfassung xvii
1 Introduction 1
1.1 Systems biology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.1.1 A typical systems biology workflow . . . . . . . . . . . . . . . . . . . . 2
1.1.2 Bioinformatics in systems biology . . . . . . . . . . . . . . . . . . . . . 2
1.2 MicroRNAs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
1.2.1 Discovery of microRNAs in C. elegans . . . . . . . . . . . . . . . . . . 7
1.2.2 MicroRNA biogenesis . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
1.2.3 Regulatory mechanisms of microRNAs . . . . . . . . . . . . . . . . . . 8
1.2.4 Biological function of microRNAs . . . . . . . . . . . . . . . . . . . . . 10
1.2.5 Bioinformatics for microRNAs . . . . . . . . . . . . . . . . . . . . . . . 11
1.3 Herpes viruses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
1.3.1 Phylogeny . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
1.3.2 Life cycle, symptoms and prevalence . . . . . . . . . . . . . . . . . . . 15
1.3.3 Viral microRNAs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
2 Datasets 19
2.1 Primer on experimental techniques . . . . . . . . . . . . . . . . . . . . . . . . . 19
2.1.1 Microarrays, metabolic labeling and RIP-Chip . . . . . . . . . . . . . . 19
2.1.2 Sequencing, sRNA-seq and PAR-CLIP . . . . . . . . . . . . . . . . . . 21
2.1.3 LC-MS/MS and SILAC . . . . . . . . . . . . . . . . . . . . . . . . . . 22
2.2 Cell lines and available datasets . . . . . . . . . . . . . . . . . . . . . . . . . . 23
2.2.1 KSHV related cell lines . . . . . . . . . . . . . . . . . . . . . . . . . . 24
2.2.2 EBV related cell lines . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
2.2.3 VZV related cell lines . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
3 Classification of ncRNAs using position and size information in deep sequencing
data 29
3.1 Abstract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
3.1.1 Motivation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
viii CONTENTS
3.1.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
3.1.3 Availability . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
3.2 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
3.3 Approach . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
3.4 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
3.5 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
3.6 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
3.7 Conclusion and Outlook . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
4 PARma: identification of microRNA target sites in AGO-PAR-CLIP data 43
4.1 Abstract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
4.2 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
4.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46
4.3.1 PARma overview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46
4.3.2 Cluster detection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
4.3.3 Generative model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52
4.3.4 KmerExplain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53
4.3.5 Seed activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53
4.3.6 Inferred models . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
4.3.7 Evaluation using differential PAR-CLIP . . . . . . . . . . . . . . . . . . 56
4.3.8 Validation against RIP-Chip data . . . . . . . . . . . . . . . . . . . . . . 59
4.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60
4.4.1 PAR-CLIP clusters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60
4.4.2 PARma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61
4.4.3 Comparison to PARalyzer . . . . . . . . . . . . . . . . . . . . . . . . . 62
4.4.4 Differential PAR-CLIP . . . . . . . . . . . . . . . . . . . . . . . . . . . 63
4.5 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64
4.5.1 Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64
4.5.2 Raw data processing and cluster definition . . . . . . . . . . . . . . . . . 64
4.5.3 PARma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66
4.6 Software availability . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69
5 RIP-chip enrichment analysis 71
5.1 Abstract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72
5.1.1 Motivation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72
5.1.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72
5.1.3 Availability . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72
5.2 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72
5.3 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75
5.3.1 Data processing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75
5.3.2 Mixture model fitting . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75
5.3.3 PCA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76
5.4 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 77
CONTENTS ix
5.4.1 Select relevant genes . . . . . . . . . . . . . . . . . . . . . . . . . . . . 77
5.4.2 Determining microRNA targets . . . . . . . . . . . . . . . . . . . . . . 79
5.4.3 Taking replicates into account . . . . . . . . . . . . . . . . . . . . . . . 80
5.4.4 Determining differential microRNA targets . . . . . . . . . . . . . . . . 82
5.5 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 83
5.6 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85
6 Widespread context-dependency of microRNA-mediated regulation 87
6.1 Abstract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89
6.2 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89
6.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91
6.3.1 Differential analysis of PAR-CLIP data . . . . . . . . . . . . . . . . . . 91
6.3.2 Technical bias . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 94
6.3.3 Context-dependent target sites of KSHV microRNAs . . . . . . . . . . . 96
6.3.4 Context-dependent target sites of cellular microRNAs . . . . . . . . . . 103
6.3.5 mRNA levels and flanking sequence motifs explain context-dependent
microRNA/target interactions . . . . . . . . . . . . . . . . . . . . . . . 106
6.3.6 Context-dependent target sites are less conserved than constitutive sites . 110
6.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 111
6.4.1 Contributors to the cellular context . . . . . . . . . . . . . . . . . . . . . 111
6.4.2 Other contributors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 112
6.4.3 Functional considerations of context-dependent regulation . . . . . . . . 113
6.4.4 Consequences of context-dependency . . . . . . . . . . . . . . . . . . . 114
6.5 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 115
6.5.1 Cell lines . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 115
6.5.2 PAR-CLIP and sequencing . . . . . . . . . . . . . . . . . . . . . . . . . 115
6.5.3 SILAC-based proteomics . . . . . . . . . . . . . . . . . . . . . . . . . . 116
6.5.4 RIP-Chip analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 116
6.5.5 RNA half-life measurements by 4sU-tagging . . . . . . . . . . . . . . . 116
6.5.6 PARma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 116
6.5.7 Correcting for sampling noise . . . . . . . . . . . . . . . . . . . . . . . 117
7 Detection of outlier peptides 121
7.1 Abstract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 122
7.2 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 122
7.3 Materials and methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 125
7.3.1 Data processing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 125
7.3.2 Detecting outlier peptides . . . . . . . . . . . . . . . . . . . . . . . . . 125
7.3.3 In-silico data generation . . . . . . . . . . . . . . . . . . . . . . . . . . 126
7.4 Results and Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 127
7.4.1 Test on in-silico generated data . . . . . . . . . . . . . . . . . . . . . . . 128
7.4.2 Outlier peptides in real data . . . . . . . . . . . . . . . . . . . . . . . . 129
7.4.3 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 135
x CONTENTS
7.5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 136
8 FERN - Stochastic Simulation and Evaluation of Reaction Networks 137
8.1 Abstract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 138
8.2 Background . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 138
8.2.1 Petri nets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 139
8.2.2 Stochastic chemical kinetics . . . . . . . . . . . . . . . . . . . . . . . . 140
8.2.3 Stochastic simulation methods . . . . . . . . . . . . . . . . . . . . . . . 142
8.3 Implementation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 145
8.3.1 Other implementations . . . . . . . . . . . . . . . . . . . . . . . . . . . 146
8.3.2 FERN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 146
8.3.3 Implementation details . . . . . . . . . . . . . . . . . . . . . . . . . . . 148
8.3.4 Accuracy and runtime performance of FERN . . . . . . . . . . . . . . . 151
8.4 Using FERN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 152
8.4.1 Command line tool . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 152
8.4.2 Basic usage of FERN . . . . . . . . . . . . . . . . . . . . . . . . . . . . 153
8.4.3 Cytoscape plugin for stochastic simulation . . . . . . . . . . . . . . . . 154
8.4.4 Simulation of cell growth and division using observers . . . . . . . . . . 156
8.5 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 157
9 Conclusion and outlook 159
Bibliography 163
List of abreviations 189
Acknowledgements 191
List of Figures
1.1 Systems biology workflow . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
1.2 Phylogeny of herpes viruses . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
2.1 Proteomics data for DG75-eGFP,DG75-10/12 and BCBL1 . . . . . . . . . . . . 25
2.2 Read length distribution of the VZV sRNA-seq experiments . . . . . . . . . . . 27
3.1 Typical position and length dependent pattern matrices . . . . . . . . . . . . . . 33
3.2 Freeshift alignment of hsa-mir-99b and hsa-mir-185 . . . . . . . . . . . . . . . . 37
3.3 Inner and outer score distributions for microRNAs . . . . . . . . . . . . . . . . . 38
3.4 Evaluation for the scoring system (H2,1, sum-min,−0.01,−0.005, freeshift) . . . 40
4.1 PARma overview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47
4.2 PAR-CLIP data viewer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49
4.3 Illustration of the PARma procedure . . . . . . . . . . . . . . . . . . . . . . . . 50
4.4 Overlapping PAR-CLIP clusters . . . . . . . . . . . . . . . . . . . . . . . . . . 51
4.5 Correlation of microRNA expression to the number of assigned clusters . . . . . 54
4.6 PARma model for replicate A of the DG75 experiment . . . . . . . . . . . . . . 55
4.7 Model scores for the cluster in Figure 4.2a . . . . . . . . . . . . . . . . . . . . . 57
4.8 Evaluation using differential PAR-CLIP . . . . . . . . . . . . . . . . . . . . . . 58
4.9 Validation against RIP-Chip . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60
5.1 Measurement distributions for our Ago2 RIP-chip experiment . . . . . . . . . . 73
5.2 Selecting expressed genes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 78
5.3 Background subtraction is necessary . . . . . . . . . . . . . . . . . . . . . . . . 79
5.4 Computed FDRs are valid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 81
5.5 Average number of HITS-Clip target sites per target/non-target gene . . . . . . . 82
5.6 Differing IP efficiencies require normalization before computing summary values 83
5.7 Differing IP efficiencies require normalization before computing differential targets 84
6.1 Validation of PAR-CLIP experiments . . . . . . . . . . . . . . . . . . . . . . . . 92
6.2 Comparison of PAR-CLIP experiments with available datasets . . . . . . . . . . 93
6.3 Comparison of PAR-CLIP datasets . . . . . . . . . . . . . . . . . . . . . . . . . 94
6.4 Correlations of PAR-CLIP cluster quantifications . . . . . . . . . . . . . . . . . 95
6.5 miR-K12-4-3p heatmap . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 97
xii LIST OF FIGURES
6.6 Context dependent target sites of KSHV microRNAs . . . . . . . . . . . . . . . 98
6.7 KSHV PAR-CLIP targets in RIP-Chip data . . . . . . . . . . . . . . . . . . . . 99
6.8 KSHV PAR-CLIP targets in mRNA half-life data . . . . . . . . . . . . . . . . . 101
6.9 KSHV PAR-CLIP targets in expression data . . . . . . . . . . . . . . . . . . . . 102
6.10 Context-dependent target interactions of human microRNAs . . . . . . . . . . . 103
6.11 Cellular PAR-CLIP targets in RIP-Chip and mRNA half-life data . . . . . . . . . 104
6.12 Cellular PAR-CLIP targets in expression data . . . . . . . . . . . . . . . . . . . 105
6.13 Comparison of mRNA fold changes to PAR-CLIP read count fold changes . . . . 107
6.14 Role of sequence motifs for context-dependent target sites . . . . . . . . . . . . 108
6.15 Motif randomization results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 109
6.16 Conservation of target sites . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110
6.17 PAR-CLIP read count correlation with expression . . . . . . . . . . . . . . . . . 117
6.18 Conditional gamma distribution fit . . . . . . . . . . . . . . . . . . . . . . . . . 119
7.1 Example MS peptide quantifications for a gene with several isoforms . . . . . . . 124
7.2 Number of measurements per peptide . . . . . . . . . . . . . . . . . . . . . . . 128
7.3 Evaluation on in-silico generated data . . . . . . . . . . . . . . . . . . . . . . . 130
7.4 Heteroscedastic ANOVA applied to the experimental data . . . . . . . . . . . . . 131
7.5 Evidence for misidentifications in outlier peptides . . . . . . . . . . . . . . . . . 132
7.6 Evidence for misquantifications in outlier peptides . . . . . . . . . . . . . . . . . 133
7.7 Evidence for saturation in our dataset . . . . . . . . . . . . . . . . . . . . . . . 134
8.1 A Petri net and the firing of a transition. . . . . . . . . . . . . . . . . . . . . . . 142
8.2 Flow of one simulation step . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143
8.3 Software design . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 147
8.4 Trajectories of the EGF signalling pathway . . . . . . . . . . . . . . . . . . . . 153
8.5 EGF signalling pathway loaded into Cytoscape . . . . . . . . . . . . . . . . . . 155
8.6 Average results of 1,000 simulations for LacZ . . . . . . . . . . . . . . . . . . . 157
List of Tables
1.1 Experimentally discovered microRNAs of human herpes viruses . . . . . . . . . 17
2.1 Datasets for the cell lines DG75-eGFP, DG75-10/12 and BCBL1 . . . . . . . . . 24
3.1 Annotations from mirBase, gtRNAdb, Ensembl and RefSeq . . . . . . . . . . . . 36
6.1 Identified motifs by MERCI . . . . . . . . . . . . . . . . . . . . . . . . . . . . 106
8.1 Mass action propensity functions for basic reactions . . . . . . . . . . . . . . . . 141
xiv LIST OF TABLES
Summary
Recent technological advances have made it possible to measure various parameters of biological
processes in a genome-wide manner. While traditional molecular biology focusses on individual
processes using targeted experiments (reductionistic approach), the field of systems biology
utilizes high-throughput experiments to determine the state of a complete system such as a
cell at once (holistic approach). Systems biology is not only carried out in wet-lab, but for the
most part also requires tailored computational methods. High-throughput experiments are able
to produce massive amounts of data, that are often too complex for a human to comprehend
directly, that are affected by substantial noise, i.e. random measurement variation, and that are
often subject to considerable bias, i.e. systematic deviations of the measurement from the truth.
Thus, computer science and statistical methods are necessary for a proper analysis of raw data
from such large-scale experiments.
The goal of systems biology is to understand a whole system such as a cell in a quantitative
manner. Thus, the computational part does not end with analyzing raw data but also involves
visualization, statistical analyses, integration and interpretation. One example for these four
computational tasks is as follows: Processes in biological systems are often modeled as networks,
for instance, gene regulatory networks (GRNs) that represent the interactions of transcription
factors (TFs) and their target genes. Experiments can provide both, the identity and wiring of
all constituent parts of the network as well as parameters that allow to describe the processes in
the system in a quantative manner. A network provides a straight-forward way to visualize the
state and processes of a whole system, its statistical analysis can reveal interesting properties
of biological systems, it is able to integrate several datasets from various experiments and
simulations of the network can aid to interpret the data.
In recent years, microRNAs emerged as important contributors to gene regulation in eukaryotes,
breaking the traditional dogma of molecular biology, where DNA is transcribed to RNA which
is subsequently translated into proteins. MicroRNAs are small RNAs that are not translated but
functional as RNAs: They are able to target specific messenger RNAs (mRNA) and typically
lead to their downregulation. Thus, in addition to TFs, microRNAs also play important roles in
GRNs. Interestingly, not only animal genomes including the human genome encode microRNAs,
but microRNAs are also encoded by several pathogens such as viruses.
In this work I developed several computational systems biology methods and applied them to
high-throughout experimental data in the context of a project about herpes viral microRNAs.
Three methods, ALPS, PARma and REA, are designed for the analysis of certain types of
raw data, namely short RNA-seq, PAR-CLIP and RIP-Chip data, respectively. All of theses
xvi Summary
experiments are widely used and my methods are publicly available on the internet and can
be utilized by the research community to analyze new datasets. For these methods I developed
non-trivial statistical methods (e.g. the EM algorithm kmerExplain in PARma) and implemented
and adapted algorithms from traditional computer science and bioinformatics (e.g. alignment of
pattern matrices in ALPS).
I applied these novel methods to data measured by our cooperation partners in the herpes virus
project. I.a., I discovered and investigated an important aspect of microRNA-mediated regulation:
MicroRNAs recognize their targets in a context-dependent manner. The widespread impact of
context on regulation is widely accepted for transcriptional regulation, and only few examples
are known for microRNA-mediated regulation. By integrating various herpes-related datasets, I
could show that context-dependency is not restricted to few examples but is a widespread feature
in post-transcriptional regulation mediated by microRNAs. Importantly, this is true for both, for
human host microRNAs as well as for viral microRNAs.
Furthermore, I considered additional aspects in the data measured in the context of the herpes
virus project: Alternative splicing has been shown to be a major contributor to protein diversity.
Splicing is tightly regulated and possibly important in virus infection. Mass spectrometry is able
to measure peptides quantitatively genome-wide in high-throughput. However, no method was
available to detect splicing patterns in mass spectrometry data, which was one of the datasets
that has been meausred in the project. Thus, I investigated whether mass spectrometry offers the
opportunity to identify cases of differential splicing in large-scale.
Finally, I also focussed on networks in systems biology, especially on their simulation. To be
able to simulate networks for the prediction of the behavior of systems is one of the central goals
in computational systems biology. In my diploma thesis, I developed a comprehensive modeling
platform (PNMA, the Petri net modeling application), that is able to simulate biological systems
in various ways. For highly detailed simulations, I further developed FERN, a framework for
stochastic simulation that is not only integrated in PNMA, but also available stand-alone or as
plugins for the widely used software tools Cytoscape or CellDesigner.
In systems biology, the major bottleneck is computational analysis, not the generation of data.
Experiments become cheaper every year and the throughput and diversity of data increases
accordingly. Thus, developing new methods and usable software tools is essential for further
progress. The methods I have developed in this work are a step into this direction but it is
apparent, that more effort must be devoted to keep up with the massive amounts of data that
is being produced and will be produced in the future.
Zusammenfassung
Der technische Fortschritt in den letzten Jahren hat ermo¨glicht, dass vielerlei Parameter
von biologischen Prozessen genomweit gemessen werden ko¨nnen. Wa¨hrend die traditionelle
Molekularbiologie sich mit Hilfe gezielter Experimente auf individuelle Prozesse konzentriert
(reduktionistischer Ansatz), verwendet das Feld der Systembiologie Hochdurchsatz-Experimente
um den Zustand eines vollsta¨ndigen Systems wie einer Zelle auf einmal zu bestimmen (holistis-
cher Ansatz). Dabei besteht Systembiologie nicht nur aus Laborarbeit, sondern beno¨tigt zu einem
großen Teil auch speziell zurechtgeschnittene computergestu¨tzte Methoden. Hochdurchsatz-
Experimente ko¨nnen riesige Mengen an Daten produzieren, welche oft zu komplex sind um von
einem Menschen direkt verstanden zu werden, welche beeintra¨chtigt sind von substantiellem
Rauschen, das heißt zufa¨lliger Messvariation, und welche oft betra¨chtlichem Bias unterliegen,
also systematischen Abweichungen der Messungen von der tatsa¨chlichen Gro¨ße. Daher sind
informatische und statistische Methoden notwendig fu¨r eine geeignete Analyse der Rohdaten
eines groß angelegten systembiologischen Experiments.
Das Ziel der Systembiologoe ist ein ganzen System wie eine Zelle in quantitativer Weise
zu verstehen. Daher endet der computergestu¨tzte Teil nicht mit der Analyse der Rohdaten,
sondern beinhaltet ebenfalls Visualisierung, statistische Analyse, Integration und Interpretation.
Ein Beispiel dieser vier rechnergestu¨tzten Aufgaben ist wie folgt: Prozesse in biologischen
Systemen werden oft in Netzwerken modelliert. Zum Beispiel werden in genregulatorischen
Netzwerken (GRNs) die Interaktionen zwischen Transkriptionsfaktoren (TFs) und deren Ziel-
genen repra¨sentiert. Mit Experimenten kann man sowohl die Identita¨t und die Vernetzung aller
Bestandteile des Netzwerkes messen, wie auch die Parameter, mit denen man die Prozesse des
Systems in quantitativer Weise beschreiben kann. Mit Hilfe eines Netzwerkes kann man auf
einfache und direkte Weise den Zustand und die Prozesse eines ganzen Systems visualisieren, die
statistische Analyse des Netzwerks kann interessante Eigenschaften eines biologischen Systems
aufdecken, es bietet die Mo¨glichkeit, verschiedene experimentelle Daten zu integrieren und seine
Simulation kann bei der Interpretation der Daten helfen.
Erst vor wenigen Jahren stelle sich heraus, dass sogenannte microRNAs die Genregula-
tion in Eukaryonten maßgeblich beeinflussen. Das steht im Widersprich zum traditionellen
Dogma der Molekularbiologie, bei dem die genetische Information aus der DNA in RNA
transkribiert wird, welche anschließend in Proteine translatiert wird. MicroRNAs hingegen
sind kurze RNAs, welche nicht translatiert werden, sondern als RNAs funktional sind. Sie
ko¨nnen spezifische messenger RNAs (mRNAs) binden und fu¨hren dann typischerweise zu deren
Inhibition. Zusa¨tzlich zu Transkriptionsfaktoren spielen also microRNAs eine wichtige Rolle
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in GRNs. Interessanterweise enkodieren nicht nur tierische Genome, das menschliche Genom
eingeschlossen, microRNAs, sondern viele Pathogene wie Viren exprimieren ihre eigenen
microRNAs in infizierten Wirtszellen.
In dieser Arbeit habe ich mehrere computergestu¨tzte Methoden fu¨r die Anwendung in der
Systembiologie entwickelt und auf Hochdurchsatz-Daten angewendet, die im Kontext eines
Projektes u¨ber herpesvirale microRNAs vermessen wurden. Drei Methoden, ALPS, PARma
und REA, habe ich fu¨r die Analyse von bestimmten Typen von Rohdaten entworfen, na¨mlich
jeweils short RNA-seq, PAR-CLIP und RIP-Chip. All diese Experimente sind weit verbreitet
im Einsatz und meine Methoden sind im Internet o¨ffentlich verfu¨gbar und ko¨nnen von der
Forschungsgemeinschaft zur Analyse der Rohdaten der jeweiligen Experimente verwendet
werden. Fu¨r diese Methoden entwickelte ich nicht-triviale statistische Methoden (z.B. den
EM Algorithmus kmerExplain in PARma) und implementierte und adaptierte Algorithmen
aus der traditionellen Informatik wie auch aus der Bioinformatik (z.B. Sequenzalignment der
Mustermatrizen in ALPS).
Ich wendete diese neuen Methoden auf Daten an, die von unseren Kooperationspartner im
Herpesviren Projekt gemessenen wurden. Dabei entdeckte und erforschte ich unter anderem
einen wichtigen Aspekt der Regulation durch microRNAs: MicroRNAs erkennen ihre Targets
in kontext-abha¨ngiger Weise. Die weitverbreiteten Auswirkungen von Kontext ist weithin
akzeptiert fu¨r transkriptionelle Regulation und es sind nur wenige Beispiele von kontext-
spezifischer microRNA gesteuerte Regulation bekannt. Indem ich mehrere Herpes-relevante
Datensa¨tze integriert analysiert habe, konnte ich zeigen, dass Kontext-Abha¨ngigkeit nicht nur
auf ein paar Beispiele beschra¨nkt ist, sondern dass es ebenfalls ein weitverbreitetes Merkmal
der post-transkriptionellen Regulation gesteuert durch microRNAs ist, dass Zielgene kontext-
abha¨ngig erkannt werden. Das gilt sowohl fu¨r die menschlichen microRNAs der Wirtszelle wie
auch fu¨r die exogenen viralen microRNAs.
Desweiteren habe ich zusa¨tzliche Aspekte der Daten des Herpesviren-Projektes betrachtet: Es
wurde gezeigt, dass alternatives Spleißen maßgeblich zur Diversita¨t von Proteinen beitra¨gt.
Spleißen ist streng reguliert und mo¨glicherweise wichtig bei der Virusinfektion. Massen-
spektrometrie kann Peptide genomweit in quantitativer Weise messen. Allerdings stand keine
Methode zur Verfu¨gung, um Spleiß-Muster in Massenspektrometrie-Daten, wie sie im Pro-
jekt gemessen wurden, zu detektieren. Aus diesem Grund habe ich untersucht, ob es mit
Massenspektrometrie-Daten mo¨glich ist, Fa¨lle von alternativen Spleißen im großen Umfang zu
identifizieren.
Letztendlich habe ich mich auch auf systembiologische Netzwerke und im Speziellen auf deren
Simulation konzentriert. Netzwerke simulieren zu ko¨nnen um das Verhalten von Systemen
vorherzusagen ist eines der zentralen Ziele der rechnergestu¨tzten Systembiologie. Bereits in
meiner Diplomarbeit habe dafu¨r ich eine umfassende Modellierplatform (PNMA, the Petri net
modelling application) entwickelt. Damit ist es mo¨glich, biologische Systeme auf vielerlei Arten
zu simulieren. Fu¨r sehr detailierte Simulationen habe ich dann FERN entwickelt, ein Framework
zur stochastischen Simulation, welches nicht nur in PNMA integriert ist, sondern auch als
eigensta¨ndige Software wie auch also Plugin fu¨r die weitverbreiteten Programme Cytoscape und
CellDesigner verfu¨gbar ist.
xix
Der Engpass in der Systembiologie ist mehr und mehr die rechnergestu¨tzte Analyse der
Daten und nicht deren Generierung. Experimente werden jedes Jahr gu¨nstiger und der Durch-
satz und die Diversita¨t der Daten wa¨chst dementsprechend. Daher is es fu¨r den weiteren
wissenschaftlichen Fortschritt essentiell, neue Methoden und benutzbare Softwarepakete zu
entwickeln. Die Methoden, die ich in dieser Arbeit entwickelt habe, stellen einen Schritt in diese
Richtung dar, aber es ist offensichtlich, dass mehr Anstrengungen aufgewendet werden mu¨ssen,
um Schritt halten zu ko¨nnen mit den riesigen Mengen an Daten die produziert werden und in der
Zukunft noch produziert werden.
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Chapter 1
Introduction
1.1 Systems biology
The advent of high-throughput technologies has revolutionized biological research and has
heavily contributed to the increasing importance of the field of systems biology [Stelling, 2004;
Westerhoff and Palsson, 2004; Kitano, 2002; Ideker et al., 2001; Ideker and Lauffenburger,
2003]. Instead of focussing on single or few biological entities such as genes or proteins, high-
throughput methods allow to investigate a complex biological system such as a cell or cell culture
in its entirety.
In the top-down approach of systems biology [Ideker and Lauffenburger, 2003], so-called omics
experiments are applied, which are based on these high-throughput technologies and measure
a certain type of data in a genome-wide manner: These omics experiments include, but are
not limited to, genomics measuring the DNA sequence of complete genomes including intra-
or inter-species variation [Lander et al., 2001; Venter et al., 2001; Lindblad-Toh et al., 2011;
Consortium, 2012b], transcriptomics measuring the identity and quantity of expressed messenger
RNAs (mRNAs) and non-coding RNAs (ncRNAs) [Schena et al., 1995; Mortazavi et al., 2008],
proteomics measuring the expression and modifications of proteins [Ong and Mann, 2005;
Cox and Mann, 2007], metabolomics measuring concentrations of metabolites [Nicholson and
Wilson, 2003; German et al., 2005], interactomics measuring all interactions between molecules
[Schwikowski et al., 2000; Rual et al., 2005] and many more.
The goal of systems biology is to integrate all these omics measurements in order to understand
and characterize processes that are important in the system under consideration in a holistic
manner [Sauer et al., 2007; Noble, 2008]. Naturally, due to the massive amount of data from
such experiments, bioinformatics plays an irreplaceable role in systems biology [Scholz et al.,
2012; Likic´ et al., 2010].
In this work, I developed computational methods for the analysis of high-throughput experiments
and applied them to data measured in the context of a project about herpes viruses with a focus on
post-transcriptional regulation by microRNAs. In this first chapter, I give a pragmatic overview
of the methods by classifying them into a typical workflow in systems biology and, after an
introduction of microRNAs, I describe the impact of the proposed approaches on analyzing
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microRNA related experiments in general. A brief introduction of herpes virus biology concludes
this chapter. In the second chapter, I briefly describe the experimental techniques and datasets
used in this work, followed by an overview about how all developed methods have been applied
to the data. Then, I describe all methods and results of the analyses in detail in the subsequent
chapters. I conclude this work with an outlook and future developments.
1.1.1 A typical systems biology workflow
The output of a high-throughput experiments is a certain type of data, which by itself is not to be
mistaken for information about or understanding of a system. Bioinformatics is needed to extract
information and, further on, to interpret the data in order to understand the system. Making the
distinction between information and understanding, the role of bioinformatics is twofold: First,
the raw data coming from a high-throughput experiment must be analyzed. For instance, data may
consist of short sequencing reads or fluorescence intensities from a microarray. Computational
methods must be applied to extract useful information, e.g. an expression value per gene in a
transcriptomics study, and often these values can be presented in a tabular format. Such tables
often contain thousands of rows that represent entities such as genes and dozens of columns
representing different pieces of information or different statistics about the data.
Due to the complexity of this massive amount of information, it is often impossible to quickly
come to an understanding of the system. This is the second task for bioinformatics: Provide
tools and methods to interpret such per-entity values in the context of the system. Such tools
and methods may be as simple as overrepresentation analysis [Breitling et al., 2004] or gene set
enrichment [Subramanian et al., 2005], or they may make use of more sophisticated methods
integrating multiple datasets or existing knowledge [Consortium, 2012b; Gerstein et al., 2012].
In systems biology, such advanced methods are of uttermost importance since the goal is to
understand a complex biological system as a whole with all its interdependencies and not only
to investigate individual components.
Thus, a typical workflow in top-down systems biology can be subdivided into four steps (see also
Figure 1.1): First, a biological system, for instance a cell culture, is subjected to several sample
preparation steps, e.g. to isolate mRNA in form of cDNA. Then, the actual high-throughput
measurement takes place, for instance RNA-seq, where the sequence of millions of isolated
mRNA fragments is determined. After this second step, further work takes place in front of a
computer instead of in the laboratory: As indicated above, the raw data must be analyzed, for
instance by mapping the RNA-seq reads to known genes and computing per-gene expression
values by counting sequenced reads. Finally, these per-gene values can be further analyzed and
interpreted depending on the intention of the study. Of course, this workflow makes no claim
to be complete and depending on the nature and goal of a study, further wet-lab validations or
high-throughput measurements may be necessary [Mortazavi et al., 2008].
1.1.2 Bioinformatics in systems biology
There are several issues associated with both major computational steps, raw data analysis and
downstream interpretation, which I have approached in this work.
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First, while most omics experiments are based on common high-throughput technologies, there
is a huge variety of differing sample preparation steps. Thus, even if the raw data may be of
the same kind for various experiments, the demands on the analysis methods may be highly
diverse. For instance, currently a multitude of omics experiments are based on next generation
sequencing (NGS), e.g. DNA resequencing in genomics [Consortium, 2012a], RNA-seq in
transcriptomics [Mortazavi et al., 2008] or CLIP-seq in interactomics [Chi et al., 2009; Ko¨nig
et al., 2010; Hafner et al., 2010]. For all these experiments, the raw data consists of millions of
short sequencing reads, ranging from 35 nucleotides (nt) to more than 100 nt. Thus, the first step
of data analysis is similar for most experiments, i.e. to align these reads to a reference sequence
such as the genome or transcriptome. However, further data analysis is often highly diverse: DNA
resequencing usually has the goal to detect single nucleotide polymorphisms (SNPs) or copy
number variations (CNVs) and further analysis therefore includes the detection of significant
mismatches or coverage differences with respect to the genome [Consortium, 2012a]. In contrast,
RNA-seq is designed to quantify all mRNAs in a sample and, thus, methods must be applied
to properly estimate mRNA abundance or identify significantly differentially expressed genes
[Mortazavi et al., 2008; Anders and Huber, 2010]. Moreover, for CLIP-seq experiments, RNA
is crosslinked to proteins, the protein of interest is isolated using immunoprecipitation (IP) and
digested fragments crosslinked to this proteins are sequenced [Chi et al., 2009]. Thus, in order to
identify the mRNA binding sites of the protein, locations must be found where many sequencing
reads have been aligned to. Furthermore, several modifications have been developed for the CLIP
protocol [Ko¨nig et al., 2010; Hafner et al., 2010], which lead to additional characteristics in the
data for the identification of bona-fide binding sites. For instance, in PAR-CLIP [Hafner et al.,
2010], the usage of the uridine analogue 4-thio-uridine (4sU) and a certain wavelength of the
laser used for crosslinking leads to so-called T to C conversions, since crosslinked 4sU is read
as a C and not as a T during cDNA synthesis. Thus, even if raw data may be similar across a
multitude of experiments such as sequencing experiments, specialized experimental assays such
as CLIP-seq require specialized analysis methods and considering special features of variants of
such assays, e.g. PAR-CLIP, may yield more or more reliable information. In chapter 4, I describe
an analysis method I developed that addresses this important issue. PARma utilizes characteristic
features of PAR-CLIP data and thereby outperforms existing approaches in identifying reliable
microRNA/target interactions Erhard et al. [2013a].
Second, in some cases, existing methods for one kind of experiments may be directly applicable
to another kind of experiment to a certain extent, but they may neglect bias that does not affect
Figure 1.1 (following page): Systems biology workflow. Starting from a biological system, either
in-vitro or in-vivo, samples are prepared and subjected to a high-throughout platform (Wet-lab
work). After that, raw data from the experiment must be analyzed, which often results in a table
with biological entities in rows (e.g. genes) and various kinds of data in columns. The final step
is to interpret these tables, for instance by statistical analysis (I), functional analysis (II), network
analysis (III) or simulation of a network model (IV). Often, interpreting these tables leads to new
hypothesis for new experiments, i.e. further wet-lab work.
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the type of experiment which the methods have been originally designed for. For instance, RIP-
Chip, another interactomics experiment type, utilizes microarrays, which are widely applied to
mRNA quantification in transcriptomics. In RIP-Chip, RNA binding proteins (RBPs) are co-
immunoprecipitated with their associated mRNAs and the abundance of isolated mRNA is then
compared to the total abundance of the same mRNA in full cell lysate or the isolate from a
control IP using an unspecific antibody [Tenenbaum et al., 2000]. This is very similar to standard
differential expression (DE) analysis using microarrays, where total RNA in one condition is
compared to total RNA in another condition Miller and Tang [2009]. While in DE, the ratio
between conditions corresponds to the expression fold change, for a RIP-Chip experiment, the
ratio expresses the enrichment of an mRNA in the IP fraction. Consequently, in previous studies,
transcriptomics data analysis methods have directly been applied to RIP-Chip data [Mukherjee
et al., 2009; Hendrickson et al., 2008; Karginov et al., 2007; Stoecklin et al., 2008; Landthaler
et al., 2008; Do¨lken et al., 2010]. However, differing efficiencies of the IP that are generally
observed in RIP-Chip experiments introduces severe bias that must be accounted for before
further analyzing RIP-Chip data. This is topic of chapter 5 and has been published in Erhard
et al. [2013b].
Third, there may be information present in high-throughput data that is not considered by
existing analysis tools and awaits uncovering by specialized methods. This information can be
subcategorized into (a) additional characteristics of the entities that were originally intended to
be measured and (b) features of additional entities that were not in the focus of the original
experimental design. An example of additional characteristics is described in chapter 5 and
published in Erhard et al. [2013b]: By inspecting the distribution of IP enrichments of all
mRNAs, it is possible to test whether an mRNA is significantly targeted by an RBP by computing
false discovery rates (FDRs). Importantly, this FDR does not correspond to the reproducibility
of the enrichment but assesses whether the magnitude of the enrichment is high enough to
speak of a functionally relevant enrichment. Therefore, this is complementary to other methods
to compute FDRs that are computed by considering replicate measurements, e.g. by using t
statistics [Mukherjee et al., 2009] or moderated t statistics [Hendrickson et al., 2008], and assess
the reproducibility of the enrichment. Thus, the FDR as computed by our method represents
an additional property of a set of genes that is hidden in the data and can be uncovered by
specialized analysis methods. Furthermore, as indicated above, an experiment may also yield
additional data about entities that were not originally intended to be measured by the assay’s
design. For instance, the goal of small RNA-seq experiments is to profile the expression of a
certain kind of ncRNAs, namely microRNAs (see below). However, in such an experiment, not
only microRNAs are sequenced, but a variety of other known and unknown ncRNAs or ncRNA
fragments. Usually, these are discarded and excluded from further analysis. However, we have
shown that relative positions and lengths of these fragments provide information for the important
task of classification of ncRNAs [Erhard and Zimmer, 2010], which is described in chapter 3.
Fourth, even if information has been extracted from the experimental data properly, i.e. if proper
per-entity values are available, specialized downstream analysis methods may be necessary to
answer specialized biological questions. For instance, alternative splicing is one of the key
contributors to the diversity of gene products observed for most multi-cellular organisms [Wang
and Burge, 2008]. Importantly, the alternative splicing pattern may be highly diverse across
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different conditions such as cell types and finding differentially spliced genes is therefore a
hot topic in current RNA-seq research [Richard et al., 2010; Trapnell et al., 2013]. However,
differential splicing of mRNAs only has functional impact if the corresponding transcripts are
translated into proteins. Therefore, we sought to identify differential splicing on protein level
using stable isotope labelling of amino acids in cell culture (SILAC) based high-throughput
liquid chromatography tandem mass spectrometry (LC-MS/MS) data. In comparison to RNA-
seq data, LC-MS/MS data is more sparse, i.e. there are usually only few peptides measured per
transcript in comparison to transcripts that are often fully covered by sequencing reads. Thus, we
investigated, how and to what extent LC-MS/MS data can nevertheless be used to reliably find
cases of differentially spliced genes [Erhard and Zimmer, 2012], which is described in chapter 7.
Fifth, the variety of available omics experiments leads to a growing demand of methods to
integrate different datasets, which is not a trivial task. For instance, in such experiments, distinct
entities may be primarily measured: While most microarrays measure expression of genes by
using probesets directed against 3’-untranslated regions (UTRs) (that are often common to all
transcript isoforms), RNA-seq can be used to directly measure transcript abundances, CLIP-
seq identifies binding sites and SILAC based LC-MS/MS measures fold changes of peptides.
It is of great importance to integrate all these measurements properly for many reasons. For
instance, since high-throughput experiments are affected by noise, i.e. random measurement
errors, and bias, i.e. a systematic deviation from the truth, interpretations based on such
data must be validated. This is often done by targeted experiments that are more reliable
but not applicable in large-scale, or, alternatively, by additional independent high-throughput
experiments. In some cases, considering additional high-throughput experiments may be the
better choice to confirm interpretations: In chapter 6 I present our analysis of the widespread
context-dependence of microRNA-mediated regulation. This context-dependence has already
been shown for few examples by using targeted experiments. However, without large-scale
experiments, it is impossible to judge whether these are rare exceptions or if context-dependence
is a general feature of microRNA-mediated regulation. Thus, we integrated multiple datasets to
confirm this hypothesis of widespread context-dependence of microRNA-mediated regulation
[Erhard et al., 2013c], namely RIP-Chip experiments of the microRNA containing RNA induced
silencing complex (RISC), AGO-PAR-CLIP, microarray experiments for mRNA steady-state
levels and half-lives based on metabolic labeling and SILAC based LC-MS/MS experiments
for protein expression levels.
Finally, as indicated above, simple overrepresentation analysis of the set of differentially
expressed genes among predefined gene sets [Breitling et al., 2004] or gene set enrichment
analysis on continuous data such as all fold changes of mRNAs [Subramanian et al., 2005] may
provide a first handle to interpret the information from a high-throughput experiment. However,
they fall far too short for a mechanistic understanding of processes or a whole system. Therefore,
a widely used approach in computational systems biology is to model a biological system as
a network or graph: For instance, the interplay between all contributors of gene regulation is
commonly called gene regulatory network (GRN). Here, each node of the network represents
a certain gene and a node A is connected to a node B, if the gene product of A regulates the
expression of B. If detailed information, e.g. coming from multiple high-throughput datasets,
is available about a system, such a network-based model can be simulated [Jaeger et al., 2004;
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Segal et al., 2008; Erhard, 2008]. Hence, a valid model should be able to explain or reproduce the
data of the system. In my diploma thesis [Erhard, 2008], I started the development of PNMA, the
Petri net modeling application, which is a comprehensive modeling tool for systems biology. In
chapter 8, I describe a further development of PNMA, the integration of methods for stochastic
simulation (FERN, Erhard et al. [2008]).
1.2 MicroRNAs
Only in recent years, it has become apparent that gene regulation is not only carried out by
transcription factors (TFs), i.e. during transcription, but that there is also another regulatory layer
that controls expression levels of genes post-transcriptionally. MicroRNAs (often also referred to
as miRNAs or miRs) are small, 20-24 nt long RNA molecules that have emerged as important
mediators of post-transcriptional gene regulation [Bartel, 2004; He and Hannon, 2004; Bartel,
2009; Ghildiyal and Zamore, 2009; Pasquinelli, 2012]. They can be found in all kingdoms of
life, most prominently in metazoans [Pasquinelli et al., 2000; Wheeler et al., 2009] and in plants
[Jones-Rhoades et al., 2006], but also in viruses [Kincaid and Sullivan, 2012] and bacteria [Zhao
et al., 2007]. Additionally, microRNA like molecules have also been identified in fungi [Lee
et al., 2010].
1.2.1 Discovery of microRNAs in C. elegans
More than 20 years ago, a genetic screen identified a genetic locus called lin-4 that takes part
in the control of larval development in the nematode Caenorhabditis elegans. Loss-of-function
of lin-4 leads to abnormal development due to early regulatory programs repeating themselves
in later stages of development [Ambros, 1989]. At that time, it was a major surprise that this
genetic locus did not encode a protein but gave rise to two small RNA molecules that are
partly complementary to multiple sites in the 3’-UTR of lin-14, another gene implicated in
developmental processes. These RNAs are conserved in multiple nematode species and they
were shown to decrease LIN-14 protein levels without affecting mRNA levels [Lee et al., 1993;
Wightman et al., 1993].
First, this was not believed to be a widespread mechanism [Bartel, 2004], but years later, let7,
another ncRNA implicated in developmental processes of C. elegans was found to be conserved
throughout the metazoan clade [Pasquinelli et al., 2000]. Up until now, hundreds of these
ncRNAs, which were later termed microRNAs, were cloned and sequenced [Lagos-Quintana
et al., 2001; Landgraf et al., 2007]. Due to the advent of NGS, microRNAs can now be sequenced
on large-scale and NGS is commonly applied to discover new microRNAs and to profile their
expression levels in various cell-types and conditions [Berezikov et al., 2006; Morin et al., 2008;
Witten et al., 2010]. In particular, the centralized microRNA repository miRBase [Griffiths-
Jones, 2004], version 19, lists 25,141 mature microRNAs from 193 species, for instance 370
in C. elegans, 422 in the fruit fly Drosophila melanogaster, 1,281 in mouse and 2,042 in human.
Almost at the same time, a cellular mechanism called RNA interference (RNAi) was discovered
in C.elegans [Fire et al., 1998]. The uptake of exogenous double-stranded RNA molecules leads
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to a knock-down of complementary mRNAs. This gene silencing is mediated by another class
of ncRNAs called siRNAs. The discovery of RNAi lead to the development of potent research
tools also for mammalian cell lines [Elbashir et al., 2001] and was awarded a nobel price in 2006.
Later, it became clear that siRNAs and microRNAs share large parts of their maturation pathway
as well as their effector complex called RISC [Bartel, 2004; Kim et al., 2009b].
1.2.2 MicroRNA biogenesis
Canonical mammalian microRNAs are transcribed by RNA polymerase II, often as clusters of
many microRNAs on the same primary transcript. After transcription, short hairpin structures
called pre-microRNAs of∼ 65 nt length are cleaved out of the primary transcript by the RNase III
Drosha, which are subsequently tranported out of the nucleus by the nuclear export factor
exportin 5. In a second processing step, the hairpin loop is cleaved from the pre-microRNA
by another RNase III, Dicer, which is in complex with Argonaute (AGO). Finally, one strand
of the remaining duplex, the mature microRNA, resides on AGO1-4 and the RNA induced
silencing complex (RISC) is assembled, whereas the other strand is rapidly degraded (reviewed
in Bartel [2004]; Kim et al. [2009b]). This canonical biogenesis pathway is widely conserved
and orthologs of Drosha,Dicer and AGO can be found in mouse, flies and nematodes.
Intriguingly, there are many alternative roads that can be taken by microRNAs: Most promi-
nently, many microRNAs are not transcribed from their own primary transcripts but are located
in introns of protein coding mRNAs. The processing of these so-called mirtrons may be very
similar to canonical microRNAs, i.e. Drosha cleaves before or after splicing is complete and
the hairpin enters the canonical pathway. Alternatively, mirtrons may mature without Dicer:
The spliceosome may directly produce pre-microRNAs, or additional nucleotides upstream or
downstream of the hairpin may be trimmed by 5’ or 3’ exonucleases [Kim et al., 2009b; Ruby
et al., 2007; Ladewig et al., 2012].
Moreover, various other alternatives of the canonical pathway have been identified including
microRNAs that circumvent Drosha and/or Dicer processing by utilizing tRNaseZ [Bogerd et al.,
2010], the integrator complex [Cazalla et al., 2011] or AGO [Cheloufi et al., 2010; Yang et al.,
2010; Cifuentes et al., 2010] or microRNAs that are derived from other ncRNAs such as tRNAs
[Haussecker et al., 2010] or snoRNAs [Ender et al., 2008; Taft et al., 2009].
In addition to microRNAs, several other ncRNAs have been identified and implicated in
regulation, most prominently piRNAs and endo-siRNAs that share parts of the microRNA
biogenesis pathway or are similar in their regulatory mechanisms [Ghildiyal and Zamore, 2009;
Kim et al., 2009b].
1.2.3 Regulatory mechanisms of microRNAs
As indicated above, microRNAs are important contributors to post-transcriptional regulation.
The canonical model of microRNA action is that microRNAs recognize binding sites in the
3’-UTR of a target mRNA by the so-called seed (microRNA bases 2-7 or 2-8), and RISC,
which is associated with the microRNA, then downregulates protein expression by inhibiting
translation or inducing mRNA degradation [Bartel, 2009]. The notion of a microRNA seed
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was first postulated by results from high-throughput experiments, where mRNA expression
was meausured differentially for cells overexpressing a certain microRNA as compared to
control cells lacking this microRNA using microarrays [Lim et al., 2005; Grimson et al., 2007].
The importance of the seed was later corrobated by high-resolution three-dimensional crystal
structures of AGO microRNA complexes, which showed that the seed bases are solvent exposed
in contrast to the other microRNA bases [Schirle and MacRae, 2012].
However, the existence of a seed site within a 3’-UTR, i.e. a sequence that is reverse
complementary to a microRNA seed, is neither sufficient nor necessary for target recognition:
If every hexamer seed site, i.e. complementary to bases 2-7 of a microRNA, could indeed be
targeted by a microRNA, then a microRNA would have target sites about every 4 kilobases (kb)
by chance or in about every fourth transcript (assuming a mean 3’-UTR length of 1000 nt).
Moreover, since there are about 1,300 distinct human seeds annotated in miRBase version 19
[Griffiths-Jones, 2004], every 3’-UTR would be fully covered by seed sites by expectation.
This is not the case and there are several lines of evidence suggesting that additional factors
such as target site location [Grimson et al., 2007], additional basepairing at the microRNA
3’ end [Brennecke et al., 2005], target site accessibility [Kertesz et al., 2007] or other factors
such as RNA binding proteins [Jacobsen et al., 2010] or microRNA and mRNA copy numbers
[Ben-Moshe et al., 2012] play important roles in distinguishing functional target sites from non-
functional seed sites. In addition, not even the most general seed site (microRNA positions 2-7) is
necessary for seed binding: It has been shown that GU wobbles within the seed-seed site duplex
may not necessarily destroy efficient regulation [Didiano and Hobert, 2006] and that microRNA
target recognition may also be mediated by other parts of the microRNA than the canonical seed
and lead to target downregulation [Shin et al., 2010]. Furthermore, this canonical model is also
challenged from another direction by recent studies, since not only 3’-UTR sites seem lead to
efficient regulation, but also sites located in protein coding sequences [Tay et al., 2008; Duursma
et al., 2008; Reczko et al., 2012; Hausser et al., 2013].
The canonical model introduced above dictates that target protein expression is downregulated
upon binding of the microRNA. Various mechanistic explanations for this downregulation have
been proposed, including endonucleolytic cleavage (slicing) by AGO2, deadenylation and/or
decapping followed by rapid mRNA degradation, deadenylation leading to diminished mRNA
circularization, inhibition of translation initiation or elongation, co-translational degradation of
the growing peptide chain or sequestering the target mRNA to P-bodies (reviewed in Eulalio et al.
[2008]; Pasquinelli [2012]). Some of these modes of action have been challenged [Kozak, 2008],
and even if unifying models have been proposed [Djuranovic et al., 2011], recent large-scale
studies still report varying estimates about the relative importance of the various mechanisms
[Guo et al., 2010; Djuranovic et al., 2012; Bazzini et al., 2012; Mishima et al., 2012]. To make
things even more complicated, there is increasing evidence that microRNAs are not only able
to downregulate their targets but also that they may lead to an upregulation either directly or
indirectly (reviewed in Vasudevan [2012]).
Another important mechanistic aspect of microRNA-mediated regulation is the magnitude of
the impact on protein levels. Early examples indicated that microRNAs act in a switch-like
manner: For instance, the seminal work on the regulation of LIN-14 by lin-4 showed a complete
abrogation of LIN-14 protein levels in lin-4 wildtype individuals as comparted to lin-4 mutants
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[Lee et al., 1993; Wightman et al., 1993]. Also, another nematode microRNA, lsy-6, has been
shown to be decisive for the cell fate of the receptor neurons ASE left and ASE right [Johnston
and Hobert, 2003]. However, later high-throughput experiments indicated that microRNAs
generally lead to mild but widespread repression of gene expression [Lim et al., 2005; Grimson
et al., 2007; Baek et al., 2008; Selbach et al., 2008]. A recent study revealed that the magnitude
of the effect of microRNAs is dose-dependent ranging from mild repression for highly expressed
genes to a switch-like behavior for mRNAs expressed below a certain threshold [Mukherji et al.,
2011].
1.2.4 Biological function of microRNAs
As indicated above, microRNAs give rise to a whole layer of gene regulation in addition to
transcriptional regulation by TFs. From a functional point of view, microRNAs share many
aspects with TFs: For instance, in both cases there is a many-to-many relationship between
regulator and target genes, i.e. a microRNA as well as a TF usually regulates multiple target
genes and each gene may be regulated by multiple microRNAs as well as TFs. In addition,
the expression of both microRNAs and TFs is thightly regulated itself, givin rise to intricate
regulatory networks [Hobert, 2008].
MicroRNAs have important functions in development. Most prominently, the regulation of
LIN-14 by the microRNA lin-4, which gave rise to the discovery of microRNAs, is essential
for normal larval development in C. elegans [Lee et al., 1993; Wightman et al., 1993] and
regulation of COG-1 by the microRNA lsy-6 determines left/right assymetry of C. elegans
taste receptor neurons [Johnston and Hobert, 2003]. Further examples of such essential roles
of microRNAs in developmental processes can be found in Wienholds and Plasterk [2005].
In addition, high-throughput experiments showed that microRNAs are differentially expressed
during differentiation of embryonic stem cells [Morin et al., 2008] and exhibit tissue specificity
in general [Landgraf et al., 2007; Sayed and Abdellatif, 2011]. Thus, microRNAs are implicated
in the regulatory networks that determine differentiation events and cell fate [Ivey and Srivastava,
2010].
There is also evidence that microRNAs play important roles in evolution, similarly to TFs [Chen
and Rajewsky, 2007]. Some microRNAs show extreme patterns of evolutionary conservation,
e.g. let7 is conserved from human to worm corresponding to an age of more then 600 million
years [Pasquinelli et al., 2000; Wheeler et al., 2009], and microRNA families have been added
to the regulatory repertoire especially of higher organisms without frequent substitutions or
secondary loss [Wheeler et al., 2009]. Importantly, tissue specific expression of those microRNA
families is maintained over evolution [Christodoulou et al., 2010]. Thus, microRNAs may have
essential functions in speciation and may contribute to macro-evolution and the development of
tissues and complex body plans. Intriguingly, the diversity of microRNAs in the human brain
as compared to our closest evolutionary relatives, chimpanzees, suggests that they may even
have contributed to the evolutionary development of higher brain functions found in humans
[Berezikov et al., 2006].
Another functional aspect of microRNAs concerns disease: In an overwhelming amount of
studies it has been shown that microRNA related alterations are associated with diverse types of
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cancer (e.g. reviewed in Farazi et al. [2011]). Interestingly, different cancer types show different
and specific expression patterns of microRNAs, and, thus, microRNAs are promising candidates
for prognostic and diagnostic markers for cancer [Calin and Croce, 2006; Witten et al., 2010;
Farazi et al., 2011].
Furthermore, the initial hypothesis for the main function of RNAi was defence against viral
infection [Jeang, 2012]. This has been confirmed in plants,insects and nematodes, but evidence
in mammals is still lacking [Kincaid and Sullivan, 2012]. Intriguingly, viruses also exploit
the RNAi machinery for pro-viral purposes, either by regulating host microRNAs or encoding
their own microRNAs [Kincaid and Sullivan, 2012]. Since the discovery of microRNAs in
Epstein-Barr virus (EBV), a human herpes virus, by Pfeffer et al. [2004], microRNAs have been
identified in the genomes of various viruses, where the herpes viruses comprise the class with
the highest number of known microRNAs. Similarly to the mimicry of host proteins by several
viral proteins, there are a few microRNAs that share seed sequences with host microRNAs, but
most viral microRNAs do now show homology to any host microRNA [Kincaid and Sullivan,
2012]. Functional understanding of viral microRNA function is still lacking, but the few existing
examples indicate functions in preventing apoptosis, immune evasion and regulation of viral
genes [Kincaid and Sullivan, 2012].
1.2.5 Bioinformatics for microRNAs
Computational approaches related to microRNA biology can be grouped into two categories
[Mendes et al., 2009]: microRNA gene identifiation and microRNA target identification.
For the identification of microRNA genes, i.e. loci on the genome that give rise to functional
mature microRNAs, mainly three criteria have been used, often combined and using machine
learning (reviewed in Mendes et al. [2009]). First, since known pre-microRNAs exhibit a
characteristic secondary structure, i.e. a hairpin of ∼ 65 nt, secondary structure predictions or
features derived from the minimal free energy structure such as number and size of internal loops
or the free energy have been shown to be potent characteristics for microRNA gene finding. Later,
a mechanistic explanation for the necessity of the hairpin structure has been found, since both the
microprocessor complex and Dicer have structural requirements for their substrates [Han et al.,
2006; MacRae et al., 2007]. Specifically, the microprocessor complex can only cleavae hairpin
loops of a certain length and internal loop composition and Dicer recognizes specific double
stranded structures. Second, many microRNAs are broadly conserved [Pasquinelli et al., 2000;
Wheeler et al., 2009] and highly specific conservation patterns across the precursor hairpin have
been found [Stark et al., 2007]. Consequently, evolutionary conservation of hairpin structures
have been shown to be a potent filter for true microRNA genes [Stark et al., 2007]. And finally,
microRNA obviously have to be expressed to be functional and, consequently, NGS has been
utilized to identify novel microRNAs [Berezikov et al., 2006; Morin et al., 2008; Witten et al.,
2010].
Each of these criteria entails certain shortcomings: As described above, not all microRNAs and
regulatory small RNAs in general are processed by Drosha/Dicer and, thus, a hairpin secondary
structure may not be necessary. Also, not all microRNAs are conserved and evolutionary late
microRNAs are not less interesting than widely conserved ones. Thus, a method to find regulatory
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small RNA without relying on secondary structure or conservation may be of great benefit. In
addition, only a relatively small fraction (one to two third) of typical deep sequencing data of
small RNAs corresponds to microRNA reads [Berezikov et al., 2006; Morin et al., 2008; Witten
et al., 2010] and the function of the remaining part is largely unknown and usually ignored in
analyses. Therefore, we developed ALPS (see chapter 3 and ref. [Erhard and Zimmer, 2010]),
which is a method to classify ncRNAs with respect to similar deep sequencing read patterns.
ALPS can be used to identify unannotated regions in the genome that shows similar read patterns
as microRNAs or other regulatory RNAs without relying on secondary structure predictions or
conservation. Furthermore, it can be used to cluster all expressed ncRNAs according to their read
pattern.
The second category for microRNA related computational approaches is the identification of
microRNA targets. This can either be done by means of prediction, by analyzing experimental
data or combinations thereof. Since the discovery of microRNAs, a plethora of microRNA target
prediction methods has been proposed (e.g. reviewed in refs. [Thomas et al., 2010; Sethupathy
et al., 2006; Ritchie et al., 2009; Mendes et al., 2009]). In principle, prediction methods first
identify a set of possible sites (e.g. by identifying seed sites) and then apply certain filtering
criteria such as target site location [Grimson et al., 2007], additional basepairing at the microRNA
3’ end [Brennecke et al., 2005], target site accessibility [Kertesz et al., 2007] or microRNA and
mRNA copy numbers [Ben-Moshe et al., 2012]. Often, these additional criteria are integrated
into the prediction using machine learning techniques [Betel et al., 2010; Sturm et al., 2010].
However, in general predicted targets of microRNAs are not deemed highly reliable [Ritchie
et al., 2009; Thomas et al., 2010], indicating that important criteria for finding true microRNA
targets are currently still missed.
As a remedy to those unreliable predictions, several experimental high-throughput techniques
have been proposed to discover microRNA targets, either based on expression profiling upon
microRNA overexpression or knock-down [Lim et al., 2005; Grimson et al., 2007; Baek et al.,
2008; Selbach et al., 2008], or based on biochemical isolation of RISC in association with target
transcripts (RIP-Chip/RIP-seq, see refs. Mukherjee et al. [2009]; Hendrickson et al. [2008];
Karginov et al. [2007]; Stoecklin et al. [2008]; Landthaler et al. [2008]) or target sites (AGO-
CLIP, see refs. Chi et al. [2009]; Ko¨nig et al. [2010]; Hafner et al. [2010]). In order to extract
bone-fide target or target sites from such kind of data, computational methods are necessary for
proper analysis. In chapters 5 and 4 I describe methods that I developed to analyze RIP-Chip and
AGO-CLIP data, respectively [Erhard et al., 2013b,a].
Apart from methods that belong to the two categories introduced by Mendes et al. [2009] (see
above), I developed further computational methods that are related to microRNA biology. First,
microRNAs and ncRNAs in general have been implicated in the regulation of alternatively
spliced transcripts. There are examples of indirect regulation of alternative splicing either by
microRNAs targeting splicing factors such as nPTB by miR-133 during muscle development
[Boutz et al., 2007], PTBP1 by miR-124 during brain development [Makeyev et al., 2007]
or CELF proteins by miR-23 during heart development [Kalsotra et al., 2010] or by target
sites located on alternative exons [Tay et al., 2008; Duursma et al., 2008; Yang et al., 2012].
Additionally small RNAs may even be directly contributing to regulation of splicing, e.g. by
blocking splice sites, the branch point or other regulatory elements important for differential
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splicing [Khanna and Stamm, 2010]. Thus, a systems biology approach to analyze differential
spliced genes in large-scale is to examine appropriate high-throughput data for indications of
exons that behave differently than other exons from the same gene in terms of quantification fold
changes. There are several methods already available for RNA-seq data [Richard et al., 2010;
Trapnell et al., 2013], however, ultimately, differential splicing only matters on protein level.
Thus, I investigated, to which extent high-throughput SILAC based mass spectrometry can be
used to infer differential splicing [Erhard and Zimmer, 2012], which is described in chapter 7.
Second, an important aspect of transcriptional regulation is context-dependence: One of the
most striking results from the ENCODE project [Consortium, 2012b] is that the binding of
transcription factors (TFs) does not only depend on the presence of the TF, but also on other,
context-dependent factors and that this is a general feature of TFs-mediated regulation [Thurman
et al., 2012; Neph et al., 2012b]. Context-dependent regulation leads to a complex rewiring of the
cells regulatory network dependent on the context [Gerstein et al., 2012]. Whether or not context-
dependence is also a general feature of post-transcriptional regulation mediated by microRNAs
has not been investigated so far in large-scale. Thus, I integrated several high-throughput datasets
measured for the same system and found strong evidence for a widespread context-dependence
of microRNA-mediated gene regulation (see chapter 6 and ref. Erhard et al. [2013c]).
Finally, the ultimate goal in systems biology is a predictive understanding of a whole system.
This predictive understanding can be achieved if a detailed model of a system can be constructed,
which is able to accurately predict its behavior. Such a model is often based on a network or graph
and predictions are made by means of simulation. Two components must be established for the
simulation of such a network involving microRNA-mediated regulation: a mathematical model
that desribes the regulatory mechanisms of microRNAs and the network itself including the
information which microRNAs target which mRNAs and parameter values for the mathematical
model. Since mechanistic aspects of microRNA-mediated regulation is still under heavy debate
[Djuranovic et al., 2011; Eulalio et al., 2008; Guo et al., 2010; Kozak, 2008; Mishima et al.,
2012], mathematically modeling these meachanisms is still in ifs infancy although a few attempts
have already been made [Khanin and Vinciotti, 2008; Morozova et al., 2012; Eduati et al., 2012].
However, due to various high-throughput methods that are now commonly applied in microRNA
research, a multitude of target information and parameter values will be readily available in the
near future. Bioinformatic tools will be necessary to cope with all these data and to be able to
establish useful models for microRNA-mediated regulation. Thus, already in my Diploma thesis,
I started the development of PNMA, a comprehensive modeling platform that is based on a
general graph based model, Petri Nets [Murata, 1989], and is highly flexible in the mathematical
model that is used for simulation: In my diploma thesis, I integrated Fuzzy logic into PNMA
to describe the mathematics for interactions, which is beneficial when only rough knowledge
is available about the simulation parameters. However, when more detailed data is available,
more detailed simulations are possible. Therefore, I integrated FERN [Erhard et al., 2008] into
PNMA, which is a framework for stochastic simulation of mass action kinetics. This is described
in chapter 8.
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1.3 Herpes viruses
Herpes viruses are double-stranded DNA viruses that are extremely widespread among the
human population and other mammals. There are several species that can infect a wide range of
host organisms. They have in common a relatively large linear genome of 124-230 kb and their
characteristic hallmark is their ability for life-long persistence in a latent form. Usually herpes
viruses do not cause life-threatening diseases but some species may contribute to cancerogenesis
in immune suppressed patients [Knipe et al., 2007].
Mature herpesvirus virions vary in size from 120 to as much as 260 nm. The virions are composed
of the core containing the genome, an icosahedric capsid built of viral proteins, the tegument
containing several viral proteins and an envelope with up to 1000 glycoproteins [Knipe et al.,
2007]. According to the NCBI taxonomy database (accessed 15.2.2013), 51 genomes from the
family herpesviridae are sequenced, including all eight known human herpes viruses. Herpes
virus genomes contain 70-200 protein coding genes, of which 40 core genes are conserved across
the whole family. Most viral genes do not contain any introns, overlapping genes are common
within the genomes and many proteins are multifunctional. Their associated functions include
DNA replication, packaging of viral genomes, viral replication, immune evasion, establishment
of latency [Knipe et al., 2007].
Importantly, all herpes viruses excluding Varicella-Zoster Virus (VZV) [Umbach et al., 2009]
encode a set of microRNAs. In contrast to viral proteins, with a few exceptions, viral microRNAs
are not conserved across species but are believed to fulfill similar purposes [Kincaid and Sullivan,
2012].
1.3.1 Phylogeny
Based on their protein sequences 702 herpes viruses are classified into the order herpesvirales
according to the NCBI taxonomy database (accessed 15.2.2013, see Figure 1.2). The order
comprises three families, herpesviridae that includes mammalian, avian and reptilian viruses,
alloherpesviridae including fish and amphibian viruses and malacoherpesviridae that consists of
a single herpes virus infecting a certain oyster species [Davison et al., 2009].
There is no protein conserved within the order herpesvirales that is not also found in other viruses
apart from herpes viruses [Davison et al., 2009], but 40 genes are conserved within the family
herpesviridae. In addition, the genomic organization is highly conserved. Thus, it is believed that
there was a common ancestor of those herpes viruses that already contained ancestral variants of
those 40 genes [Knipe et al., 2007].
The family herpesviridae consists of three subfamilies, the alpha-, beta- and gammaher-
pesvirinae. Generally, alphaherpesvirinae are neurotropic and have relatively short reproductive
cycles, whereas betaherpesvirinae have a broad range of host cells and slow reproduction. The
gammaherpesvirinae mainly infect lymphocytes. Each subfamily is further split into several
genera, each of which consists of several herpes virus species. Human specific herpes viruses
can be found in all three subfamilies: Herpes Simplex virus 1 (HSV1) and Herpes Simplex
virus 2 (HSV2) belong to the alphaherpesvirinae together with VZV. The betaherpesvirinae
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Figure 1.2: Phylogeny of herpes viruses. All herpes viruses are classified into the order her-
pesvirales. The family herpesviridae contains all mammalian herpes viruses, alloherpesviridae
include fish and amphibian viruses (omitted here) and malacoherpesviridae consist of a single
virus infecting oysters. The subfamilies are further subdivided into genera which are also omitted
here. Only the human herpes viruses are included.
include the Human Cytomegalovirus (HCMV) and Human Herpes viruses 6 and 7. The
human gammaherpesvirinae are EBV and Kaposi’s Sarcoma-associated Herpesvirus (KSHV).
Many of those have close relatives that infect other mammalian species, for instance Murine
Cytomegalovirus (MCMV), which is closely related to HCMV, infects mice and also belongs
to the betaherpesvirinae. Between HCMV and MCMV, 70 proteins are conserved [Knipe et al.,
2007].
1.3.2 Life cycle, symptoms and prevalence
As indicated above, herpes viruses are characterized by two modes of infection: In latency, the
viral genome remains in circular form in the nucleus of the host cell, where only a small subset
of genes including microRNAs is expressed. It is able to reactivate, often upon cellular stress and
to transition into a lytic phase, where the virus replicates DNA and creates its structural proteins.
Mature virions are then assembled in the cytoplasm until the host cell bursts,thereby releasing
the viral progeny [Knipe et al., 2007].
Thus, herpes viruses are able to cause life-long infections in general. Some species cause certain
clinical symptoms upon primary infection, e.g. VZV causes chickenpox upon infection during
childhood and often shingles upon infection of adults. Other herpes viruses cause frequently
recurring symptoms such as cold sores by HSV1. Infection by other herpes virus species may
also stay completely unnoticed, e.g. typically for HCMV. In immunosupressed patients, however,
herpes viruses are associated with cancer.
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Due to their effective strategy of latent infections, herpes viruses have relatively high prevalence
in the human population in general. For instance, ˜80% of the human population is infected
with HSV1 and more than 90% are infected with EBV, which is relatively uniform across
demographic parameters such as sex, ethnicity or prosperity. KSHV, which is often occurring
in AIDS patients and not only associated with its namesake Kaposi’s sarcoma but also with
primary effusion lymphoma and Castleman’s disease, occurs in less then 5% in Northern america
and europe but has a prevalence of more than 90% in africa.
1.3.3 Viral microRNAs
An intriguing feature of most herpes viruses is that they encode not only protein coding genes on
their genome but also microRNAs [Pfeffer et al., 2004; Kincaid and Sullivan, 2012]. In general,
they are highly conserved across strains from the same viral species but interestingly not between
different species [Cullen, 2010; Kincaid and Sullivan, 2012]. There are notable exceptions for
closely related herpes viruses, e.g. 22 of the 25 EBV microRNAs are conserved in the related
Rhesus monkey Lymphocryptovirus (rLCV), but none of the known human specific herpes virus
microRNAs is conserved in any other human specific virus. Importantly, this is in sharp contrast
to several widely conserved herpes viral core proteins. Interestingly, even though microRNAs
are not conserved by their sequence, their genomic localization is similar among most herpes
viruses, which indicates that a common ancestor may already have encoded microRNAs. Thus,
microRNAs may be a causative agent for viral speciation [Kincaid and Sullivan, 2012].
Most of the human herpes viruses encode dozens of microRNAs (see Table 1.1), with the
exception of VZV [Umbach et al., 2009]. An explanation for the lack of microRNAs in VZV
is still missing. It is possible, although unlikely, that the expression levels of existing VZV
microRNAs is below the detection limit of the sequencing experiments of Umbach et al. [2009],
but it it could also be that VZV microRNAs are only expressed during lytic infection, which is
difficult to establish in cell culture [Umbach et al., 2009].
Functions of viral microRNAs are largely unknown, but they participate in immune evasion,
avoidance of apoptosis and maintenance of latency [Cullen, 2006, 2010; Kincaid and Sullivan,
2012]. For instance, even if respective microRNAs are not homologous, three different human
herpes viruses (HCMV,EBV and KSHV) have been shown to target the pro-apoptotic host gene
BclAF1 [Kincaid and Sullivan, 2012]. Utilizing microRNAs instead of TFs for regulation may
be highly beneficial for the virus: In contrast to proteins, microRNAs are invisible to the immune
surveillance system [Cullen, 2006, 2010].
In addition to microRNAs encoded on their own genome, herpes viruses may also exploit host
microRNAs for their purposes. For instance, in EBV infected cell lines, the human microRNA
hsa-miR-155, which is implicated in cellular processes such as apoptosis and proliferation, is
highly induced [Speck and Ganem, 2010; Cullen, 2010]. Intriguingly, while the related gamma
herpes virus KSHV does not induce hsa-miR-155 expression upon infection, its kshv-miR-K12-
11 is a so-called seed homologue of this host microRNA, i.e. it shares the same seed sequence
and should thus recognize similar targets.
Due to their only relatively recent discovery, there are many open questions regarding herpes-
viral microRNAs, as indicated above. These include, but are not limited to, which microRNAs
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Table 1.1: Experimentally discovered microRNAs of human
herpes viruses (according to miRBase [Griffiths-Jones, 2004]
version 19).
Virus Family pre-microRNAs mature microRNAs
HSV1 α 17 26
HSV2 α 18 24
VZV α 0 0
HCMV β 11 17
HH6 β 4 8
HH7 1 β - -
KSHV 2 γ 13 25
EBV γ 25 44
1 No experimental data is available for Human herpesvirus 7, in
contrast to VZV, where several cell lines where considered but no
microRNA was found
2 Often, only 12 KSHV pre-microRNAs are accounted for, since kshv-
miR-K12-10a and kshv-miR-K12-10b are highly similar.
are encoded by herpes viruses and when are they expressed; what are the targets of those
microRNAs and of dysregulated host microRNAs; and what is the biological function of
these microRNA/target interactions. The purpose of our project Pathogenic role of miRNAs in
herpesvirus infection, which has been funded by the German Bundesministerium fu¨r Bildung
und Forschung in the context of the NGFN-plus programme, is to approach these questions
with a combination of high-throughput methods, bioinformatics and wet-lab validation. In the
context of this project, diverse high-throughput datasets have been generated by our collaboration
partners, and the herein presented method have been developed to answer specific questions
using these high-throughput datasets. In the next chapter, I will give a short overview about the
experiments that have been performed and indicate how the methods were applied to answer
specific questions.
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Chapter 2
Datasets
2.1 Primer on experimental techniques
Omics experiment rely on high-throughput technologies to produce massive amounts of data that
are relevant for the biological system under consideration. The most widely used high-throughput
technologies, which were also used in the context of our NGFN project, are DNA microarrays,
NGS and mass spectrometry. Depending on the nature of the samples that are subjected to one
of those technologies, various kinds of data can be obtained. For instance, NGS has heavily
contributed to the success of the ENCODE project [Consortium, 2012b] and allowed to produce
genome-wide data for multiple cell lines of DNase hypersensitive sites [Thurman et al., 2012], of
footprints of DNA binding proteins [Neph et al., 2012b], of transcription start sites and full length
transcripts of protein coding genes and ncRNAs [Djebali et al., 2012], of chromatin modification
sites [Arvey et al., 2012], binding sites of specific TFs [Landt et al., 2012] and many more
[Consortium, 2012b].
2.1.1 Microarrays, metabolic labeling and RIP-Chip
Before NGS became available, DNA microarrays (also called DNA chips) were the method-
of-choice, when the identity and quantity of DNA or RNA molecules had to be determined. In
principle, a DNA microarray consists of a huge amount of DNA probes immobilized on a solid
surface, where each of the probes is designed to be reverse complementary to a specific known
DNA sequence. For instance, the GeneChip Human Exon ST Array from Affymetrix contain
more than 5.5 Million probes directed against more than 1 Million exons or putative exons. In the
basic experimental protocol, first DNA or RNA is isolated from the sample, followed by cDNA
synthesis (only for RNA). The DNA is labeled using fluorescence dyes and then hybridized to
the microarray. After washing, the microarray is scanned by a laser, in essence producing a large
table containing fluorescence intensity information for each probe as the data output [Miller
and Tang, 2009]. The probe determines the identity of the DNA or RNA fragment, whereas its
fluorescence signal intensity corresponds to the fragment’s abundance in the sample. Introduced
by Schena et al. [1995], the number of publications that are based on microarray data exploded
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in the years after and is further growing [Miller and Tang, 2009]. It is widely applied to profile
expression levels of mRNAs in various conditions [Eisen et al., 1998] and for SNP or CNV
detection in individual genomes [Gresham et al., 2008; Miller and Tang, 2009].
By using several modifications or different sample preparation techniques, microarrays can also
be used to measure additional kinds of data. For instance, by metabolically labeling newly
transcribed RNA by the uridine analogue 4sU, it is possible to biochemically separate newly
transcribed from preexisting RNA [Do¨lken et al., 2008]. These RNA fractions, as well as total
RNA can be measured using microarrays, which allows to simultaneously study RNA synthesis
and decay. The absolute RNA half-life can be computed either by considering the ratio of
preexisting to total RNA or the ratio of newly transcribed to total RNA [Do¨lken et al., 2008]
by
t1/2 = −t ln 2/ ln
At
A0
(2.1)
= −t ln 2/
(
1− ln
A∗t
A0
)
(2.2)
Here, A0 is the measured amount of total RNA, At and A∗t the amount of preexisting and newly
transcribed RNA after labeling for time t. The RNA half-life is closely related to the RNA
decay rate λ = ln 2/t1/2 and, thus, an extremely interesting parameter in microRNA related
research. Consequently, I considered microarray measurements obtained after metabolic labeling
to investigate whether context-dependent microRNA/target interactions have context-dependent
influence on RNA decay rates (see Erhard et al. [2013c] and chapter 6).
Another application of microarrays is RIP-Chip [Mukherjee et al., 2009; Hendrickson et al.,
2008; Karginov et al., 2007; Stoecklin et al., 2008; Landthaler et al., 2008; Do¨lken et al., 2010].
Here, in the sample preparation, RNA binding proteins (RBPs) are immunoprecipitated using
specific antibodies and co-immunoprecipitated RNA is purified. As a control, this is repeated
using an unspecific antibody or total RNA is used. Then, both fractions are measured on
microarrays. For each gene, an enrichment value can then be computed:
e =
As
Ac
(2.3)
As is the amount of RNA in the specific IP fraction, whereas Ac is the amount of control RNA.
In generial, binding partners of the RBP have high enrichment values and mRNAs that is not
bound by the RBP should have low enrichment values. Furthermore, these enrichment values are
quantitative: Higher values indicate, that an mRNA is a stronger target of the RBP, i.e. a large
fraction of all expressed mRNAs is bound by the RBP. However, it is not straight-forward to
decide on a cutoff on these enrichment values to define a set of reliable targets. Furthermore, the
IP in the sample preparation does not always work with the same efficiency, which introduces
bias not existing in standard microarray experiments. Both, the decision of a meaningful cutoff
and proper normalization acounting for this bias in described in Erhard et al. [2013b] and is topic
of chapter 5.
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Importantly, the effector complex of microRNA-mediated regulation, a constituent part of the
RNA induced silencing complex (RISC) is an AGO protein, for which antibodies are available.
Thus, RIP-Chip can also be used to determine microRNA targets. As a consequence, I also
considered RIP-Chip measurements of RISC to investigate context-dependent microRNA/target
interactions (see Erhard et al. [2013c] and chapter 6).
2.1.2 Sequencing, sRNA-seq and PAR-CLIP
In recent years, NGS has started to outstrip microarrays. The major disadvantage of microarrays
is that the sequence of all RNAs or DNAs to be interogated must be known beforehand, and
the millions of probes on a current microarray are still far away from fully covering a complex
mammalian genome and transcriptome. Sequencing in general is the process of determining the
sequence of DNA (or RNA). The first generation of sequencers was based on the technology
developed by Sanger and Coulson [1975] and was for instance used to determine the full
sequence of several genomes including the human genome [Lander et al., 2001; Venter et al.,
2001]. Several technologies are counted among the next generation of sequencers that emerged
in the last decade (e.g. review by Fuller et al. [2009]; Mardis [2008]; Ozsolak and Milos [2011]).
In comparison to microarrays, in NGS experiments, the identity of DNA fragments is not
determined by their hybridization to complementary probes but by directly determining their
sequences and the abundance is not quantified by the fluorescence intensity of the labeling dye
but by counting the number of observed sequences. Thus, the typical data output of an NGS
experiment is a huge file containing millions of sequences, often acompanied by per-base quality
scores. For instance, the four libraries of our PAR-CLIP experiment (see below) were sequenced
using a single lane on a Illumina Genome Analyzer IIx and yielded 120 million sequencing reads,
each 50 base pairs long.
One specific omics experiment that is based on NGS is short RNA profiling [Pritchard et al.,
2012]. Here, short RNAs, i.e. of length about 20-24 nt are specifically selected from cell lysates
using gel purification and subjected to NGS. Such datasets can be used for the discovery of novel
microRNAs [Berezikov et al., 2006; Morin et al., 2008; Friedlander et al., 2008] and to profile the
expression levels of all known microRNAs [Calin and Croce, 2006; Witten et al., 2010; Farazi
et al., 2011]. As we and others have noticed, however, there are not only microRNAs that are
sequenced, but also many other ncRNAs [Erhard and Zimmer, 2010; Langenberger et al., 2012].
In particular, I developed a method that allows to compare and classify ncRNAs with respect to
their pattern of sequencing reads from the NGS experiment, which is described in chapter 3.
NGS is not only about to replace microarrays in standard experiments such as expression
profiling of mRNAs or short RNAs, but also the above mentioned microarray based assays
have been adapted to use NGS instead, for instance to determine mRNA half lifes [Windhager
et al., 2012; Rabani et al., 2011] or binding partners of RBPs [Zhao et al., 2010]. However, NGS
has capabilities that exceed those of microarrays. In particular, by using sequencing, it is not
only possible to identify target genes of RBPs, but also to determine the specific target sites
with basepair resolution. This is done by so-called crosslinking and immunoprecipitation (CLIP)
experiments [Chi et al., 2009; Ko¨nig et al., 2010; Hafner et al., 2010]: Irradition of cells using
UV light with a specific wavelength crosslinks proteins to RNA, i.e. covalent bonds between
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RNA bases and amino acids are formed. Then, the RNA is digested enzymatically such that
a small footprint of a few dozen nt remains crosslinked to all RBPs. The RBP of interest is
then isolated using IP and the protein is digested. Thus, footprints of the RBP remain, which
correspond to binding sites and are sequenced using NGS. Importantly, due to these crosslinks,
the efficiency of co-immunopurifying target sites is much higher than without crosslinking in
RIP-Chip. Unfortunately, there is also a counteracting aspect in most CLIP protocols, since
the cDNA synthesis, which is necessary before NGS, is hindered by amino acid residues still
crosslinked to the RNA. One of the specific CLIP protocols, iCLIP [Ko¨nig et al., 2010] has a
very promising solution for this issue: Only a single reverse transcription primer is used and
cDNA synthesis stops at the crosslinking site. This end is then ligated to the other end of the
primer, i.e. the cDNA is circularized. Then, the circular cDNA is cut within the primer yielding
a single-stranded, linear DNA molecule suitable for PCR and sequencing.
Another recent modification of CLIP is Photoactivatable-Ribonucleoside-Enhanced Crosslinking
and Immunoprecipitation (PAR-CLIP), which has been used by various groups to identify
microRNA binding sites [Hafner et al., 2010; Gottwein et al., 2011; Lipchina et al., 2011;
Kishore et al., 2011; Skalsky et al., 2012]. For PAR-CLIP, cells are labeled using 4sU, which
is specifically and efficiently crosslinked at a different wavelength than used in the original CLIP
protocol. Specifically means that effectively only incorporated 4sU and not other nucleosides get
crosslinked, and efficiently means that cells can be irradiated using less energy than in normal
CLIP experiments. Importantly, crosslinked 4sU is not read as uridine during cDNA synthesis
but as cytidine. Thus, after aligning sequencing reads to the reference sequence (genome or
transcriptome), characteristic T to C mismatches can be observed in true binding sites. These
mismatches constitute a powerful feature to identify true binding sites [Corcoran et al., 2011;
Erhard et al., 2013a]. In addition to the identification of true binding sites, for AGO-PAR-
CLIP experiments there is another important task in the data analysis: Determine the specific
microRNAs that binds to each of the identified target sites. For this task, these conversions can
also be exploited (in addition to other features of PAR-CLIP data), since conversions occur at
specific positions relative to the microRNA seed site [Erhard et al., 2013a]. How these feature
can be utilized to accurately identify true binding sites and the correct microRNA binding there
is described in chapter 4.
2.1.3 LC-MS/MS and SILAC
Both technologies, DNA microarrays and NGS are able to interogate RNA or DNA. For other
domains of biological molecules, namely proteins and metabolites, a different technology has
been established: mass spectrometry [Ong and Mann, 2005; Cox and Mann, 2007]. In particular,
to identify and quantify proteins, a widely used platform is liquid chromatography tandem mass
spectrometry (LC-MS/MS) based on stable isotope labelling of amino acids in cell culture
(SILAC). Here, proteins of a sample are isolated and digested into peptides. These are then
injected into a high resolution tandem mass spectrometer using a chromatographic column. In
principle, a mass spectrometer is able to measure the masses of many molecules simultaneously
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in a quantitative way 1. Thus, a mass spectrum is a list of masses with associated intensities.
Tandem mass spectrometers are able to measure two kinds of mass spectra: First, masses and
intensities of all peptides in the mass spectrometer are determined, followed by one or multiple
secondary measurements. For each of these secondary measurements (called tandem mass
spectra), one peptide is selected, fragmented by collision with an inert gas and peptide fragments
are measured. Thus, the output of a typical LC-MS/MS experiment consists of thousands of
primary mass spectra and tens of thousands of tandem mass spectra [Cox and Mann, 2008;
Michalski et al., 2011].
In general, tandem mass spectra are used to identify peptide sequences [Cox and Mann, 2008;
Cox et al., 2011]. After the collision induced fragmentation, the most abundant fragments are
prefixes and suffixes of the original peptide. Based on mass differences of these fragments,
both the identity of amino acids as well as their sequence can be inferred [Cox et al., 2011].
This inference is often done by comparing the measured spectra to theoretical spectra computed
from sequences of known peptides. A decoy peptide approach is often used to assess the false
discovery rate (FDR) [Elias and Gygi, 2007]: Experimental spectra are not only compared to
computed spectra of real peptides but also of decoy peptides, e.g. randomized or reversed peptide
sequences. Obviously, all identified decoy peptides are erroneous identifications. Thus, the
fraction of identified decoy peptides should correspond to the fraction of erroneous identifications
of real peptides. In a typical mass spectrometry experiment 60-80% of all measured tandem mass
spectra can be assigned with an FDR of 1% [Cox et al., 2011; Michalski et al., 2011].
The primary mass spectra are used to quantify peptides [Ong and Mann, 2005; Cox and Mann,
2008]. This is often done after metabolic labeling (SILAC): To compare protein levels in two
cell cultures, one of them is grown on a medium with heavy isotopes of the amino acids Arginine
and Lysine, which are then incorporated into proteins. Then, proteins are isolated from both
cell cultures and mixed. This protein mix is digested using Trypsin, which specifically cleaves
after Arginine or Lysine. Hence, each tryptic peptide apart from the C-terminal peptide contains
either an Arginine or Lysine and thus, the source cell culture of each peptide molecule can be
determined by its mass. Since the heavy isotope does not alter the physico-chemical properties of
the peptide, both, the light and the heavy peptide elute at the same time from the chromatographic
column. Therefore, in the primary mass spectra, peptide pairs are observed that are characterized
by a mass shift corresponding to the mass difference of the labeled amino acid. The ratio of
the intensities of peptide pairs then corresponds to the peptide fold change between the two
cell cultures. Importantly, it is also possible to compare three cell cultures at once using two
different heavy isotopes [Cox and Mann, 2008] and systems are available to perform SILAC in
vivo [Zanivan et al., 2012].
2.2 Cell lines and available datasets
Studies about human herpes viruses are usually conducted in in-vitro systems using stable cell
lines [Knipe et al., 2007]. Often, such cell lines are established after extraction from tumor tissue
1To be precise, the mass over charge ratio of ions is measured.
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Table 2.1: Datasets for the cell lines DG75-eGFP, DG75-10/12 and BCBL1. The numbers denote
replicate measurements.
Experiment Parameters Publication Comments
Microarray mRNA levels [Do¨lken et al., 2010]
Microarray (4sU) mRNA half lives [Do¨lken et al., 2010] Labeling time 60 min
LC-MS/MS Protein levels [Erhard et al., 2013c] SILAC triple labeling
RIP-Chip microRNA targets [Do¨lken et al., 2010] Ago2 specific antibody
PAR-CLIP 1 microRNA target sites [Erhard et al., 2013a,c] Ago2 specific antibody
1 No PAR-CLIP was performed for DG75-10/12
(e.g. described by Ben-Bassat et al. [1977]; Renne et al. [1996]), or are immortalized by infection
with EBV (e.g. in Skalsky et al. [2012]). Our NGFN-plus project Pathogenic role of miRNAs in
herpesvirus infection focussed on a few cell lines that where either infected by a specific herpes
virus or not. To allow an integrative approach, several high-throughput experiments have been
performed in the same cell lines (see chapter 6).
2.2.1 KSHV related cell lines
The main system of cell lines used in this work consists of three cell lines, DG75-eGFP, DG75-
10/12 and BCBL1. DG75 is a relatively old B-cell line that is EBV and KSHV negative and has
been extracted from a patient with primary abdominal lymphoma [Ben-Bassat et al., 1977]. This
cell line has been transduced with a lentiviral vector either expressing enhanced green fluoresent
protein (eGFP) or 10 of the 12 KSHV microRNAs 2 that are encoded within an intron of the
Kaposin gene [Do¨lken et al., 2010]. BCBL1 is an EBV negative B-cell line extracted from a
patient with body-cavity based lymphoma that is latently infected with KSHV [Renne et al.,
1996].
Various high-throughput experiments have been conducted for these three cell lines by our
collaboration partners in the NGFN-plus project, namely microarray measurements of total,
newly transcribed and preexisting RNA (see above), SILAC based LC-MS/MS, AGO-RIP-Chip
and AGO-PAR-CLIP (excluding DG75-10/12; see also table 2.1). I analyzed these datasets using
the methods I developed (see chapters 5,4 and 7) or already available methods [Do¨lken et al.,
2008; Cox and Mann, 2008] and integrated them in order to investigate the widespread context-
dependence of microRNA-mediated regulation (see chapter 6). For the same analysis, I also
integrated publicly available PAR-CLIP data from Gottwein et al. [2011], where other KSHV
positive B-cell lines were measured (BC1 and BC3). For the evalution of the accuracy of PARma,
I also considered our PAR-CLIP data set in DG75 and BCBL1 as well as the BC1 and BC3 data
from Gottwein et al. [2011].
2The missing microRNAs are kshv-mir-K12-10 and kshv-mir-K12-12
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Figure 2.1: Proteomics data for DG75-eGFP,DG75-10/12 and BCBL1. In figure 2.1a, the gene
log2 fold change correlations are shown for all pairs of replicates. The values in the upper triangle
represent the Pearson correleation coefficient for the respective pair of replicates. All genes with
at least two measured peptides were considered. Three independent biological replicates have
been measured (rep1-3), two of which have been repeated with different collision techniques
(CID, collision induced dissociation; HCD, higher-energy collisional dissociation) and therefore
represent technical replicates. The overal correlation of log fold changes between replicates was
about 0.9, which indicates a very good reproducibility of the experiments. Figure 2.1b illustrates
the sparseness with respect to peptide coverage of the mass spectrometry data. For each gene,
the number of identified peptides was divided by the number of exons. Thus, this cumulative
distribution shows how many genes have at least a specific average number of peptides per exon.
In particular, for only about 15% of all identified genes, at least half of the exons contain an
identified peptide on average and for about 50% of all genes, 10% or less of the exons contain
a peptide on average. This average number of peptides per exon becomes even lower when only
repeatedly measured peptides are considered, which are important for a reliably identifiation of
differential splicing.
In addition to the context-dependence of microRNA/target interactions, I also investigated the
effect of herpes viruses, and their microRNAs in particular, on alternative splicing patterns of
host genes. To this end, I considered the LC-MS/MS data measured for the three cell lines (see
table 2.1). First, I investigated, to which extend SILAC bases mass spectrometry data can be
used to identify genes that are differentially spliced on protein level (see chapter 7 and Erhard
and Zimmer [2012]). Unfortunately, even if the quality of the data was quite good (see Figure
2.1a) and the experiment yielded a deep coverage of the proteome with respect to the number
of proteins (peptides mapping to 5247 Ensembl genes could be identified with an FDR of 1%),
no promising candidates for differential splicing could be found in the data. The main reason
for that is probaly the low peptide coverage per protein (see Figure 2.1b). Of course, in order
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to reliably identify differentially spliced genes, peptides must be identified that distinguish the
differential isoforms. Thus, due to the sparseness of the measurements interesting canidates of
differential splicing may have been missed and therefore, the question about differential splicing
in these cell lines cannot be answered by the mass spectrometry experiments alone (see chapter
7 and Erhard and Zimmer [2012]).
2.2.2 EBV related cell lines
At the time I developed REA (Erhard et al. [2013b]; see also chapter 5), which is a method to
analyze RIP-Chip data, no matching PAR-CLIP data was available for comparison in BCBL1.
However, in Do¨lken et al. [2010], RIP-Chip was not only performed for DG75-eGFP, DG75-
10/12 and BCBL1, but also for three other B-cell lines, BL41, BL41/B95.8 and Jijoye. All of
these are derived from Burkitt’s lymphoma patients and are either herpes virus negative (BL41),
infected by EBV (Jijoye) or infected by the EBV strain B95.8 that lost several of its microRNAs
(BL41/B95.8). Importantly, HITS-CLIP data was publicly available for Jijoye from another lab
[Riley et al., 2012a], which I used for evaluations of REA.
2.2.3 VZV related cell lines
I developed ALPS originally to analyze sRNA-seq data measured for VZV infected MeWo cells,
which is a melanoma derived skin cell line. The purpose of this study was to investigate whether
VZV indeed does not possess any microRNAs: In Umbach et al. [2009], primary cells from
trigeminal ganglia, i.e. nerve tissue, were extracted from deceased patients that did not show any
signs of virus reactivation. Thus, these cells represented only the latent stage of VZV infection.
Even if in these cells, no microRNAs could be found, VZV could nevertheless possess its own
microRNAs, for instance only expressed during lytic infection. Thus, skin cells were infected
with VZV, which represent the natural host cells for lytic infection and exhibit the clinical
symptoms of VZV (chickenpox and shingles). Short RNAs from cells infected by the v-Oka
strain of VZV, as well as from mock-infected and uninfected cells were then subjected to NGS
by our collaboration partners. Unfortunately, by close inspection of the sequencing data, I found
out that something must have gone wrong with the experiments: Sequencing reads were too
short (see Figure 2.2) for all libraries and almost no reads could be reliably mapped to the VZV
genome (data not shown).
In the following chapters, all methods that I introduced above are presented in detail. Each
of these chapters has already been published in a peer-reviewed journal or is submitted for
publication. As a preface for each chapter, I briefly state the status of the publications as well
as my contributions.
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Figure 2.2: Read length distribution of the VZV sRNA-seq experiments. The number of reads
per million reads in the library is shown for the three experiments performed (0hpi, uninfected;
mock, mock-infected; v-Oka, infected). In all experiments, most read lengths are in the range of
14 to 19, in contrast to usual microRNA sequencing experiments where most reads are typically
about 23 bases long [Berezikov et al., 2006; Morin et al., 2008; Friedlander et al., 2008; Witten
et al., 2010], indicating severe experimental problems.
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Chapter 3
Classification of ncRNAs using position and
size information in deep sequencing data
Motivation: As indicated in section 2.2.3, one of the still unresolved questions regarding
microRNAs and herpes viruses is whether VZV does or does not encode and express its
own microRNAs. All other herpes viruses apart from VZV have been found to express own
microRNAs (see above), however, studies specifically investigating possible VZV microRNAs in
latently infected cell lines have failed so far to identify any [Umbach et al., 2009]. Thus, our
collaboration partners considered a different system, infection of the melanoma derived MeWo
cell line. Importantly, other then previous studies, MeWo cell lines represent cell types where
VZV exhibits lytic infections and its clinical symptoms (chickenpox and shingles). However, these
experiments did not yield any results due to problems with the libraries that were submitted for
sequencing (see section 2.2.3). Nevertheless, while analyzing the MeWo sequencing data and, for
comparison, data from a published short RNA sequencing study [Morin et al., 2008], I noticed
that sequencing reads do not only come from microRNA loci, but also from tRNAs, snoRNA,
snRNAs and many other ncRNA classes. Intriguingly, reads seemed to exhibit class specific
patterns with respect to relative start positions and lengths. Thus, I systematically investigated
to which extent these patterns can be used to distinguish ncRNA classes and to discover putative
ncRNAs that exhibit similar patterns to regulatory RNAs such as microRNAs. Notably, this idea
has subsequently also been picked up by others [Langenberger et al., 2012].
Publication: This chapter has been published in Bioinformatics [Erhard and Zimmer, 2010] and
I presented this work at the European Conference on Computational Biology (ECCB) 2010 in
Ghent, Belgium in the proceedings track. Here, I adapted the layout and made minor corrections
to the text.
My contribution: I came up with the idea and the method, implemented the method, carried out
evaluations and wrote the paper.
Contribution of co-authors: Ralf Zimmer supervised the work and helped to revise the
manuscript
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3.1 Abstract
3.1.1 Motivation
Small non-coding RNAs (ncRNAs) play important roles in various cellular functions in all clades
of life. With next generation sequencing techniques, it has become possible to study ncRNAs in a
high-throughput manner and by using specialized algorithms ncRNA classes such as microRNAs
can be detected in deep sequencing data. Typically, such methods are targeted to a certain class
of ncRNA. Many methods rely on RNA secondary structure prediction, which is not always
accurate and not all ncRNA classes have are characterized by a common secondary structure.
Unbiased classification methods for ncRNAs could be important to improve accuracy and to
detect new ncRNA classes in sequencing data.
3.1.2 Results
Here, we present a scoring system called ALPS (alignment of pattern matrices score) that uses
primary information from a deep sequencing experiment, i.e. the relative positions and lengths
of reads, to classify ncRNAs. ALPS makes no further assumptions e.g. about common structural
properties in the ncRNA class and is nevertheless able to identify ncRNA classes with high
accuracy. Since ALPS is not designed to recognize a certain class of ncRNA, it can be used to
detect novel ncRNA classes, as long as these unknown ncRNAs have a characteristic pattern of
deep sequencing read lengths and positions. We evaluate our scoring system on publicly available
deep sequencing data and show that it is able to classify known ncRNAs with high sensitivity
and specificity.
3.1.3 Availability
Calculated pattern matrices of the datasets hESC and EB are available at the project website
http://www.bio.ifi.lmu.de/ALPS. An implementation of the described method is available upon
request from the authors.
3.2 Introduction
Next generation sequencing platforms such as Solexa/Illumna, Abi Solid or 454/Roche are
extensively used to sequence small RNAs of roughly 14-36 nt length at astonishing rates
in various organisms [Morin et al., 2008; Babiarz et al., 2008; Czech et al., 2008; Rathjen
et al., 2009; Kato et al., 2009]. For instance, they are used to determine expression profiles
of microRNAs, 20-24 nt long RNA molecules, that have emerged in recent years as important
post-transcriptional regulators in all known multicellular organisms and that are known to play
roles in development, tumorigenesis and viral infection [Bartel, 2004]. Besides microRNAs
other small non-coding RNA (ncRNA) classes such as piRNAs [Aravin et al., 2001], snoRNAs
[Bachellerie et al., 2002] or scaRNAs [Gerard et al., 2010] have been investigated. Only recently,
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454 sequencing revealed the existence of 16 nt long RNA (therefore termed unusual small RNA
or usRNAs) in cells infected with KSHV [Li et al., 2009]. usRNAs are derived from both virus
and host cell and are associated with the RNA induced silencing complex (RISC). Advances in
throughput, accuracy and the ability to sequence longer reads will not only lead to more and
more precise detection of already known ncRNA classes, but also to the discovery of new types.
It is therefore of great interest to develop methods for automatic classification of ncRNA using
deep sequencing data.
Most ncRNAs have very specific structural properties that have been used to classify them [Will
et al., 2007], e.g. tRNAs possess a cloverleaf structure, whereas microRNA precursors form
stable hairpins. However, these methods rely on the prediction of RNA secondary structure and
even for short molecules the current RNA secondary structure energy model is not always able
to predict the native structure [Dowell and Eddy, 2004; Doshi et al., 2004]. For instance, the
predicted optimal secondary structure of 43 out of 579 murine microRNA precursors in miRbase
[Griffiths-Jones et al., 2008] is not an unbranched hairpin (data not shown). This can be explained
by the fact that the minimal free energy structure is not necessarily the native one due to unknown
modifications or kinetic effects [Higgs and Morgan, 1995]. In the case of de-novo prediction of
e.g. microRNAs, the exact pre-microRNA sequence is not known a-priori. Even if the hairpin can
be predicted for the pre-microRNA sequence, it could be disrupted, if a few bases upstream or
downstream are appended or removed from this sequence. Therefore, multiple windows around
a putative microRNA are folded or a local folding tool such as RNALfold [Hofacker et al., 2004]
is used. This however necessarily leads to an increased false positive rate since many genomic
sequences that do not encode microRNAs can fold into stable hairpins [Bentwich, 2005].
In addition, secondary structure prediction is very sensitive to the exact range that is used for
prediction. A microRNA hairpin that can correctly be predicted if one uses the correct genomic
range, could be disrupted if a few bases upstream or downstream of the microRNA precursor
are included for prediction. Furthermore, according to predictions, many genomic sequences can
fold into stable hairpins [Bentwich, 2005] which makes methods using structural features alone
quite unspecific.
Deep sequencing offers additional criteria to distinguish ncRNA classes. A typical experimental
setup is to determine the content of small ncRNA in a cell under certain conditions. Therefore,
only intervals on the genome are considered, where enough sequencing reads have been aligned
to. The specific number of reads depends on the tradeoff between sensitivity and specificity.
If the experiment aims to identify a special class of ncRNAs, specialized algorithms can be
applied that detect specific features of that ncRNA class based on biological knowledge. E.g.
in microRNA biogenesis, one strand of the precursor is preferentially included into RISC (the
mature microRNA) and the other is rapidly degraded (microRNA star). Considering this bias
together with structural microRNA properties can dramatically increase specificity of microRNA
detection, as shown before [Morin et al., 2008; Friedlander et al., 2008].
microRNAs recognize their targets by their seed region [Grimson et al., 2007] and, due to their
biogenesis, have specific lengths [MacRae et al., 2007]. Both features of microRNAs should
be detectable in an excess of deep sequencing reads that align to a specific genomic position
and have a specific length. However, this is not always the case for microRNAs in large scale
experiments (e.g. [Morin et al., 2008]). The read start position of many microRNAs follow a
32 3. Classification of ncRNAs using position and size information in deep sequencing data
narrow distribution that is often skewed towards the microRNA 3’ end and read lengths are often
variable (see also Figure 3.1b). Such alternative mature microRNA forms are often referred to as
isomiRs [Morin et al., 2008].
In addition to positioning and lengths of reads, distances of reads aligned in close proximity of
other reads also carry information about ncRNA classes: At least for animals, the microRNA star
should be detectable at a distance of roughly 40 nt to the mature microRNA [Friedlander et al.,
2008]. Distance information also helps to distinguish microRNAs from degradation products of
other abundant RNA species such as tRNAs or snRNAs (see Figure 3.1). And, most importantly,
using this information can help to classify novel ncRNA or ncRNAs that do not possess a
characteristic secondary structure.
In this paper, we show how to exploit position and length dependent read patterns to classify
ncRNAs. We make no further assumptions about structural and other class specific properties
and only consider primary information from the alignment of deep sequencing reads on the
genome. Our method ALPS allows to detect microRNAs and other known ncRNA classes with
high accuracy and due to its unbiased nature, it also provides a straight-forward way to discover
and classify novel ncRNAs. Our approach is complementary to existing methods that rely on
structural properties and we expect that their combination with our approach allows to increase
their sensitivity and specificity.
3.3 Approach
The starting point for ALPS is the output of a short read aligner (e.g. Bowtie [Langmead et al.,
2009] or BWA [Li et al., 2009]) consisting of the positions in the genome, where deep sequencing
reads have been aligned to. Then, intervals are identified by clustering these positions such that
(1) each interval contains at least m reads, (2) there is no consecutive part of length > t within
an interval, that is not covered by a read and (3) t nucleotides downstream and upstream are
not covered by a read. The classification problem of ncRNAs using deep sequencing data then
is to assign a class label, e.g. microRNA,tRNA,snoRNA,... to each of these intervals. For a well-
annotated organism such as human, mouse or yeast such class labels are already available for
many of these intervals in public databases. Then, class labels for the intervals without annotation
can be predicted based on similarity to intervals with known annotation, which is often called
(semi-) supervised learning. If no or only very few annotations are available for the organism in
question, intervals can still be clustered in an unsupervised manner. Both approaches need a way
to calculate the similarity between two intervals.
ALPS is such a similarity score computed by an alignment of their so called pattern matrices.
These contain the information about the positions and lengths of aligned reads. Since we cannot
assume, that all exact distances between aligned reads are always representative for an ncRNA
class, we allow gaps in ALPS. For instance, to respect the distance of the mature microRNA and
their corresponding microRNA star, our algorithm must be allowed to align the start positions of
the two mature microRNAs as well as the start positions of the two microRNA stars, even if the
loops of the two percursor microRNAs have different lengths (see also Figure 3.2).
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(a) tRNA for Gly/GCC
(b) mir-423 (c) U2 snRNA
Figure 3.1: Typical position and length dependent pattern matrices for a tRNA, a microRNA and
a snRNA. Frequencies of reads starting at position (x axis) and of length (y axis) are visualized
in different shades of gray. Note that both the snRNA and the tRNA could easily be mistaken
for a microRNA, if only the most abundant read is considered. Graphical respresentations for all
pattern matrices are available on the project website.
Usually, for many intervals, annotations are already available in public databases and these can
be used to classify unknown - so far not annotated - intervals similar to them. Generally, ALPS
similarities are not biased towards a special class of ncRNAs, since they are only based on the
primary data from the deep sequencing experiment. Therefore, used as a distance measure for
any unsupervised clustering, the similarity of pattern matrices (ALP score) will find groups of
ncRNAs, that exhibit similar distributions (with respect to relative position and length) of deep
sequencing reads. If such a distribution is characteristic for an unknown class of ncRNAs, the
clustering based on our score should be able to detect it.
In this paper, the focus is not on the detection of unknown classes and hierarchies of ncRNAs but
on the detection of already known ncRNA classes to demonstrate the usefulness of our scoring
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system. Based on annotations retrieved from mirBase [Griffiths-Jones et al., 2008], gtRNAdb
[Chan and Lowe, 2009], Ensembl and Refseq, we identify intervals of known ncRNA classes
in published deep sequencing data and benchmark our scoring system based on its ability to
reassign an interval to its correct class, after its class label has been removed.
3.4 Methods
To identify the set of intervals I and their corresponding pattern matrices, we iterate over the
sorted read alignments and add a read r = (r1, r2) to the current interval I = (i1, i2) as long as
i2 > r1 − t, where r1 and r2 are genomic start and end of r, respectively, and t is a user-defined
tolerance (we use t = 50 throughout the paper). Since we do these iterations per chromosome
and per strand, each interval spans reads that mapped to one strand of a single chromosome in
close proximity to each other and reads of two different intervals are either on different strands or
chromosomes or more than t nt apart from each other. An entry N I [l, i] of the pattern matrix N I
of interval I is the number of reads of length l starting at position i in this interval. Positions are
according to the strand direction, i.e. if i1 and i2 are genomic start and end of an interval on the -
strand and a read r = (r1, r2) falls into that interval, it contributes to the entry N I [r2−r1, i2−r2]
of the pattern matrix. Since we want to compare pattern matrices for similarity regarding bias of
read start positions and lengths frequencies and we have to respect that two ncRNAs of the same
class can be expressed at different levels, we normalize each pattern matrix:
N˜ I [l, i] =
N I [l, i]∑
l′,i′ N
I [l′, i′]
(3.1)
To quantify the similarity of two intervals I, J ∈ I, we consider their normalized pattern matrices
N˜ I and N˜J as sequences of column vectors (N˜ I [•, i])i=1..|I| and (N˜J [•, j])j=1..|J | and compute
their optimal alignment. Here we adopt the notation, thatA[•, i] is the ith column vector of matrix
A. Thus, a column vector is the length distribution of deep sequencing reads, that start at a certain
position within the interval. Note, that this distribution is normalized to the proportion of reads
that start at this position. The similarity score SI,J(i, j) for aligning position i in interval I to
position j in interval J is computed according to
SI,J(i, j) = (N˜ I [•, i])T ⊗M ⊗ N˜J [•, j] (3.2)
whereM is aL×L matrix (L is the maximal read length). In the simplest case, the identity matrix
M = idL is used and ⊗ is the usual matrix multiplication. Then the similarity score is basically
just the scalar product of the corresponding column vectors. However, since ncRNA classes are
usually not defined by a specific length but by a narrow distribution of lengths, it is reasonable to
reward not only exact length matches but also small differences and to penalize large deviations
of peaks in the length distributions. Therefore, we use a matrix M = Hk,λ derived from the
sigmoidal function:
H [i, j]k,λ = hk,λ(|i− j|) (3.3)
hk,λ(x) = 1−
2xk
λk + xk
(3.4)
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This matrix rewards differences in read lengths, as long as the absolute difference is at most λ
and penalizes all deviations of more than λ. The parameter k describes the steepness of rewards
and penalties. The standard sum-product matrix multiplication can also be replaced by a sum-
min matrix multiplication. If M = idL is used and the two column vectors are considered as
functions, this score can be geometrically interpreted as their common integral. Again, a hill
function derived matrix Hk,λ can be used to respect length distributions (after negative entries in
the matrix have been removed). The ALPS similarity, i.e. the optimal alignment score of the two
intervals I and J then is:
sˆ(I, J) = max
A
{
∑
(i,j)∈A
SI,J(i, j) +
∑
n∈G(A)
g(n)} (3.5)
g(n) = o+ e · n (3.6)
The maximum in equation 3.5 is over all possible alignments A of the intervals I and J and
G(A) is the set of all gaps in alignment A. Note that the affine gap cost function 3.6 penalizes
many short gaps more then few long gaps, which is important for our similarity scoring. We can
calculate sˆ(I, J) efficiently using the algorithm of [Gotoh, 1982] in time O(|I| · |J | · L) after
a preprocessing of the scoring function S in time O(|J | · L2). The preprocessing involves the
computations of the second matrix multiplication M ⊗ N˜J [•, j] for all j ∈ [1; |J |].
The score in equation 3.5 corresponds to an optimal global alignment. However, we can also
define other variants of ALPS similarity: The optimal freeshift (also often called semi-global)
alignment score sˆf(I, J) is given as in equation 3.5 by replacing G(A) by Gf(A), that contains
all gaps from G(A) but the longer of the two leading gaps and the longer of the two trailing
gaps. Similarly, for the optimal local alignment score, sˆl(I, J), Gl(A) is used instead of G(A),
that contains all but both leading and both trailing gaps. This is equivalent to the usual definition
of local alignment, i.e. the optimal global alignment of two subsequences. Note, that we can
compute the optimal local and freeshift alignments efficiently using a modified version of the
Gotoh algorithm, as suggested in [Smith and Waterman, 1981].
Thus, a scoring system for pairwise ALPS similarities can be described by the 5-tuple S =
(M,⊗, o, e,mode), where M is the matrix and ⊗ the operator for the calculation of the column
vector similarity, respectively, o, e are the gap open and gap extend parameters for the affine gap
cost function and mode is the alignment mode (global, local or freeshift).
We compute the pairwise ALPS similarities sˆ(I, J) for all intervals I, J ∈ Im,t that contain
at least m reads with tolerance t given a scoring system S. Then we assign a class to each of
the intervals by using annotations from mirBase [Griffiths-Jones et al., 2008], gtRNAdb [Chan
and Lowe, 2009], Ensembl and RefSeq. For intervals with multiple assigned annotations, we
prioritize annotations according to table 3.1 and we combine similar annotations. All intervals
annotated with A are thus partitioned into a cluster CA. We define the inner and outer similarity
scores of class A as the sets
Dinner(A) = {sˆ(I, J)|I, J ∈ CA} (3.7)
Douter(A) = {sˆ(I, J)|I ∈ CA, J /∈ CA} (3.8)
Using their respective distributions P inner(A) and P outer(A), we can estimate the ability of S
to separate A from all other classes. This means, by using general optimization techniques such
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Table 3.1: Annotations from mirBase, gtRNAdb, Ensembl and RefSeq, ordered by their priority
used for the initial class assignment. Similar annotations are combined and the number of
respective intervals in the two datasets used for benchmarking is given.
Origin Annotation Combined hESC EB
mirBase/Ensembl microRNA microRNA 103 101
Ensembl microRNA pseudogene microRNA
gtRNAdb/Ensembl tRNA tRNA 158 99
Ensembl tRNA pseudogene tRNA
Ensembl Mt tRNA tRNA
Ensembl Mt tRNA pseudogene tRNA
Ensembl rRNA rRNA 43 27
Ensembl rRNA pseudogene rRNA
Ensembl Mt rRNA rRNA
Ensembl snRNA snRNA 13 12
Ensembl snRNA pseudogene snRNA
Ensembl snoRNA snoRNA 10 6
Ensembl snoRNA pseudogene snoRNA
Ensembl misc RNA misc RNA 94 85
Ensembl misc RNA pseudogene misc RNA
Ensembl lincRNA misc RNA
Ensembl scRNA misc RNA
Ensembl scRNA pseudogene misc RNA
Ensembl pseudogene misc RNA
RefSeq CDS misc RNA
RefSeq INTRON misc RNA
RefSeq UTR misc RNA
RefSeq 3FLANK misc RNA
RefSeq 5FLANK misc RNA
unknown unknown 80 56
as simple grid search, genetic algorithms or specialized methods such as VALP [Zien et al.,
2000], we can optimize S for many purposes, e.g. a median based hierarchical clustering that
is supposed to separate all classes equally well would require a scoring system, that maximizes∑
A median(P inner)−median(P outer).
Here we use only P outer(A) to test the null hypothesis, that an interval I without annotation is
not from class A. We calculate an empirical p-value for each sˆ(I, J), J ∈ CA from the right tail
of P outer(A) and combine each of these |CA| p-values using Fisher’s method [Fisher, 1970]. We
then select the class with the smallest p-value.
3.5 Results 37
(a) o = −0.005, e = −0.001 (b) o = −0.01, e = −0.001
Figure 3.2: Freeshift alignment of hsa-mir-99b and hsa-mir-185. Pattern matrix frequencies are
visualized in different shades of gray and white areas correspond to unaligned parts of the
matrices. Note that with the gap cost function in 3.2a, the microRNA star start positions on
the right parts of the matrices are correctly aligned, whereas slightly altered parameters in 3.2b
erroneously move the necessary gap to the end, where it is not penalized.
3.5 Results
We applied our method to previously published Solexa sequencing data of human embryonic
stem cells [Morin et al., 2008], where small RNAs of human embryonic stem cells (hESC) and
embryoid body cells (EB) have been sequenced. We used Bowtie to align the trimmed reads to
the human genome (hg19) obtained from the UCSC genome browser. We allowed no mismatches
but did not restrict the number of loci a read can be aligned to. We identified intervals as described
in the methods section (t = 50, m = 1000) and assigned them to the classes in table 3.1. We
determined the normalized pattern matrices (see project website for graphical visualizations) and
computed all pairwise ALPS similarities for various scoring systems.
First, we checked which choices of gap parameters make differences in the alignments of
intervals. We considered the intervals of hsa-mir-99b and hsa-mir-185, that are both 5’ donors
(i.e. the mature microRNA originates from the 5’ arm of the precursor), are expressed at similar
levels (1892 and 2148 reads in EB, respectively) and have different loop lengths. Thus, a
correct alignment must introduce a gap between the positions of the mature microRNA and the
microRNA star in the sequence of column vectors of mir-185 (which has the shorter loop). If
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(a) M = idL,⊗ =sum-min (b) M = idL,⊗ =sum-product
(c) M = H4,1,⊗ =sum-product (d) M = H8,1,⊗ =sum-product
Figure 3.3: Inner and outer score distributions for microRNAs. The EB dataset is used and shown
are scores for freeshift alignments with o = −0.05, e = −0.01. In all cases, the inner and outer
distributions are significantly different, although not completely separated.
we calculate the optimal freeshift alignment using the hill matrix H2,1 and min-product matrix
multiplication, gap parameters of o = −0.005 and e = −0.001 are indeed able to produce a
correct alignment (see Figure 3.2). We emphasize, that meaningful ranges of gap parameters
are highly dependent on the other parameters and that automated parameter optimization could
resolve these ranges.
A second theoretical consideration can be made by examining the inner and outer score
distributions (see Figure 3.3). When the sum-min and the sum-product operator is used with
the same matrix (the identity matrix), scores of the former naturally tend to be higher than scores
of the later. If the identity matrix is replaced by H4,1 or H8,1, scores also tend to increase. For all
parameter choices, it is apparent that inner and outer scores are significantly different, but their
distributions are not completely separated. The outer distribution describes all ALPS similarities
between pairs of intervals, one annotated as microRNA, the other not annotated as microRNA.
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However, mirBase is not complete, and as a consequence, it is possible that the outer score
distribution contains microRNA-microRNA scores, which can explain the elongated right tail of
all P outer. The inner distribution consists of all pairwise ALPS similarities of two intervals both
annotated as microRNA. Especially when using M = idL, many scores tend to be small, since
only exact agreements in length are rewarded, and two mature microRNAs may have differing
sizes. In addition, microRNA may be 5’ donors or 3’ donors or both mature and microRNA star
are expressed at very similar levels. As a consequence, P inner does not only contain overall high
scores, but also scores indicating differing subclasses.
However, all these parameter choices are able to separate microRNAs from other ncRNAs, when
we use all scores for classification. Using any aggregate statistics fails in many cases: If the
maximal scores is used, a true microRNA may be too similar to an interval with unknown
annotation, which is in fact a still unknown microRNA, leading to a misclassification. If one
uses the minimum, the inner scoring is hampered by subclasses. Therefore, using all scores and
a statistically robust method to combine them (such as Fisher’s method) is necessary for reliable
classification.
In order to assess whether ALPS is able to classify ncRNA reliably, we applied the following
procedure: Each annotated interval I was removed from its cluster CA and the described method
was used to determine the class of I . Since we did not restrict the number of loci a read could
align to, and many of the abundant ncRNAs are present in multiple copies in the human genome,
we considered only scores sˆ(I, J) where the genomic sequences of I and J did not contain
common subsequences of length > 10, i.e. no deep sequencing read has been counted in both
intervals I and J . For all other scores, p-values were calculated and combined as described.
We then calculated recall and precision for each class A separately as the number of intervals
correctly assigned divided by the number of intervals originally belonging to CA (recall) and
divided by the number of intervals assigned to CA (precision), respectively.
As indicated above, we tried various parameter combinations to classify ncRNAs. Since there
are only very few unique snRNAs, snoRNAs and rRNAs, we only considered microRNAs and
tRNAs for evaluation. Except for some obviously too extreme parameter combinations (e.g. too
negative gap parameters for global alignments), the classification performance was remarkably
stable with recall values of up to 98% at a precision of 60% for microRNAs (see Figure 3.4).
These relatively low precision values in the microRNA class rise the question, whether our
scoring tends to classify too many intervals as microRNAs. However, the classes unknown and
misc RNA are not excluded from our analyses, and nearly all of the intervals additionally assigned
to the class microRNA originate from unknown and misc RNA whose pattern matrix indeed is
very similar to that of microRNAs. We predicted the secondary structures of the corresponding
sequences using RNAfold [Hofacker et al., 1994] and some of them are indeed predicted to
be able to fold into hairpins. Whether these reads really correspond to mature microRNAs, are
degradation products or otherwise processed RNAs must still be elucidated, however.
Here, we applied our method only to abundant ncRNAs. This is inherent to the method as we
have to estimate the distribution of read lengths per position for an ncRNA gene, which is only
possible, if enough reads have been sequenced. Due to further development of current sequencing
techniques, it will be possible to achieve more and more sequencing depth at lower costs and
therefore, also low abundant ncRNAs will be represented by enough sequencing reads.
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Figure 3.4: Evaluation for the scoring system (H2,1, sum-min,−0.01,−0.005, freeshift). The
recall for a class is the number of intervals correctly assigned divided by the number of intervals
originally belonging to this class and the precision is the number of intervals correctly assigned
divided by the number of intervals assigned to the class.
3.6 Discussion
Deep sequencing reads of ncRNAs follow very specific patterns regarding their length and
positions with respect to their genes. Classes of ncRNAs are defined by their function and
biogenesis and often share a common structure. Each of these can contribute to a biased
distribution of reads on the ncRNA gene:
• Regulatory RNAs such as microRNAs, piRNAs or siRNAs are believed to recognize their
targets by a short complementary region (seed). Therefore, for a proper function, the cell
has to take care that the seed of these RNA classes is not shifted and, as a consequence,
a wealth of deep sequencing reads starting at specific positions should be detectable. This
can be observed in the pattern matrices computed for high-throughput sequencing data.
The consideration of reads starting at adjacent positions allows to distinguish these ncRNA
classes from degradation products of other abundant species.
• The specific pattern observed for longer ncRNAs like tRNAs (see Figure 3.1a) can possibly
be explained by their degradation: Cleavage by RNAses can be biased towards certain
parts of the tRNA, which leads in the case of the cloverleaf structured tRNAs to a
pattern of tRNA halves or quarters [Thompson and Parker, 2009]. Although some of
these degradation products can be mistaken for e.g. a microRNA due to similar length,
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the consideration of longer intervals and the distances between such subintervals can
be used to separate these classes of ncRNAs. It has been observed, that degradation
products of tRNAs are associated with RISC [Haussecker et al., 2010], which could explain
microRNA-like read patterns of tRNAs. In spite of that, ALPS is able to separate these
tRNAs from microRNAs.
• Patterns generated by microRNA biogenesis are obvious when looking at graphical repre-
sentations of pattern matrices. In addition to the mature microRNA and the microRNA
star, additional reads are present for some intervals. These can either be explained by
degradation products or by additional drosha products that have been observed previously
[Shi et al., 2009].
It is currently unclear which classes of ncRNAs exhibit characteristic patterns of deep sequencing
reads, but the points discussed above indicate that in theory all ncRNA classes defined by a
common function or biogenesis should have such a pattern and should therefore be amenable to
classification by ALPS.
As indicated in Figure 3.2, exact distances between the start positions e.g. of the mature
microRNA and the microRNA star within such patterns are not fixed and in plants, the microRNA
hairpin is longer and even more variable than in animals. Allowing gaps in the alignment
therefore enables ALPS to compute reasonable similarity scores for ncRNA classes, where such
distances are highly variable. It is furthermore important to allow affine gap cost functions since
linear gap costs tend to disrupt correct alignments. Gap parameters can be adjusted, such that
single alignments become correct (e.g. as in Figure 3.2). However, we observed that classification
accuracy in our test datasets is not heavily influenced by gap parameters. This is a consequence
of the strong signal of the mature microRNA read that contributes in many cases enough score
to the ALPS similarity to separate microRNAs from non-microRNAs. Thus, for classification
of ncRNAs exhibiting such dissimilar patterns as in our test set, results are very robust and
independent of the scoring system, i.e., a single reasonable scoring system can be used for
classification of all ncRNAs in such a case.
If patterns for ncRNA classes are not as distinct as for the microRNAs and tRNAs in our test
set, gap parameters and the matrix M can be tuned for proper classification. We described an
approach to evaluate parameter sets based on the inner and outer score distributions and we
note that already available methods to optimize other alignment based scoring systems e.g. for
homology modelling and of protein (structure) alignment can directly be applied to ALPS.
We emphasize, that ALPS similarities should be calculated per experiment and comparisons
across different datasets, generated in different labs with different protocols or even different
sequencing plattforms, should be performed with care. In the two datasets we used for validation,
pattern matrices were highly concordant for intervals observed in both datasets. However, it is
not clear how much technical bias is introduced into pattern matrices, i.e. pattern components,
that are not due to biology but introduced by technical factors. Comparing pattern matrices of
different protocols or sequencing techniques is subject for further studies.
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3.7 Conclusion and Outlook
We developed an alignment based method, that allows to quantify the similarity of ncRNAs
solely based on primary deep sequencing data by considering the position and length dependent
patterns of reads aligned to short intervals on the genome. ALPS similarity rewards matching
positions of reads of similar length in the two intervals. It can be computed efficiently and can be
used to classify intervals of unknown function in various ways, one of which we have presented
here.
ALPS only considers data, that is available by a deep sequencing experiment and makes no
further assumption about the common secondary structure of an ncRNA class. Such a scoring
system is important not only because the RNA secondary structure prediction is not always
accurate, but also because some ncRNA classes may not even have a common secondary
structure. As long as members of a class share a similar pattern of read lengths and positions,
our method is able to detect it. For instance, there is no method available to accurately detect
usRNAs [Li et al., 2009] in deep sequencing data in an automated manner. Since usRNAs are
associated with RISC and their importance in post-transcriptional regulation has been shown, it
is of great importance to provide a tool for their detection. Since they are characterized by their
short length and fixed positions, ALPS similarity can be expected to identify them accurately in
a deep sequencing experiment.
Our method can be used to support other, e.g. structure based, methods for the discovery of
(specific) ncRNA classes by incorporating our similarity scores into the respective probabilistic
model or machine learning scheme. As discussed, parameters of our scoring system can be
finetuned in favor of any class of ncRNAs. In addition, if read lengths and positioning is also
characteristic for subclasses, our scoring can be used to recover this hierarchy and for instance
divide the class of microRNAs into the subclasses of 5’ and 3’ donors.
It has been suggested, that microRNAs are modified after maturation [Morin et al., 2008].
These modifications are detectable in a deep sequencing experiment, and if they are specific
for microRNAs, incorporating them into a scoring system should further boost the identification
of microRNAs. This can easily be incorporated into the calculation of the similarity score by
extending the column vectors and defining appropriate matrices M . Even structural information
could be integrated the same way.
We have shown that only considering positions and lengths of deep sequencing reads already
allows to accurately identify abundant microRNAs and tRNAs in a large-scale dataset. Our
scoring system was not biased towards the identification of a specific class of ncRNAs and as a
consequence, we expect it not only to be useful for the classification of known ncRNA types, but
also for novel classes, as long as they exhibit a characteristic pattern of deep sequencing reads.
Chapter 4
PARma: identification of microRNA target
sites in AGO-PAR-CLIP data
Motivation: The main idea of ALPS scores described in the previous chapter is to specifically
exploit features of aligned sequencing reads and to find similar loci on the genome with
respect to these features. Here, this idea is reused and developed further: Instead of computing
similarities between pairs of loci, a general model of sequencing read features is built and all
loci are classified with respect to the similarity to this model instead of computing all pairwise
similarities. Furthermore, while the goal of ALPS scores was to classify ncRNAs in regular short
RNA-seq data, PARma analyzes PAR-CLIP data in order to identify microRNA target sites as
well as the microRNAs that target each site. Thus, due to the different nature of the data, the
features used in PARma are different from the features in ALPS. Furthermore, based on close
inspection of PAR-CLIP data using the data viewer described below, it was straight-forward to
build a general model instead of all pairwise comparisons for valid microRNA target sites, while
for short RNA-seq data, general models for the various ncRNA classes seemed not feasable. I
applied PARma to new PAR-CLIP data generated by our collaboration partners as well as to
published datasets. The results of these analyses are presented in chapter 6.
Publication: This chapter has been published in Genome Biology [Erhard et al., 2013a]. Here,
I adapted the layout and made minor corrections to the text.
My contribution: I came up with the idea and the method, implemented the method, carried out
evaluations and wrote the paper.
Contribution of co-authors: Lukas Jaskiewicz performed PAR-CLIP experiments. Lars Do¨lken
contributed ideas and helped to revise the manuscript. Ralf Zimmer supervised the work and
helped to revise the manuscript
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4.1 Abstract
AGO-PAR-CLIP is a high-throughput method to identify target sites of microRNAs based on
immunoprecipitation (IP) of the RNA induced silencing complex (RISC) and deep sequencing
Argonaute (Ago)-protected RNA fragments crosslinked to Ago. This approach provides clusters
of reads spanning 30-50 nucleotides containing the microRNA binding sites. The identity of the
microRNA binding in each cluster is a priori not clear and must be revealed by matching the
correct microRNA seed sequence to the cluster sequence, which is not a trivial task.
Specific characteristics of PAR-CLIP data can be utilized to aid this problem, most notably,
frequent T to C conversions that are indicative for crosslinking sites. We utilize these and
additional features to accurately determine the seed site. Our method, PARma, consists of two
main components: A generative model incorporates PAR-CLIP specific features to compute
likely seed site positions and the novel pattern discovery tool kmerExplain estimates seed activity
probabilites based on the likelihood inferred by the model.
The final PAR-CLIP model is in agreement with known binding mechanisms of microRNAs and
with structural knowledge of AGO and many active k-mers correspond to seeds of expressed
microRNAs. Based on the analysis of differential PAR-CLIP data from both a publicly available
dataset as well as from a new dataset, we show that PARma is more accurate than existing
approaches in terms of correct seed assignments.
PARma is freely available from the project website http://www.bio.ifi.lmu.de/PARma.
4.2 Introduction
MicroRNAs have emerged as important post-transcriptional regulators in all known multicellular
organisms. These 20-24 nucleotide (nt) long RNA molecules play roles in development,
tumorigenesis and viral infection [Bartel, 2004]. Generally, they bind to 3’ UTRs of their
target transcripts inhibiting translation or inducing degradation of the target mRNA [Bartel,
2009]. Neither the exact mode of binding nor the mechanisms of downregulation are completely
understood and are under heavy debate [Djuranovic et al., 2011; Eulalio et al., 2008; Guo et al.,
2010; Kozak, 2008; Mishima et al., 2012]. It is believed that microRNAs recognize their target
sites using only a small portion of bases at their 5’ end called the seed [Wee et al., 2012] and that
other factors such as additional base pairing at the 3’ end [Bartel, 2009], target site accessibility
[Kertesz et al., 2007], target site location, AU content around the target site contribute to
recognition [Grimson et al., 2007]. These factors, as well as evolutionary conservation of target
sites (in case of conserved microRNAs) have been used to predict target sites of microRNAs
[Friedman et al., 2008; Krek et al., 2005]. However, all known prediction methods are hampered
by a huge number of false positives and false negatives [Ritchie et al., 2009]. Recently, several
high-throughput assays have been developed which allow accurate identification of microRNA
targets (reviewed in Thomson et al. [2011]).
Immunoprecipitation (IP) of the Argonaute (AGO) protein, the major component of the RNA
induced silencing complex (RISC), allows the identification of microRNA mediated recruitment
of hundreds of different transcripts to the RISC. Target mRNAs of microRNAs co-precipitate
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with AGO and can thus be identified either using microarrays (RIP-Chip) or Next-Generation-
Sequencing (RIP-seq) [Easow et al., 2007; Beitzinger et al., 2007; Hendrickson et al., 2008;
Karginov et al., 2007; Landthaler et al., 2008; Do¨lken et al., 2010]. However, these RIP
experiments only give information about target genes or transcripts and neither about the precise
location of target sites nor the actual microRNA targeting these sites. As a remedy to that, novel
techniques including HITS-CLIP, iCLIP and PAR-CLIP have been developed. Before the IP,
RNA is cross-linked to proteins using UV light, which allows then to determine the precise
location of the target site by deep sequencing of cross-linked RNA after digestion of non-cross-
linked RNA [Chi et al., 2009; Ko¨nig et al., 2010; Hafner et al., 2010]. Still, the actual microRNA
binding at these sites have to be determined.
Both techniques, RIP and CLIP, need specialized bioinformatic analysis methods. RIP is very
similar to standard gene expression experiments and, thus, advanced analysis methods are readily
available. In addition to these standard approaches, in a recent paper, we described additional
algorithms which need to be employed to consider and cope with the characteristic features of
RIP data [Erhard et al., 2013b]. In contrast, CLIP data are more complex: First, short sequencing
reads must be aligned to the genome or transcriptome and then clustered [Chi et al., 2009;
Ko¨nig et al., 2010; Hafner et al., 2010]. True target sites have to be idenfied among all clusters
and the specific microRNA targeting each site has to be determined. Depending on the exact
experimental protocol, true target sites may look quite distinctive: While for HITS-CLIP, narrow
peaks in the read coverage are expected [Chi et al., 2009], iCLIP clusters show specific read start
positions [Ko¨nig et al., 2010] and PAR-CLIP clusters are characterized by T to C conversions
[Hafner et al., 2010]. Here, we focus on PAR-CLIP, a technique that has been used by several
groups to identify microRNA target sites [Hafner et al., 2010; Gottwein et al., 2011; Lipchina
et al., 2011; Skalsky et al., 2012].
In their original PAR-Clip paper, Hafner et al. [Hafner et al., 2010] used several manually chosen
parameters to define target sites (e.g. at least two distinct conversion positions per cluster and at
least 5 sequencing reads). They recognized that the region downstream of the main conversion
site is enriched for sequences complementary to the seeds of top expressed microRNAs.
PARalyzer is a software package specifically designed to define RNA binding sites from PAR-
CLIP data. Reads are first clustered and filtered using similar parameters as Hafner et al. Then,
conversion and non-conversion distributions are computed by counting the respective events and
employing kernel density estimation along each cluster. All positions with a higher conversion
than non-conversion density are considered target sites and surrounding sequences are submitted
to a standard motif discovery tool that uses linear regression to determine microRNA seed sites
enriched among clusters with many conversion events [Corcoran et al., 2011].
There are several open points in PAR-CLIP data analysis: First, it is unclear which microRNAs
should be taken as starting point for searching seed sites in PAR-CLIP clusters. In all published
studies, the top N microRNAs according to microRNA read counts in the PAR-CLIP experiment
or an additional experiment are taken. However, read counts provide a potentially strongly biased
estimate of microRNA expression levels [Raabe et al., 2011; Linsen et al., 2009]. In addition, it
is unclear how many miRNAs should be used. Finally, it may not be sufficient to only consider
known microRNAs: First, there are indications that there are many still unknown microRNAs
[Ladewig et al., 2012] and second, not only microRNAs (as defined by their maturation pathway)
46 4. PARma: identification of microRNA target sites in AGO-PAR-CLIP data
may be associated with AGO and used for target recognition, but there may be other pathways
that lead to the incorporation of small RNAs into RISC [Haussecker et al., 2010; Cheloufi et al.,
2010; Yang et al., 2010; Cifuentes et al., 2010; Taft et al., 2009].
Second, the specific information given by the PAR-CLIP experiment is only partially exploited:
In the PAR-CLIP protocol, RNase T1 is used to digest RNA, which cleaves specifically after
guanine [Pace et al., 1991]. This information could be used to exclude seed sites spanning read
start or end positions under the assumption that these sites are protected from digestion by the
microRNA. Also, it is known that positions in the mRNA bound to the microRNA cannot be
efficiently cross-linked and thus, seed sites spanning a cross-linking site could also be excluded
[Hafner et al., 2010]. Currently, there is no method available that directly uses the information
from RNase cleavage sites or conversion sites for the discovery of motifs or the assignment of
seed sites.
Third, there is no scoring system available that has been demonstrated to reliably identify clusters
or assigned microRNAs.
Here, we present a method to address these aspects: PARma seeks explanations for the presence
of each identified PAR-CLIP cluster. Here, an explanation is a k nt long sequence (k-mer) within
a cluster that corresponds to the seed of the microRNA binding this site. PARma explains each
PAR-CLIP cluster by a k-mer that is (a) explaining multiple clusters with high probability and (b)
matching a generative model for the experimental data (i.e. the data observed in the experiment
is likely to be generated by a microRNA binding at the determined position). The determined
k-mer can identify respective microRNA families that are characterized by a seed matching the
k-mer. The model is able to score each k-mer in a cluster according to the observed conversions
and RNase cleavage sites. Parameters as well as k-mer activity probabilities are estimated in
an iterative manner. The model assigns the most probable seed to a PAR-CLIP cluster, to score
clusters according to the confidence of being a true microRNA target site and also to score the
confidence of the assignment of the correct seed.
Differential PAR-CLIP data are used to evaluate our methods: When paired PAR-CLIP datasets
with microRNAs that are known to be present only in dataset A and not in B are analyzed, target
sites (PAR-CLIP clusters) of these microRNAs should only be present in dataset A. We used
our own PAR-CLIP datasets of the two B-cell lines DG75 and BCBL1, of which only the latter
is infected with Kaposi’s sarcoma-associated herpesvirus (KSHV), a herpesvirus encoding 25
mature microRNAs. In this data, we expect the viral microRNAs and hence its targets only to
be present in the infected cell line. We also repeated our evaluations using a published dataset
of Epstein-Barr-Virus (EBV; encoding 44 mature microRNAs) positive and negative cell lines
[Gottwein et al., 2011].
4.3 Results
4.3.1 PARma overview
We developed a complete workflow for the analysis of PAR-CLIP data (see Figure 4.1). The
main steps are (a) mapping of the sequencing reads to reference sequences, (b) detection of read
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Figure 4.1: PARma overview. The PARma workflow starts with the raw data from PAR-CLIP
experiments (replicates or different conditions), i.e. several fastq files containing sequencing
reads. First, we utilize Bowtie [Langmead et al., 2009] to align these reads to multiple reference
sequences such as the human genome and transcriptome or viral genomes resulting in several sam
files, one for each fastq file and reference sequence. Second, for each read from each experiment
we identify all optimal alignments in terms of mismatches, considering T to C conversions as
matches, and map transcriptomic reads that span splice junctions to the genome. Third, possible
target sites of microRNAs are identified by clustering reads from all datasets simultaneously.
The clusters including additional annotations such as the number of conversions and cleavages
per position are written to separate files for each experiment individually. The cluster detection
implements a splitting procedure to identify target sites with overlapping reads and is able to
handle target sites that span splice junctions. Fourth, for each dataset, the core PARma component
estimates a generative model for the data and k-mer activity probabilities using kmerExplain in
an iterative manner (see also Figure 4.3). Fifth, the models and the activity probabilities are used
to score clusters and to assign the most probable microRNA. Target sites with various annotations
such as gene ids are written to tabular files that can be further analyzed and visualized.
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clusters corresponding to target sites, (c) estimating a model that represents characteristic features
of PAR-CLIP data and microRNA (seed) activities and (d) the final assignment of microRNAs
to target sites and their scoring using the derived model. Furthermore, we developed a tailored,
web-based visualization for PAR-CLIP data, that helped us during the development of PARma
and can be used to manually investigate specific target sites (see Figure 4.2).
The central idea of PARma is that microRNAs binding a target site will generate specific data in
a PAR-CLIP experiment (conversion positions and RNAse T1 cleavage sites, see Figure 4.2a).
Thus, given experimental data and a model representing these features, it is possible to infer
the binding site that has generated these data with the highest likelihood. Additionally, given
the experimental data and the correct binding sites, it is straight-forward to infer the model
parameters. Thus, we are facing a chicken-or-egg dilemma: If we knew the binding sites we
could infer the model, and if we knew the model, we could infer the binding sites. In PARma,
this is resolved using an iterative procedure (see Figure 4.3). We start by computing statistically
overrepresented k-mers in clusters and take these as initial estimates for the correct binding sites.
Then, we infer model parameters and iteratively refine all estimates until convergence.
During these iterations, seed activity probabilities are estimated, corresponding to the likelihood-
weighted number of target sites. Importantly, it is possible - but not necessary - to specify
an a-priory set of allowed microRNAs. This is a highly desirable feature since in general it is
unknown, which microRNAs are active in an experiment and the read count of the microRNAs
themselves in the PAR-CLIP experiment or an external sequencing experiment is only a weak
proxy for their activity, as shown below.
In the final output of PARma, for each cluster the most probable seed is assigned together with
a cluster score (Cscore) and a microRNA assignment score (MAscore). The Cscore indicates
how well the observed data (conversions and RNase cleavage sites) fit the model without
considering the k-mer probability and therefore indicates, whether an observed clusters is indeed
a true microRNA target site. The MAscore corresponds to the confidence of the assignment, i.e.
whether there are other active k-mers in the cluster that also match the observed data well.
4.3.2 Cluster detection
After read mapping (see Methods), the first main step of PAR-CLIP data analysis is to identify
clusters of reads corresponding to target sites. Overall, we use a similar procedure as has been
used previously with a few but important modifications:
First, PARma is able to search for clusters using multiple datasets simultaneously. This not
only increases sensitivity, but also provides a straight-forward way for a differential analysis
of target sites, since it is not necessary to identify corresponding clusters from different
experiments afterwards. During the cluster identification, clusters are determined for all datasets
simultaneously, and each cluster is quantified for each dataset.
Second, the original definition of PAR-CLIP clusters (i.e. target sites) by Hafner et al. [2010]
involved a single linkage clustering of overlapping reads. However, we observed several cases
where such a procedure tends to link multiple target sites into a single cluster due to few spurious
reads that connect two obviously distinct clusters (see Figure 4.4a for an example). Such cases
are relatively frequent (see Figure 4.4b) and may be of special interest: For instance, there are
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Figure 4.2: PAR-CLIP data viewer. From top to bottom both panels show conservation scores
(branch lengths of 7-mers as described by Friedman et al. [2008] and the widely used phyloP
[Pollard et al., 2010] and phastCons [Siepel et al., 2005] scores, all computed for the 46-way
vertebrate multiple alignment obtained from the UCSC genome browser [Dreszer et al., 2012]),
the read coverage in each experiment and the genomic sequence of cluster. Below the sequence,
SNP positions according to the 1000 genomes project are indicated in red (here only in Figure
4.2a) and the actual sequencing reads are shown as black bars for each of the experiments.
Mismatches are color-coded as in the genomic sequence on the top (i.e. in both clusters, there
are T to C conversions only). The height of the bar directly corresponds to the read count in
the PAR-CLIP experiment up to a count of 15 reads and more than 15 reads are indicated in
white. Ensembl genes and transcripts are shown below the reads (here only in Figure 4.2a),
together with PAR-CLIP clusters in yellow and seed site assignments in blue. In Figure 4.2a
an experimentally validated targets site of hsa-miR-15 in the 3’UTR of DMTF1 is shown. It
illustrates the characteristic features of many valid target sites (see main text). Interestingly, there
is also a known SNP (red box) in proximity to the seed site. Figure 4.2b depicts an intergenic
(i.e. there are no Ensembl genes or transcripts) cluster that does not show these characteristics.
Additionally, it does not contain a microRNA seed site nor any overrepresented 7-mer according
to PARma. The validated cluster has Cscore and MAscore > 0.9, whereas for the intergenic
cluster, both scores are 0.
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Cluster scores
k-mer activities
compute scores
kmerExplain
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Figure 4.3: Illustration of the PARma procedure. PARma is an iterative algorithm that repeatedly
executes three steps: Based on a current model of PAR-CLIP characteristics (left; see also Figure
4.6), scores are computed for each position in each cluster expressing the likelihood that the
cluster is explained by the activity of the k-mer at this position (top right; see also Figure 4.7).
These scores are fed into kmerExplain as prior probabilies, which then estimates k-mer activity
probabilities using an EM algorithm (bottom). These k-mer activities in conjunction with data
from the PAR-CLIP experiment (T to C conversions, RNase cleavage sites) are used to estimate
the parameters of the PAR-CLIP model. We start this procedure by running kmerExplain on
uniform scores and end it as soon as the model converges.
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Figure 4.4: Overlapping PAR-CLIP clusters. In Figure 4.4a two target sites are shown that would
fall into the same cluster by the definition of Hafner et al. [2010] only because in the two DG75
replicates as well as in the second BCBL1 replicate a few random reads from the right target site
overlap the left target site. Our cluster definition splits all reads into two overlapping clusters (see
the yellow boxes on the bottom. PARma rates both clusters with high Cscores (> 0.6 and > 0.9
for the left and right cluster, respectively) and assigns the KSHV microRNA kshv-miR-K12-7
to the left and the human microRNA hsa-miR-519 to the right cluster with MAscores > 0.9 in
both cases. There is additional evidence that both assignments are correct, since the left cluster
has reads only in KSHV positive cell lines (BCBL1, BC1 and BC3) whereas the right cluster
contains reads in all experiments. Figure 4.4b illustrates that there are hundreds of such cases in
both experiments.
cases known, where viral microRNAs bind to sites in close neighborhood to target sites of human
microRNAs [Nachmani et al., 2010]. Missing individual clusters due to overlapping reads would
be detrimental to such an analysis. Thus, we devised a cluster splitting procedure, that is able to
effectively detect such cases.
And third, we align PAR-CLIP reads to the transcriptome as well as the genome. Transcriptomic
reads are then mapped to genomic coordinates and may therefore produce spliced reads. These
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are properly respected during cluster detection, i.e. PARma is able to detect target sites spanning
exon-exon junctions. In previous studies about AGO-PAR-CLIP data [Hafner et al., 2010;
Gottwein et al., 2011; Lipchina et al., 2011; Skalsky et al., 2012], this has not been considered,
probably missing several highly interesting target sites. Indeed, in the datasets we analyzed,
22.4% of all clusters in the coding region of transcripts span splice junctions (about 6% of all
clusters).
4.3.3 Generative model
The novel feature in PAR-CLIP (in comparison to other CLIP protocols) is the usage of the
uridine analogue 4-thiouridine which is not read as U but as C during cDNA synthesis following
its cross-linking to proteins [Hafner et al., 2010]. Thus, T to C mismatches of aligned sequencing
reads are characteristic for cross-linked sites and, therefore, for contacts of the examined protein
with RNA. Since RNase T1 is used in the PAR-CLIP protocol, which cleaves specifically
downstream of guanine, it is of importance where sequencing reads start and end. It is important
to note that in most cases, the RNase products are shorter than the number of sequencing cycles
(36 for the data of Gottwein et al. [2011] and 50 for our data). Therefore, in these cases the
complete RNA fragments are known.
Visual inspection of these features for known target sites of microRNAs using our PAR-CLIP
data browser (see Figure 4.2) showed several characteristics of these targets sites that go beyond
the characteristics of individual PAR-CLIP sequencing reads (see Figure 4.2a): In most cases,
there is a main cross-linking site and ≥ 60% of all conversions in the cluster belong to this
site, a fact that has been recognized before [Hafner et al., 2010]. In addition, this main cross-
linking site tends to lie in the center of most sequencing reads and T sites upstream tend to
be cross-linked more often than T sites downstream of the main site. Another well-established
feature is the position of seed sites preferentially downstream of the main cross-linking site.
Finally, in addition to these main cross-linking sites, there are main RNase cleavage sites with
specific locations, one ∼10 to ∼20 nt upstream of the seed site, the other usually immediately
downstream of the seed site. While the upstream cleavage site often skips several G sites, the
downstream site is in most cases immediately after the next G.
To formaly represent these features, we developed three independent probabilistic models, the
conversion model and the upstream and downstream cleavage models. Given the position of a
seed site and the positions of uridines or guanosines, respectively, each model is able to predict
where and how many conversions or cleavages, respectively, would be generated by a PAR-
CLIP experiment. By comparing the predicted to the measured data, we compute a likelihood for
each possible seed position within a cluster. Specifically, the conversion model would generate
many conversions directly upstream of the seed position (given there is a uridine), and almost
no conversions within the seed. Thus, such a position would receive a high score only if this is
indeed observed in the experiment.
Model parameters, e.g. how many conversions are expected for each uridine within a cluster,
are directly learned from the data in a per-experiment manner using robust parameter estimation
techniques. Doing this for each dataset individually is important, since experimental conditions
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may be slightly different between experiments, potentially leading to slightly different data per
cluster.
4.3.4 KmerExplain
KmerExplain optimizes a probabilistic model that requires that each target site is targetted
by a single microRNA family, i.e. each cluster must be explained by a single k-mer (i.e.
microRNA seed). There are two conditions for the explaining k-mer implicated by the model:
First, its position in the cluster has to match the generative PAR-CLIP model, i.e. the given data
(conversions and cleavages) are likely to be generated by a seed matching to this positions. And,
second, the k-mer is likely to be active, i.e. there are many instances where this k-mer explains a
cluster. The model is fitted with an EM algorithm.
4.3.5 Seed activities
We applied PARma to a previously published PAR-CLIP dataset consisting of two replicates
for each of the two B-cell lines BC3 and BC1, as well as to our own PAR-CLIP data of two
replicates for each of the two B-cell lines DG75 and BCBL1. First, we analyzed the correlation
of microRNA expression as measured by its PAR-CLIP read count and its activity as measured
by the number of assigned target sites.
Even if it is true that the top 100 expressed microRNAs may explain > 50% of the clusters
by a 6-mer seed, the overall correlation between the microRNA expression and the number of
corresponding target sites is poor (see Figure 4.5). This is a general observation, independent
of how microRNAs have been assigned to the clusters (a variety of options have been explored:
all or a random seed site in the complete cluster, the first or a random seed inside the cluster
but downstream of the main cross-linking sites, using the top 40, 100 or 200 microRNAs, 6-mer
or 7-mer seeds). The poor correlation may be a consequence of sequencing artefacts known to
substantially bias expression estimates of microRNAs [Raabe et al., 2011; Linsen et al., 2009].
In addition, we and others proposed that not only microRNAs may enter the RISC pathway,
but there may be other maturation pathways producing small RNA molecules that could act
analogously to microRNAs in RISC [Haussecker et al., 2010; Cheloufi et al., 2010; Yang et al.,
2010; Cifuentes et al., 2010; Taft et al., 2009; Ladewig et al., 2012; Erhard and Zimmer, 2010;
Maute et al., 2013]. Furthermore, even if only the 7-mer seeds of the top 40 microRNAs are
used and seed sites are only considered when downstream of the main cross-linking site, there
are hundreds of clusters where two or more seeds match. Necessarily, this issue becomes more
severe, if more than 40 microRNAs or all seed sites whithin the cluster are used (see Figures 4.5b
and 4.5d).
Taken together, these facts suggest to abandon the paradigm of taking the top N expressed
microRNAs as candidate regulators for PAR-CLIP clusters. Therefore, we designed PARma to
identify k-mers among all possible 4k k-mers that are explaining multiple clusters with high
probability. Furthermore, they need not only to explain multiple clusters, but their positions must
be in agreement with the model that is learned from the data of all clusters.
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Figure 4.5: Correlation of microRNA expression to the number of assigned clusters. Here,
microRNAs have been assigned to a cluster, when they are among the top 200 expressed
microRNAs and match the first seed site downstream of the main cross-linking site. Neither
in the BCBL1 PAR-CLIP data (Figure 4.5a) nor in the BC3 PAR-CLIP data (Figure 4.5c) any
correlation is recognizable. Figure 4.5b and Figure 4.5d illustrate how many 7-mer seeds match
to clusters, when the top 40,100 und 200 microRNAs are considered and when seeds are searched
in the whole cluster (all) and only downstream of the main cross-linking site (xlink). Even the
strictest assignment (top 40 xlink) leads to a considerable amount of about 1000 ambiguous
clusters in both datasets and at the same time to about 80% unassigned clusters. The fraction
of unassigned clusters drops below 50% when the top 200 microRNA seeds are searched in the
whole cluster but with the cost of having thousands of ambiguous assignments.
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Figure 4.6: PARma model for replicate A of the DG75 experiment. The conversion model in
red represents the conditional propensity that a base gets cross-linked given there is a uridine at
the corresponding position. Note that the propensity is only known up to a constant factor and
arbitrarily scaled to a mode of 1. The blue and green lines illustrate the 3’ and 5’ cleavage models,
respectively. These correspond to the conditional probabilities that the RNase T1 cleavage site is
at a certain position or closer to the seed site given that there is a guanine. The model shows that
the observations made for a few visually inspected validated target sites are also true globally for
many clusters.
4.3.6 Inferred models
Next, we analyzed the generative model that is estimated by PARma. In Figure 4.6, the model
for replicate A of DG75 is illustrated. It indeed reflects the above mentioned observations:
The conversion model indicates the expected ratios of conversions around the seed site for all
positions where a T is located: For instance, if there is a T immediately upstream of the seed site
and a T immediately downstream, the expected ratio of conversions is about 10:1. Furthermore,
the first position in the seed site also seems to get cross-linked with relatively high frequency (for
an example see also Figure 4.2a).
The models from Figure 4.6 are in agreement with knowledge about microRNA target recogni-
tion [Bartel, 2009]: A canonical microRNA binding site consists of a seed site complementary
to the microRNA seed (bases 2 to 7 or 2 to 8), often base 1 is opposite of an A and often there
is additional basepairing of the microRNA 3’ end after a small loop. Thus, the seed site itself
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may be protected from cross-linking by the seed, bases immediately upstream of the seed are
accessible and further upstream bases may also be protected by the microRNA 3’ end to some
extent.
Furthermore, the model also agrees with known structural information of AGO2 [Schirle and
MacRae, 2012]: MicroRNA bases 2 to 6 are solvent exposed and there is a distinct kink
separating bases 6 and 7, which may be resolved by conformation changes of AGO [Schirle
and MacRae, 2012]. These conformation changes may be a reason for the relatively high cross-
linking probability of the first position of the seed site. Another explanation is that PARma may
find several instances of 7-mer-m8 seed sites (pairing of bases 2 to 8) as well as 7-mer-A1 seed
sites (pairing of bases 2 to 7 plus an A opposite of base 1). The first base of the identified k-mer
may therefore be opposite of base 7 or 8 of the microRNA, and, therefore, may or may not be
accessible for cross-linking.
As described above, all three submodels can be used to compute a score for each possible seed
site position within a cluster. The conversion score (see Figure 4.7a for the cluster in Figure
4.2a) indicates that either immediately upstream or downstream of the main cross-linking site
are likely positions for a seed site: The downstream position is obvious, the upstream position
however is also probable, since further upstream there is no T that could get cross-linked. Figures
4.7b and 4.7c illustrate that the seed position is restricted to a small part of the cluster due to the
clear 5’ and 3’ RNase cleavage sites. In addition, based on the estimate of kmerExplain, the k-
mer TGCTGCT (see Figure 4.7d) is highly active and indeed corresponds to the 7-mer-m8 seed
site of the in B-cells highly expressed miR-15/16 family. Hence, PARma is able to predict the
corresponding position with high confidence, which is indeed an experimentally confirmed target
site of miR-15a [Kiriakidou et al., 2004].
Although the PAR-CLIP protocol is rather stringent and thus provides reasonably pure AGO
complexes, other RNA-protein interactions of co-purified proteins or abundant cellular proteins
may be responsible for cross-linked and protein-protected RNA fragments, giving rise to non-
AGO PAR-CLIP clusters. The model we developed also allows computing a cluster score
(Cscore) indicating the likelihood by which a given cluster actually represents a microRNA
binding site, i.e. how well the observed data (conversions and RNase cleavage sites) fit the model
without considering the k-mer probability. The microRNA assignment score (MAscore) indicates
whether there are other overrepresented k-mers in the cluster that also match the observed data
well. The experimentally confirmed target site in Figure 4.2a has Cscore and MAscore of 0.9608
and 0.9777, respectively, whereas the cluster in Figure 4.2b has a Cscore of 0, indicating that
there is no position where conversions and RNase cleavage sites agree.
4.3.7 Evaluation using differential PAR-CLIP
We evaluated PARma against PARalyzer and the standard approaches of assigning seeds of the
top N microRNAs (for N=40, 100 and 200) when they are in the cluster (cluster) or downstream
of the main cross-linking site (xlink) and either assigning every seed (all) or a random/the
first seed (for cluster and xlink, respectively), when there are multiple seeds present. For the
evaluation, we exploit a unique feature of the datasets we used: In our own data, only the cell line
BCBL1 and not DG75 is infected by Kaposi’s sarcoma-associated herpesvirus (KSHV), which
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Figure 4.7: Model scores for the cluster in Figure 4.2a. Each Figure shows how well one of the
submodels of PARma matches when aligned to the 7-mer that starts at the corresponding position.
For instance in Figure 4.7a, the maximal value belongs to the 7-mer TGCTGCT and indicates
that all observed and not observed T to C conversions match very well, when TGCTGCT is
the microRNA seed site. A microRNA targeting the seed site CACATTG (corresponding to the
secondary peak upstream of TGCTGCT) is also likely to lead to the observed conversion. The
cleavage scores in Figures 4.7b and 4.7c indicate how likely the observed RNase T1 cleavages
are, given the seed site is at the corresponding position. Both submodels would allow seed sites
to start within a small window of about 10 bases and indicate that the secondary peak from 4.7a
is unlikely to correspond to the true microRNA seed site. However, they agree with the primary
peak of the conversion scores. Finally, the k-mer activity scores in Figure 4.7d indicate how
many other PAR-CLIP clusters are likely to be explained by the corresponding k-mer and also
points to the 7-mer TGCTGCT. This is indeed the 7mer-m8 seed site for miR-15a, which has
been experimentally validated to target this cluster [Kiriakidou et al., 2004].
encodes 25 mature microRNAs, some of which are highly expressed in BCBL1 [Do¨lken et al.,
2010]. Thus, PAR-CLIP clusters that are assigned to one of the KSHV microRNAs must not be
present in DG75 and we can use the number of KSHV assigned PAR-CLIP clusters in DG75 as a
measure of assignment accuracy. Although both cell lines, BC3 and BC1 in the PAR-CLIP data
from Gottwein et al. [2011] are infected by KSHV, only BC1 is coinfected by Epstein-Barr-Virus
(EBV), which encodes 44 mature microRNAs. Hence, PAR-CLIP clusters that are assigned to
one of the EBV microRNAs must not be present in BC1.
With respect to exclusive sites, PARma is more accurate than all other methods including
PARalyzer independent of the dataset used for evaluation (see Figures 4.8a and 4.8d). More
than 70% of all clusters, where PARma assigned a KSHV or EBV microRNA, only have reads
in BCBL1 or BC1, respectively. This number drops to about 50%, when any seed match of
a KSHV microRNA in a cluster is taken as evidence for a KSHV target site (all.cluster) or
PARalyzer is used. When a seed match immediatly downstream of the main cross-linking site is
used (first.xlink), the accuracy is almost as high as for PARma, but is heavily dependent on both
dataset and the number of microRNAs used. Additionally, PARma’s accuracy is significantly
higher when it is run starting with all 16,384 7-mers (PARma) instead of microRNA 7-mer
seeds only (PARma miR). This suggests, that in several cases, there are seeds of KSHV/EBV
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Figure 4.8: Evaluation using differential PAR-CLIP. KSHV microRNA target sites should only
have reads in KSHV infected cell lines (Figures 4.8a-c) and EBV microRNA target sites should
be exclusive to EBV infected cell lines (Figures 4.8d-f). PARma assigned KSHV microRNA
target sites show a higher fraction of exclusive sites than all other methods (Figures 4.8a,4.8d;
see main text for a description of all other methods) and PARma run without constraining to
known microRNA seeds yielded a higher fraction of exclusive sites than PARma using seeds
as prior. Figures 4.8b and 4.8e show the log fold changes (control/infected) of PAR-CLIP read
counts for clusters assigned to KSHV and EBV microRNAs, respectively. The log fold change of
exclusive clusters (i.e. clusters that have no reads in one of the experiments) has been set to -10 or
10. PARma does not only have the largest fraction of exclusive clusters in both datasets (compare
the left ends of Figures 4.8b and 4.8e to Figures 4.8a and 4.8d, respectively) but also the smallest
fraction of KSHV or EBV clusters that have more reads in the KSHV or EBV negative cell line.
The dependency of scores on the accuracy is shown in Figures 4.8c and 4.8f. In both datasets and
for both scores, accuracy increases when more and more low scoring clusters are removed. As a
reference, the accuracies of the other assignment methods are indicated with the same colors as
in Figures 4.8b and 4.8e.
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microRNAs in a non-exclusive cluster but there are also other overrepresented 7-mers that
explain the conversions and RNase cleavage sites better.
We noticed that often, random reads are scattered across expressed transcripts in all experiments.
Thus, a true KSHV microRNA target site may get random reads in the KSHV negative cell
line (DG75) and therefore, may not be exclusively present in BCBL1. Therefore, we considered
the number of PAR-CLIP reads in each KSHV or EBV microRNA assigned cluster and plotted
their log fold change of DG75/BCBL1 or BC3/BC1, respectively (see Figures 4.8b and 4.8e).
Independent on the fold change cutoff, PARma consistently identifies more KSHV or EBV
microRNA clusters that have less reads in DG75 than in BCBL1 or in BC3 than in BC1,
respectively. Specifically, less than 5% of KSHV cluster have more reads in DG75 than in BCBL1
for PARma assignments, which drops to below 90% for the other assignments.
In order to evaluate the computed Cscores and MAscores (see Methods section), we sorted
clusters according to Cscore or MAscore and computed the fraction of BCBL1 and BC1
exclusive sites for KSHV and EBV microRNA assigned clusters, respectively. For both datasets
the accuracy increases, when more and more of the low scoring clusters or clusters with multiple
possible microRNAs are removed, achieving accuracies of 80% or more (see Figures 4.8c and
4.8f).
4.3.8 Validation against RIP-Chip data
To further validate target sites and target site assignments that are only found by PARma, and
to invalidate target sites that have not been detected by PARma but by other methods, we
considered RIP-Chip data that we measured for the cell lines DG75 and BCBL1 [Do¨lken et al.,
2010]. In a RIP-Chip experiment, the amount of an RNA co-immunoprecipitated using an anti-
AGO2 antibody is compared to RNA from a control-IP using microarrays. Thus, it measures the
recruitment of an mRNA to Ago2-complexes in a quantitative way and is an alternative technique
to PAR-CLIP to determine microRNA targets. Using proper data analysis methods [Erhard et al.,
2013b], the differential enrichment of mRNAs with RISC can be computed between BCBL1 and
DG75, which indicates, whether an mRNA is stronger associated with RISC in BCBL1 than in
DG75. On average, this must be the case for targets of KSHV microRNAs.
Thus, we determined all genes that contain a KSHV microRNA target site according to PARma
and Paralyzer (both), that contain a KSHV microRNA target site according to PARma and no
KSHV microRNA target site according to Paralyzer (PARma only) and that contain a KSHV
microRNA target site according to Paralyzer only (Paralyzer only) and compared it to genes
without KSHV microRNA target sites (none; see Figure 4.9a). The both and PARma only genes
showed significantly elevated differential RIP-Chip enrichment values (p < 2 × 10−4 and
p < 2 × 10−7, respectively, one-sided Kolmogorov-Smirnov test), whereas Paralyzer only and
none genes were indistinguishable from background. Thus, based on the RIP-Chip data, PARma
effectively gets rid of false positive target sites detected by Paralyzer, and, in addition, picks up
false negatives not detected by Paralyzer. We also repeated the same analysis for other methods
replacing Paralyzer with similar results (see Figure 4.9b).
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Figure 4.9: Validation against RIP-Chip. Figure 4.9a shows the distribution of differential RIP-
Chip enrichments (PC2 scores) of BCBL1 and DG75 for different sets of PAR-CLIP targets.
Higher values indicate a stronger enrichment of a gene with RISC in BCBL1 than in DG75,
and, therefore, a set of KSHV microRNA targets should have a right-shifted distribution of PC2
scores. Genes that have been identified by PARma as well as Paralyzer to be KSHV microRNA
targets indeed show such a shift, as well as genes that have only been found by PARma and not by
Paralyzer (PARma only). In contrast, genes that are not targets of KSHV microRNAs according
to both PARma and Paralyzer do not show a shift. Interestingly, genes found exclusively by
Paralyzer and not by PARma are not shifted as well. We repeated this analysis for all other
methods, as illustrated in Figure 4.9b. The p-values for the comparisons of PARma to all other
methods indicate that PARma not only outperforms Paralyzer but all other methods as well.
4.4 Discussion
4.4.1 PAR-CLIP clusters
In this paper, we present a in-depth investigation of seed sites in PAR-CLIP clusters. The standard
approach to assign microRNAs in all so far published PAR-CLIP studies [Hafner et al., 2010;
Gottwein et al., 2011; Lipchina et al., 2011; Skalsky et al., 2012] was to select the top N expressed
microRNAs and identify seed sites in the respective PAR-CLIP clusters. However, it is not clear,
how N must be chosen: For small N, only a small fraction of clusters can be assigned and
for larger N, cluster assignments get more and more ambiguous. Furthermore, independent on
the choice of N or the exact way of searching for seeds, microRNA expression correlates only
poorly with the number of clusters. Also, there are multiple studies reporting small RNAs other
than microRNAs that are associated with the RISC. Thus, it seems advantageous to remove the
restriction of searching for a predefined set of seeds.
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PARma can be used for both searching for a predefined set of seeds and for an unconstrained
search for all possible k-mers. In both cases, the assigned seeds fulfill two conditions in
each cluster: First, the observed T to C conversions and RNase cleavage sites relative to the
seed position match a model derived from all clusters and second, the seed site sequence is
overrepresented. As illustrated in Figure 4.8, the unrestricted search is even more accurate in
terms of assigning KSHV or EBV microRNAs to clusters that are exclusively present in KSHV
or EBV infected cells, respectively.
We propose that the general approach of PARma can also be applied to other kinds of CLIP
data. For instance, for iCLIP data [Ko¨nig et al., 2010], reads in valid target sites should start
immediately after cross-linking sites. These specific start positions could be incorporated into
an iCLIP model instead of the PAR-CLIP model of conversions and RNase T1 cleavage sites.
However, how effective it is to exploit these characteristics of iCLIP data remains to be seen
when more and more iCLIP data becomes available.
Clusters from a CLIP experiment are not necessarily true binding sites of the protein of interest:
Neither the immunoprecipitation (IP) step nor the gel separation are 100% specific and thus,
there may be artefacts of other RNA binding proteins (RBPs). If 40 distinct microRNA seeds are
considered and matched to such clusters, more than 20% of the unspecific clusters are expected
to contain at least one seed match by chance (assuming an average cluster length of 30 bp and
a seed length of 6). This increases to almost 70%, when 200 microRNA seeds are considered.
Thus, we expect that there is a considerable amount of false positive microRNA target sites in
current PAR-CLIP datasets. Finding a reliable way of scoring clusters in order to filter such false
positives is therefore of great importance.
To our knowledge, PARma is the first method to provide a scoring system that has been proven to
improve accuracy upon filtering. The rationale for that is that there is no reason why unspecific
clusters should match our PAR-CLIP model. Indeed, Cscores of intronic clusters, which likely
are the result of unspecific IPs of other RBPs, are significantly lower than Cscores of 3’-UTR
clusters (data not shown) in both AGO-PAR-CLIP datasets, which is in agreement with known
mechanisms of microRNAs. Furthermore, even if unspecific clusters may match the PAR-CLIP
model by chance and contain active k-mers by chance, it is unlikely that these k-mers occur
at a position that matches the model. Thus, both Cscore and MAscore are expected to improve
accuracy (see also Figure 4.8c and 4.8f).
4.4.2 PARma
For the conversion model used in PARma, we assume that cross-linking events are independent
from each other. This means that given an uridine at a certain position relative to the seed site,
the probability that a cross-linking event takes place and is sequenced at this position is not
dependent on the location of other uridines. This assumption may be wrong, if one of the other
uridines is already cross-linked. However, the probability that two cross-links can occur in close
vicinity to each other is very low, since the incorporation rate of 4-thiouridine (4sU) is only about
1/40 and only 4sU gets cross-linked with high frequency at the wavelength used in PAR-CLIP
[Hafner et al., 2010]. In addition, the reverse transcriptase (RT) is known to be rather inefficient
in reading through the peptide chain still cross-linked to the 4sU-residue (which is responsible
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for the U to C transition). Therefore, it becomes rather unlikely that the RT reads through two
cross-links in a single RNA fragment.
Note also, that the model for conversions is not simply built by summing all cross-linking events
for each position globally over all clusters. Such a procedure would be heavily influenced by a
few clusters that have thousands of reads in comparison to the many clusters having only a few
dozen reads. In contrast, our parameter estimation for the conversion model does not only exploit
all clusters, but is also robust against outlier clusters by using robust regression and quadratic
programming. Robustness in the parameter estimation is an important issue especially in the
initial iterations. This is because seeds are not yet assigned with high confidence leading to many
outliers.
PARma does not necessarily assign seed sites directly downstream of cross-linking sites. When
the next uridine upstream of a true seed site is several nucleotides away, it may still get cross-
linked. In such a case, PARma may still find another k-mer closer to the cross-linking site,
dependent on the sequences, on other cross-linking events in the same cluster and on the RNase
cleavage sites. However, PARma will report a low MAscore, since the other position will score
similarly well.
PARma can be run for different values of k. The smallest reliable seed used in the literature is
microRNA bases 2-7 [Bartel, 2009; Kertesz et al., 2007; Grimson et al., 2007; Friedman et al.,
2008; Krek et al., 2005]. However, we noticed that PARma with k = 6 resulted in slightly
worse accuracies for both our data sets in comparison to k = 7 (data not shown). This may be
a consequence from the fact that random 6-mers are expected to occur every 4096 bases, and
thus, every ∼100 clusters (median length of clusters is 47). When at least 100 microRNAs with
different 6-mer seeds are considered, every single cluster would on average have a seed match by
chance. Thus, kmerExplain may have difficulties to reliably extract the signal of overrepresented
6-mers.
By the requirement that only a single k-mer is enough to explain a cluster, kmerExplain is able
to avoid overrepresented partial k-mers: Consider the 7-mer-A1 seed site UCGUCGA that is
explaining hundreds of clusters. Obviously, the sequence CGUCGAG is expected to be present
in 1
4
of these clusters and is thus highly overrepresented in the collection of all clusters. This
overrepresented partial k-mer may also occur in additional clusters, i.e. without the leading U.
Even if it is not overrepresented by itself but only due to an overlapping k-mer that is truly
overrepresented, all additional occurences may be mistaken for the seed site of a targeting
microRNA not because the microRNA is active but only because of the overlap to an active
microRNA seed. Obviously, kmerExplain avoids such overrepresented partial k-mers by the
requirement that only a single k-mer can explain a cluster.
4.4.3 Comparison to PARalyzer
PARalyzer is a software package specifically designed for the analysis of PAR-CLIP data
[Corcoran et al., 2011]. It utilizes kernel density estimation to estimate the probability of
interaction along each cluster based on the normalized numbers of conversions and non-
conversions at each position. There are two main differences to the basic approach from Hafner
et al. [2010]: First, an interaction site is called when the estimated density of conversions is
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greater than the estimated density of non-conversions instead of using the main cross-linking
site for all clusters, which are filtered by certain criteria, and second, due to the kernel, the
neighborhood of uridine sites is incorporated dependent on an arbitrarily chosen bandwidth
parameter. It is unclear whether this approach is able to effectively filter out unspecific clusters. In
addition, the pattern discovery module does not incorporate the information of cross-linking or
RNase cleavage positions and is, thus, unable to resolve and score ambiguous seed matches.
Furthermore, the PARalyzer pipeline does not include methods to handle spliced reads and,
therefore, all studies that have used PARalyzer [Corcoran et al., 2011; Gottwein et al., 2011;
Skalsky et al., 2012] may have missed all target sites that span exon-exon junctions. In the
datasets we analyzed, 22.4% of all clusters in the coding region of transcripts span splice
junctions (about 6% of all clusters).
4.4.4 Differential PAR-CLIP
In order to evaluate PARma, we directly compared the number of PAR-CLIP sequencing reads
from multiple experiments mapped to each individual cluster. Our evaluation is based on the
following consideration: When a cluster represents a valid target site of a KSHV microRNA,
for instance, AGO should not be associated with it in KSHV negative cells and, therefore, the
corresponding PAR-CLIP experiment should not yield sequencing reads mapping to this cluster
(exclusive clusters).
While this is true for ∼ 80% of all clusters assigned to a KSHV or EBV microRNA in both of
the respective datasets when PARma is used (see Figures 4.8b and 4.8e), there is a considerable
number of clusters, where this is not true. There may be several reasons for these: First, there
is a considerable amount of background in the data, i.e. sequencing reads that are not due to
specific cross-linking to AGO and indeed, almost all clusters have a positive log2 fold change
of PAR-CLIP reads, which may be a consequence of background. Second, a target site could be
targeted by multiple microRNAs. This is very probable for seed homologous viral microRNAs
(e.g. kshv-miR-K12-11 has the same seed as hsa-miR-155), but may also come from strongly
overlapping target sites. Accuracy increases when clusters are filtered by MAscore (see Figure
4.8c and 4.8f), which also indicates ambiguous assignments. Third, clusters may not be valid
target sites and just by chance contain seeds of KSHV or EBV microRNAs, respectively, since
accuracy also increases when clusters are filtered by Cscore.
It would be of great benefit to be able to convert our scores to a false discovery rate as a
statistically meaningful measure. This could be done if there was a way to determine how many
of the non exclusive clusters are still valid KSHV or EBV target sites. However, it is difficult
to estimate the background, which is dependent on transcript expression, on other RNA binding
proteins that target these transcripts and probably on many more factors. Additionally, the extent
of overlapping or truly ambiguous target sites is unclear. Furthermore, the presence of reads is
subject to stochastic sampling effects due to the relatively small numbers of reads. Thus, it is
currently not possible to estimate reliable false discovery rates based on differential PAR-CLIP.
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Conclusion
In this paper we presented PARma, a method to analyze PAR-CLIP data. Clusters are defined in a
similar way as before [Hafner et al., 2010; Corcoran et al., 2011]. The main purpose of PARma is
a) to define reliable microRNA target sites and b) to identify the microRNA responsible for each
identified target site. Therefore, two scores are computed: The Cscore assesses the likelihood that
a cluster is a valid microRNA target site and the MAscore corresponds to the confidence that the
assigned microRNA is the true regulator.
PARma utilizes features specific to PAR-CLIP data to determine seed sites: The positions of
cross-linking sites and missing cross-linkings as well as cleavage sites of RNase T1 relative to
seed sites are learned and incorporated into a generative model. This model is used to guide a
novel pattern discovery tool, kmerExplain, that estimates activity probabilies for k-mers.
Our method can be used to discover active k-mers in an unbiased manner, i.e. without assuming
a set of admissible k-mers such as the top N microRNA seeds. Each reported active k-mer
nevertheless has two properties: It explains several clusters and the positions where it occurs
match the model of PAR-CLIP data learned from all target sites.
Using differential PAR-CLIP data, we have shown that PARma is more accurate than existing
methods and that both Cscore and MAscore are useful measures to rank clusters.
4.5 Methods
4.5.1 Data
The data from Gottwein et al. [2011] has been downloaded from GEO (accession number:
GSE32113). DG75 and BCBL1 PAR-CLIP experiments have been performed as described
[Kishore et al., 2011; Jaskiewicz et al., 2012]. Briefly, a total of 3 ∗ 108 cells per replicate were
grown and treated with 4-thiouridine (Sigma) for 14 hours (final concentration 100 µM). Cells
were pelleted and washed in cold PBS. Aliquotes of 5 ∗ 107 cells were resuspended in 5 ml of
cold PBS, placed in a 15 cm petri dish and irradiated at 365 nm with 100 mJ twice on ice, with
30 s break in between. Crosslinked cells were collected, pelleted and snap-frozen. PAR-CLIP
was performed using 11A9 anti-Ago2 monoclonal antibody [Ru¨del et al., 2008]. PAR-CLIP
sequencing data have been deposited at GEO (accession number: GSE43909).
4.5.2 Raw data processing and cluster definition
The deep sequencing data have been processed using an in-house pipeline consisting of adapter
trimming, read mapping against genomes and transcriptomes, integrating all mappings and
cluster identification as well as filtering.
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Read mapping
The 3’ sequencing adapter sequence are trimmed from each sequencing read using a specially
tailored sequence alignment variant that alignes a prefix of the adapter sequence to a suffix
of each sequencing read. After that, equal sequences are collapsed and mapped to the human
genome (hg19), the KSHV genome (NC 009333.1), the EBV genome (NC 009334.1) and the
human transcriptome (Ensembl v60) using Bowtie version 0.12.7 [Langmead et al., 2009]. For
each collapsed read, all mappings for an experiment are then collected and the best in terms
of mismatches is written to a single BED file for each experiment including information about
the read count (number of sequences before collapsing), the mismatches of each alignment and
the number of alignments after mapping transcriptome alignments to the genome. Here, T to
C conversions are not counted as mismatches, since they are expected due to the experimental
protocol.
Cluster identification
All BED files are then simultaneously scanned chromosome by chromosome in a strand specific
manner and overlapping reads are clustered. We use only reads without mismatches (except for T
to C conversions). Clusters are then filtered according to similar criteria as before [Hafner et al.,
2010; Corcoran et al., 2011]: read count at least 5, at least 3 distinct read species. Clusters are
quantified using the count of the main cross-linking site. After clustering, normalization factors
are computed such that the median fold change to a reference experiment (we took the one with
the most reads) is 1. Then, in a second pass, all clusters are removed where all experiments have
less than 10 normalized read counts.
We also implemented three additional options: First, it is known that two target sites may overlap.
Especially for viral microRNAs, several of such cases are known [Nachmani et al., 2010]. Thus,
we split each cluster: Only reads spanning the main cross-linking site are used and the criteria
from above are checked. Then, the main cross-linking site of the remaining reads is determined.
This is repeated as long as all criteria are fulfilled.
Second, since target sites may span splice junctions and we mapped reads to the transcriptome,
we can also identify spliced PAR-CLIP clusters. However, when allowing for spliced reads, the
definition of a cluster is not straight-forward: For instance, for a 3’ end of an exon, there may be
reads starting in the exon and ending in the neighboring intron and reads that connect this exon
to various other exons. We resolve such inconsistencies by first removing all exon-intron reads
and then by removing reads to exons with fewer reads, if necessary.
Third, since target sites may be wider than the maximal sequence length, we extend all
untrimmed reads up to the next RNase T1 cleavage site (i.e. after the next G). This is important
because in the following, we specifically use these cleavage sites in our generative model.
Visualization
In order to visualize PAR-CLIP data apropriately, we developed a specialized web-based
visualization tool (see Figure 4.2). Other than the widely used genome browsers from UCSC
or Ensembl, our viewer offers specialized visualization tools for PAR-CLIP data: We visualize
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several evolutionary conservation scores, including k-mer branch lengths that have been used for
microRNA target prediction [Friedman et al., 2008], sequence read coverage, SNPs, the actual
reads with indicated conversions, conversion densities, transcripts and PAR-CLIP clusters. Other
than genome browsers, our viewer is able to shrink introns in a data dependent way (i.e. if there
are no reads mapped to an intron, is is not visualized in scale to the exons but shrunked to a
few pixels). This is a major advantage to showing everything in scale when visualizing transcript
related data, since usually the long introns are often not of interest in contrast to the short exons.
4.5.3 PARma
The result of our preprocessing, which is very similar to previous work [Hafner et al., 2010;
Corcoran et al., 2011], is a set of clusters L. Each cluster L ∈ L is characterized by its sequence
s(L), its conversion profile convL and two vectors startL and endL. convL is a vector containing
for each position within L the number of conversions, whereas startL and endL contain for
each position the number of reads starting and ending there, respectively. Furthermore, we define
T (L) = {i ∈ {1..|s(L)|}|s(L)i = T} as the set of possible conversion sites and G(L) = {i ∈
{1..|s(L)|}|s(L)i = G} as the set of possible RNase T1 cleavage sites.
Model fitting
The PARma model consists of three submodels, incorporating T to C conversion data, 5’ RNase
cleavage data and 3’ RNase cleavage data, respectively. The conversion model assigns each
position i relative to the seed site a cross-linking probability xlink(i). Then, the cross-linking
score sxlink for a seed position j in cluster L can be computed as
sxlink(L, j) =
∑
k∈T (L)
convL(k) · xlink(j − k)∑
k∈T (L)
convL(k) ·
∑
k∈T (L)
xlink(j − k)
This is essentially the normalized dot product of two vectors: The first vector contains the
observed conversion counts for all conversion positions, the second contains the cross-linking
probabilities for these positions. Thus, sxlink(L, j) = 1 if and only if the observed conversions
exactly meet the expected cross-links and approaches 0 when the observed counts differ from
the expected. Note that xlink must only be known up to a constant factor. This allows us to
fit the model without making any further assumptions: Given a current estimate j of the seed
position for each cluster L, we first estimate the ratio Rk,l for each pair of model positions k and
l by collecting all clusters L with j − k ∈ T (L) and j − l ∈ T (L). Then we use robust linear
regression to fit a line through the origin given the values convL(j − l) and convL(j − k) of all
collected clusters L. The slope of this line then is a robust estimate of Rk,l. Given the estimates
of Rk,l for all k < l, we obtain the final estimate of xlink by minimizing
∑
k,l
(
xlink(k)
xlink(l)
− Rk,l
)2
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subject to xlink(j) ≥ 0 and Σjxlink(j) = 1 using quadratic programming. Note that the final
constraint arbitrarily fixes the above mentioned constant factor and is necessary to get a unique
solution.
The 3’ RNase cleavage model assignes each position i relative to the seed site the cumulative
probability c3(i), that the RNase cleavage site is ≤ i. Given a cluster L, let G(L) = {k1, ..., kn}
with ki−1 < ki. Then, the downstream cleavage score sdownstream for a seed position j in cluster
L can be computed as
sdownstream(L, j) =
∑
i∈1..n
endL(ki) · p(ki)∑
i∈1..n
endL(ki)
p(k0) = c3(j − k0)
p(ki) = c3(j − ki)− c3(j − ki−1)
Note that we use cumulative probabilities here: In contrast to cross-linking positions, RNase
cleavage sites are not independent: For instance, let cluster L1 have two consecutive G 5 bp
downstream of the true seed site (=SEED=NNNNNGG...) and cluster L2 only one G 6 bp
downstream of its true seed site (=SEED=NNNNNNG...). The second G in L1 is at the same
position relative to the seed site as the single G in L2. The RNase may have enough room to cut
after the first G in L1 and thus, all reads in L1 may end 5 bp downstream of the seed site. In
cluster L2, all reads will end 6 bp downstream of the seed site. Thus, depending on where other
G sites are located, read end probabilities will differ. Using cumulative probabilities in the model
and computing the probabilities depending on G locations from cumulative probabilities is able
to alleviate this problem. c3 is estimated by using the current estimates j of the seed position for
each cluster L. The cumulative probability then is the number of times a position is upstream of
the main RNase cleavage site divided by the number of clusters.
The 5’ RNase cleavage model is formulated analogously to the 3’ model. The final score for a
position j in cluster Li then is calculated as the product of the three submodel scores:
pi,j = sxlink(Li, j) · sdownstream(Li, j) · supstream(Li, j)
KmerExplain
Given a set of sequences S = {S1, ..., Sn} and scores pi,j for each position j in cluster Li,
kmerExplain estimates k-mer activity probabilities using an EM algorithm for the following
probabilistic model: We assume that each sequence is generated by only a single k-mer. Then,
the probability of generating a sequence S by a k-mer at its jth position is
P (S|j) = αSj ·
∏
c 6=j
(1− αSc)
Here, αx is the activity probability of k-mer x and Sj denotes the jth k-mer in S. The likelihood
of S then is
68 4. PARma: identification of microRNA target sites in AGO-PAR-CLIP data
P (S) =
n∏
i=1
P (Si) =
n∏
i=1
∑
j
P (S|j)pi,j
Thus, we have to estimate αx for all k-mers x under hidden parameters j (active k-mer position
in Si). In the E-step we compute the values qi,j given the current estimates of αx as
qi,j =
pi,jP (Si|j)∑
c pi,cP (Si|c)
The values qi,j represent current estimates of the probability P (j|Si). The estimator for αx then
is (M-step; δx=y is the Kronecker delta: δx=y = 1⇔ x = y):
αx =
1
n
∑
i,j
qi,j · δx=Sj
i
(4.1)
Proof: The conditional expected value of the log likelihood and its partial derivative with respect
to αx are:
E =
∑
i,j
qi,j logP (Si|j) (4.2)
=
∑
i,j
qi,j log
(
αSj
i
·
∏
c 6=j
(1− αSc
i
)
)
(4.3)
δE
δαx
=
1
αx
Qx −
1
1− αx
Qx (4.4)
Qx =
∑
i,j
qi,j · δx=Sj
i
(4.5)
Qx =
∑
i,j
qi,j · (1− δx=Sj
i
) (4.6)
Respecting that Qx +Qx = n, setting (4.4) to zero and solving for αx yields equation (4.1). 
Final assignment and integration
The output of the final iteration consists of scores pi,j for each position j in cluster Li as well as
qi,j, which are estimates of the probability P (j|Si). The first is a quantity indicating how well
the experimental data fits the model, when any k-mer at position j has generated cluster Li. The
latter also incorporates the k-mer activity probability (i.e. how well does the experimental data
fit the model, when the given k-mer at position j has generated cluster Li). Furthermore, for each
cluster Li we get the most probable k-mer generating this cluster at position gi = argmaxj{qi,j}
We use these quantities to compute confidence scores for each cluster (Cscore) and each k-mer
assignment (MAscore):
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Cscore(i) = pi,gi (4.7)
MAscore(i) = qi,gi∑
j qi,j
(4.8)
We integrate multiple experiments (either replicates of the same condition or multiple conditions)
by first running PARma for each experiment individually and then taking the generating k-mer
by computing a weighted sum over all qi,j from all experiments (weighted by the respective read
count in the cluster) and taking the maximum. The Cscore then is the weighted sum of the pi,gi
values and the MAscore the maximal MAscore of all experiments at this position.
4.6 Software availability
PARma is published under the GNU General Public License v3 and at the project website
http://www.bio.ifi.lmu.de/PARma.
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Chapter 5
RIP-chip enrichment analysis
Motivation: In the previous chapter I presented a method to accurately identify microRNA
targets in PAR-CLIP data. PAR-CLIP is a relatively new experimental technique to discover
microRNA targets and involves several experimental steps that may potentially fail (see section
2.1.2). RIP-Chip is a more established method, it involves less experimental steps with the cost of
only identifying target genes instead of target sites. Furthermore, it inherently involves a control
experiment and, thus, RIP-Chip provides quantitative measurements of microRNA targets (i.e.
how many copies of an mRNA are bound by RISC). In any case, RIP-Chip and PAR-CLIP both
provide different aspects of microRNA targets and, therefore, complement each other. Thus, it
is not only important to analyse PAR-CLIP data properly as described in the previous chapter,
but also to handle RIP-Chip data in an appropriate way. Our collaboration partners generated
several RIP-Chip datasets [Do¨lken et al., 2010], and based on observations made from these
data, I developed analysis methods that address several issues associated with RIP-Chip data,
as described in this chapter. Equally to PARma, these methods were also applied to the available
datasets for the analyses presented in the next chapter.
Publication: This chapter has been published in Bioinformatics [Erhard et al., 2013b]. Here, I
adapted the layout and made minor corrections to the text.
My contribution: I came up with the ideas and the methods, implemented the method, carried
out evaluations and wrote the paper.
Contribution of co-authors: Lars Do¨lken provided RIP-Chip data and helped to revise the
manuscript. Ralf Zimmer supervised the work and helped to revise the manuscript
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5.1 Abstract
5.1.1 Motivation
RIP-chip is a high-throughput method to identify mRNAs that are targeted by RNA binding
proteins. The protein of interest is immunoprecipitated and the identity and relative amount
of mRNA associated with it is measured on microarrays. Even if a variety of methods is
available to analyze microarray data, e.g. to detect differentially regulated genes, the additional
experimental steps in RIP-chip require specialized methods. Here, we focus on two aspects
of RIP-chip data: First, the efficiency of the immunoprecipitation step performed in the RIP-
chip protocol varies in between different experiments introducing bias not existing in standard
microarray experiments. This requires an additional normalization step to compare different
samples and even technical replicates. Second, in contrast to standard differential gene expression
experiments, the distribution of measurements is not normal. We exploit this fact to define a set
of biologically relevant genes in a statistically meaningful way.
5.1.2 Results
Here, we propose two methods to analyse RIP-chip data: We model the measurement distribution
as a gaussian mixture distribution, which allows us to compute false discovery rates (FDRs)
for any cutoff. Thus, cutoffs can be chosen for any desired FDR. Furthermore, we use
principal component analysis to determine the normalization factors necessary to remove
immunoprecipitation bias. Both methods are evaluated on a large RIP-chip dataset measuring
targets of Ago2, the major component of the microRNA guided RNA induced silencing complex
(RISC). Using published HITS-CLIP experiments performed with the same cell line as used
for RIP-chip, we show that the mixture modelling approach is a necessary step to remove
background, that computed FDRs are valid and that the additional normalization is a necessary
step to make experiments comparable.
5.1.3 Availability
An R implementation of REA is available on the project website (http://www.bio.ifi.lmu.de/REA)
and as supplementary data file.
5.2 Introduction
Gene expression is a highly complex process that is controlled on multiple levels by various
proteins and RNAs. Various experimental protocols have been established to measure expression
levels of mRNAs or proteins, targets of transcription factors or post-transcriptional regulators
and many other parameters of gene expression in a genome-wide manner. Each step of such a
high-throughput experiment may introduce systematic errors (bias) or random variation (noise)
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Figure 5.1: Measurement distributions for our Ago2 RIP-chip experiment. Boxplots for the
intensity distributions of the measured microarrays described in the Methods section are shown
in Figure 5.1a. Altough the intensity distributions of the various arrays are properly normalized
using RMA, the enrichment distributions are significantly different from each other (see Figure
5.1b). This is a consequence of differing IP efficiencies and must be accounted for when
analyzing the respective data.
into the generated data and specialized methods are necessary to deal with particular kind of bias
and noise and to answer specific questions using high-throughput data.
The most widely used high-throughput experiments are based on microarrays or next generation
sequencing (NGS) and are designed to measure the amount of all mRNAs in one or multiple
conditions [Malone and Oliver, 2011]. Based on the raw intensities from a microarray experiment
or the sequencing reads from an NGS experiment, several analytical steps are taken, including
normalization, summarization and statistical evaluation [Gentleman, 2005]. There is a vast
amount of literature describing various methods fulfilling these steps to identify differentially
regulated genes [Park et al., 2003; Fundel et al., 2008; Marioni et al., 2008; Wang et al., 2009;
Irizarry et al., 2006].
Chromatin immunoprecipitation followed by microarray analysis or next generation sequencing
(ChIP-chip/ChIP-seq) can determine the targets of DNA binding proteins and has successfully
been applied to a wide range of transcription factors and cell types [Ren et al., 2000; Johnson
et al., 2007; Birney et al., 2007]. In addition to the above mentioned analysis methods necessary
for microarray and NGS data, it has been recognized that additional methods are necessary to
successfully determine target sites on the genome and thus, a variety of methods is described in
the literature [Zhu et al., 2010; Ho et al., 2011; Park, 2009].
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In recent years it has become apparent that transcriptional regulation is only one part of
the machinery carrying out gene regulation. RNA binding proteins (RBPs) and RNA binding
ribonucleoproteins (RNPs) play important roles and are responsible for splicing, RNA editing,
regulation of translation and RNA degradation [Witten and Ule, 2011; Nishikura, 2006; Bartel,
2009]. These processes are highly regulated by sequence-specific binding of RBPs or RNPs to
the mRNA. MicroRNAs are small 20-24 nt long RNA molecules, that have emerged in recent
years as important post-transcriptional regulators involved in all known multicellular organisms.
They play important roles in development, tumorigenesis and viral infection. They act by guiding
the RNA induced silencing complex (RISC) to mRNAs by binding to their 3’UTRs in a sequence
specific manner, which leads to inhibition of translation or RNA degradation [Bartel, 2009].
A powerful experimental high-throughput technique to detect targets of RNA binding proteins
or ribonucleoproteins such as RISC is based on immunoprecipitation (IP) of the RBP or RNP
with associated mRNAs followed by microarray or NGS measurement (RIP-chip/RIP-seq)
[Mukherjee et al., 2009; Hendrickson et al., 2008; Karginov et al., 2007; Stoecklin et al.,
2008; Landthaler et al., 2008]. Targets of the RBP/RNP are enriched in the RIP experiment
in comparison to a control measurement using an unspecific antibody or total RNA. Novel
techniques including HITS-CLIP, iCLIP and PAR-CLIP also include crosslinking of the protein
to the mRNA followed by digestion of the unprotected mRNA in order to determine the precise
location of the target site [Chi et al., 2009; Ko¨nig et al., 2010; Hafner et al., 2010].
The main question in a RIP-chip experiment is to determine the set of target genes of the
immunoprecipitated protein. A basic answer is a sorted list of enrichment values that can be
computed for each gene by dividing the intensity value in the IP fraction microarray by the
intensity in the control microarray. This is very similar to standard differential gene expression
(DE) experiments: Here, differentially regulated genes can be determined by a sorted list of fold
changes computed for each gene by dividing the intensity in condition A by the intensity in
condition B. Consequently, RIP-chip data is often analyzed using standard methods borrowed
from the DE setup such as fold changes [Stoecklin et al., 2008], t statistics [Mukherjee et al.,
2009] or moderated t statistics [Hendrickson et al., 2008].
However, as indicated above, additional experimental steps may introduce additional bias: In
contrast to log fold change distributions of DE experiments, log enrichment distributions of
RIP-chip experiments are not normal but typically have heavier right tails (Mukherjee et al.
[2009]; Do¨lken et al. [2010], see also Figure 5.1). This is an indication that RIP-chip is able
to separate true targets from the background very efficiently. Here, we exploit these skewed
distributions to estimate the biological significance of genes. Note that this is different from the
statistical significance usually computed for DE experiments, where p-values are related to the
reproducibility of the measurements and not to biological relevance.
The above mentioned question about the set of target genes in a RIP-chip experiment only
considers a single condition, in contrast to a DE experiment. However, especially for RISC-
IP experiments, an additional question is to determine differential microRNA targets between
two or several conditions. For instance, if these conditions are control and transfected microRNA
[Hendrickson et al., 2008], differential targets would be targets of the transfected microRNA,
if there are uninfected and virus infected cells, differential targets would include targets of viral
microRNAs [Do¨lken et al., 2010]. The answer to this question can be given by genes that are more
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enriched in condition A than in condition B, either by choosing two cutoffs on the corresponding
enrichment values (i.e. at least x fold enriched in A and at most y fold enriched in B) [Do¨lken
et al., 2010], by computing differential enrichment values as the ratio of the two enrichment
values [Hendrickson et al., 2008] or by a mixture of both approaches [Karginov et al., 2007].
All answers to this question necessarily have to compare enrichment values (i.e. ratios of intensi-
ties) of the conditions. However, IP efficiencies may vary between independent experiments, and
it is important to account for this bias when comparing enrichment values. Obviously, the same
problem exists for the summarization of replicate measurements (see Figures 5.1 and 5.6).
Here, we develop a suite of methods to properly analyze RIP-chip datasets, which take care
of the unique properties of such data introduced by the IP: First, we use a gaussian mixture
model approach to find statistically meaningfull cutoffs for enrichment values. We show that this
approach can be used to filter unexpressed genes, that it allows to compute false discovery rates
(FDRs) for sets of biological significant genes and that it is in fact a necessary step to make
experiments comparable to each other. We also address the problem of differing IP efficiencies
by introducing a principal component analysis (PCA) based method to normalize enrichment
distributions in a data dependent manner. We use publicly available HITS-CLIP data measured
for the same cell lines [Riley et al., 2012a] as standard-of-truth for evaluation and show that the
proposed methods provide significant improvements for the analysis of RIP-chip data.
5.3 Methods
5.3.1 Data processing
The RIP-chip data for this paper has been taken from our study of herpes viral RISC-IP
experiments [Do¨lken et al., 2010]. Since the publications of the original study, additional
replicates have been measured and all chips including the new ones have been processed as
described [Do¨lken et al., 2010]. Briefly, RNA from Ago2-IPs and either BrdU-IPs or total
RNA has been measured on Affymetrix GeneST arrays and all raw data have been normalized
using RMA [Irizarry et al., 2003], log2 enrichment values have been computed by subtracting
the control-IP/total RNA log intensity from the Ago2-IP log intensity for each probeset and
each replicate experiment. Then, probesets have been mapped to Ensembl genes by using the
annotation derived from Biomart. HITS-CLIP clusters (i.e. high confidence microRNA target
sites) used to evaluate the mixture model approach for the cell line Jijoye has been downloaded
from the supplementary data of Riley et al. [2012a]. We also repeated the same analysis using
PAR-CLIP data for Jijoye that has been measured and analyzed as described in Hafner et al.
[2010] in the lab of Markus Landthaler at the MDC Berlin (will be published elsewhere).
5.3.2 Mixture model fitting
Gaussian mixture models for sets of log enrichment values are fitted using the Mclust package in
R [Fraley and Raftery, 2002]. Z-scores for each gene can then be computed using the background
distribution:
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zscore(g) =
e(g)− µbg
σbg
(5.1)
Here, e(g) is the log2 enrichment of gene g, µbg and σbg are the mean and standard deviation of the
background component of the gaussian mixture model (which we always take as the component
with the smaller mean). The false discovery rate (FDR) for a cutoff c is defined as the expected
fraction of background genes gb with e(gb) > c under all genes g with e(g) > c:
FDR(c) =
1− cdfbg(c)
|{g|e(g) > c}|
· |BG| (5.2)
cdfbg is the cumulative distribution function of the background component of the mixture model
and |BG| the expected number of background genes (estimated by the mixture model). This is
mathematically equivalent the Benjamini-Hochberg multiple testing correction [Benjamini and
Hochberg, 1995] for the onesided p-values derived from the z-scores in (5.1) multiplied with the
expected fraction of background genes.
For the running window approach (see section 5.4.1), we first selected a window of w genes with
the smallest Ago2-IP intensities and fitted the mixture model (first window). Then we removed
the s genes with smallest Ago2-IP intensities and added the next s smallest still unselected genes
and again fitted a mixture model. This step was repeated until the window reached the top Ago2-
IP intensities. For the analyses we chose w = 1000 and s = 20.
We use two metrics to evaluate the fit of background and target distributions:
d(bg, t) =
µt − µbg
σbg
(5.3)
skew(E) = −log10(ksp(E,−E)) (5.4)
bg and t are the background and target components of the mixture model, respectively, E is
the set of log2 enrichment values used to fit the mixture model and ksp(E,−E) is the p-value
of the Kolmogorov-Smirnov test comparing the distribution of E to the distribution of negated
enrichment values−E. Thus, the distance score d(bg, t) measures the distance of the background
and target distributions with respect to the width of the background distribution, whereas the
asymetry score skew(E) measures the skewness of the distribution without the need to fit a
mixture model.
5.3.3 PCA
Principal component analysis is performed using the function prcomp in R. When there are
k experiments/replicates and, therefore, k log2 enrichment values per gene, PCA is applied to
the k-dimensional space of genes. The first principal component is the direction of the greatest
variance, and is used to compute the summary enrichment value ê(g) of gene g by taking the
dot product of the replicate measurement z-scores 〈z1(g), ..., zk(g)〉 and the direction of the first
principal component PC1 :
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ê(g) = 〈z1(g), ..., zk(g)〉 · PC1 (5.5)
The geometrical interpretation of this weighted average of the replicate enrichment values is that
the dot product does an orthogonal projection of the k dimensional point g onto the first principal
component and measures the distance to the origin.
It is not necessary to center the points before PCA, since we perform PCA on the z-scores derived
from the mixture modelling approach (see (5.1)) the point cloud is naturally centered at the means
of the background distributions and centering at the overall mean may not be appropriate. Also,
we perform PCA only on targets (as defined by an FDR of 1%). This is necessary, because if the
number of background genes is much higher than the number of target genes, stochasticity in the
background could mask the effects in the target genes to some extent.
Differential targets will deviate from this vector in a specific direction: E.g., if we have two
replicates of two conditions A and B and, therefore, an enrichment vector 〈za1 , za2 , zb1 , zb2〉,
any gene that is target specifically in A has greater enrichment in A than in B: za1 and za2
is greater than zb1 and zb2 . Thus, if there are enough differential targets, the second principal
component will point into the direction of the deviations of their enrichment vectors. Therefore,
the summarized differential enrichment value êd(g) can be computed similarly to the overall
summary enrichment value in equation 5.5 by taking the dot product of the z-score vector
〈z1(g), ..., zk(g)〉 and the direction of the second principal component PC2 :
êd(g) = 〈z1(g), ..., zk(g)〉 · PC2 (5.6)
Note that both the enrichment value ê(g) and the differential enrichment value êd(g) incorporate
a linear normalization that removes bias due to differing IP efficiencies.
5.4 Results
5.4.1 Select relevant genes
The first step in our analysis of RIP-chip data is the filtering of unexpressed genes. On modern
microarrays such as the Affymetrix GeneST arrays used for our data, probesets against all known
human genes are available. Even if virtually all probesets have non-zero intensities, we can
expect that only a fraction of all genes is expressed in a specific condition. We noticed that
the asymmetry of the log enrichment distribution is not observable over the whole range of
IP intensities (see Figures 5.2a and S2). For low intensity genes, the distribution indeed looks
normal, which is expected for a set of genes that is not or almost not expressed. Therefore, we
employed a running window approach for fitting the mixture model (see Methods) and evaluated
each window with respect to the distance of the two components of the fitted model and the
extent of asymmetry (see Figure 4.7). At intensity values ≈ 5 a significant increase in both
scores was observable. We chose to use all genes above an intensity cutoff where d(bg, t) > 1
and skew(E) > 2, i.e. where the means of the two mixture components are at least one standard
deviation away from each other and where the asymmetry becomes significant with p-value 0.01.
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Figure 5.2: Selecting expressed genes. Figure 5.2a shows a density scatterplot of the log2 IP
intensities against the log2 enrichment values of all genes for the first Jijoye RIP-chip replicate.
In Figures 5.2b and 5.2c, the distance and asymmetry scores are plotted for all windows for
replicate one and three of the DG75-eGFP experiment. Starting from intensity values of ≈ 5, the
distribution seems to be a mixture of two normal distributions. In contrast to the first replicate, the
third does not show the expected behavior of the mixture of a background and target distribution
which was a consequence of poor RNA quality in this experiment. The running window mixture
models for the three vertical lines indicated in Figure 5.2a and 5.2b are shown in Figures 5.2d-f.
In each plot, the observed distribution in black together with the mixture components (green and
red, respectively, densities scaled to their estimated fractions) is shown. For quality control, the
sum of both scaled component distributions is shown in blue as well as the remaining distribution
after subtracting the fitted background from the observations as dashed red line. Note that the
observed distribution itself is normal for the low intensity window in Figure 5.2d, but starting
from intensity values of ≈ 5, the distribution is indeed a mixture of two normal distributions.
We performed this running window approach for all previously publised RIP-chip experiments
from Do¨lken et al. [2010] as well as for two additional replicates of the control cell line
DG75-eGFP and the EBV infected cell line Jijoye, respectively. For the additional DG75-eGFP
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Figure 5.3: Background subtraction is necessary. Figures 5.3a and 5.3b show the enrichment
distributions of expressed genes in the four Jijoye RIP-chip replicates. Raw enrichment values
indicate that the IPs of replicates three and four were more efficient based on the number of genes
enriched more than two fold (see corresponding inset). After background subtraction however,
replicates one and two show a larger fraction of enriched genes. Replicates one and two have
significantly better correspondence to the HITS-CLIP experiment performed in Jijoye, which
shows the need for background subtraction.
replicates, the microarrays showed poor RNA quality and applying our running window approach
to these bad quality experiments indeed did not yield a mixture model (see Figure 5.2c). Thus we
can apply our method also for filtering poor quality experiments from a dataset and we excluded
the two additional DG75-eGFP replicates from further analyses accordingly.
We also noticed that the background distribution is not the same over the whole spectrum
of intensity values. Therefore, we computed z-scores for each gene using mean and standard
deviations obtained from the running window approach. This is very similar to well known
nonlinear normalization techniques [Yang et al., 2002], with the difference that the model for
normalization is not fitted to all data but only to the background.
5.4.2 Determining microRNA targets
Computing z-scores from the raw enrichment values based on the fitted background distribution
can be interpreted as a subtraction of this background. Note that the background here does not
consist of the unexpressed genes, but of the expressed but not targeted genes. This background
subtraction step can have a great effect: For the four Jijoye RIP-chip replicates, we observe that
without subtraction, it seems that the IPs of replicates three and four were more efficient than
of the other two replicates, since there are more genes enriched more than two fold, for instance
(see Figures 5.3a and 5.3b). However, after background subtraction replicates one and two show
a larger fraction of enriched genes.
Obviously, if an IP was more efficient than another, its induced ranking of genes will better
predict a gold standard of microRNA targets. HITS-CLIP is an experimental technique that
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is able to identify target sites of microRNAs with high confidence [Chi et al., 2009]. Thus,
using the publicly available HITS-CLIP data for Jijoye [Riley et al., 2012a] we can construct
a gold standard by taking all genes as true targets that have at least n HITS-CLIP target sites.
Independent on the choice of n, replicates one and two induce rankings that are in better
agreement with HITS-CLIP data (see Figure 5.3c for n = 1), and thus, background subtraction
is a necessary step. We also repeated this analysis using in-house, unpublished PAR-CLIP data
for Jijoye (∼ 14.000 sites on ∼ 5500 genes, will be published elsewhere) leading to the same
conclusions (data not shown).
Furthermore, we propose that the fitted background distribution allows to compute valid false
discovery rates (FDRs) for microRNA targets. For a cutoff c, the FDR is defined as the expected
fraction of nontarget genes. Obviously, a nontarget gene should contain less HITS-CLIP target
sites than target genes on average. If we compute the average number of HITS-CLIP target sites
per gene for the set of targets defined by cutoff c on the RIP-chip data, the dependence on the
corresponding FDR should thus be linear with a negative slope: For instance, if the FDR is twice
as high, we expect twice as many nontarget genes. Therefore, the average number of HITS-CLIP
target sites per gene should decrease by a factor that is dependent on the true average number of
HITS-CLIP targets sites per target gene and nontarget gene. For all four replicates the plot of the
FDR against the fraction of HITS-CLIP target sites per gene is roughly a straight line (see Figure
5.4) and even if the enrichment/z-score distributions are quite different, the slopes and intercepts
of linear fits to all four plots are very similar to each other (see Figure 5.5).
This also allows us to estimate the average number of HITS-CLIP target sites per target gene and
nontarget gene by taking the value of the linear fit at FDR=0% and FDR=100%, respectively.
Based on the RIP-chip data as a reference, we can estimate that HITS-CLIP produces ≈ 0.8
target sites per expressed target gene and ≈ 0.2 target sites per nontarget gene (see Figure 5.5).
5.4.3 Taking replicates into account
As indicated above, IP efficiencies between replicate experiments may be very different from
each other. These differences introduce bias into such a dataset and no RIP-chip study known to
us has properly accounted for that. Note that our mixture model approach also cannot remove this
bias from RIP-chip data. The problem becomes obvious when we visually inspect scatterplots
across replicate enrichment values/z-scores.
For replicates one and two of our Jijoye RIP-chip data, the main cloud of target genes roughly
scatters around the main diagonal in Figure 5.6a, whereas for the comparison of replicates one
and three, the diagonal is quite far away from the main cloud (Figure 5.6b). The canonical way
for summarizing replicates is to take the unweighted mean of the enrichment values/z-scores.
This can geometrically be interpreted as an orthogonal projection onto the diagonal vector d =
(0.25, 0.25, 0.25, 0.25) and measuring the distance of the projected point to the origin. Thus, all
four-dimensional points lying on any hyperplane orthogonal to d would get the same summary
value. Such a hyperplane would not cut the main cloud of target genes in the scatter plot of
replicates one and three orthogonally, which is only a consequence of different IP efficiencies.
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Figure 5.4: Computed FDRs are valid. The false discovery rates of the four Jijoye replicates
are plotted against the average number of HITS-Clip clusters per gene. All four show a roughly
linear behavior suggesting that the FDR is valid. Furthermore, linear fits to each of the plots
are very similar to each other, despite of quite different z-score distributions (see Figure 5.3b),
which allows us to estimate the average number of HITS-Clip target sites per RIP-chip target and
background gene (see main text for further details).
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Figure 5.5: Average number of HITS-Clip target sites per RIP-chip background and target gene.
The linear fits at FDR=0% and FDR=100% in Figure 5.5 are estimates for the number of HITS-
Clip target sites in RIP-chip target genes and background genes, respectively. Even if the IP
efficiencies were quite different (see Figure 5.1), the estimates of ≈ 2.8 target sites per expressed
target gene and ≈ 1.7 per expressed background gene are remarkably similar.
However, the first principal component of this point cloud defines such orthogonal hyperplanes
and we use the components of the corresponding rotation vector to compute a weighted mean
accounting for all linear effects of differing IP efficiencies.
We can evaluate this additional step again by using the HITS-CLIP data as reference. We consider
the differences between each normalized summary value and the corresponding unnormalized
value. The difference for HITS-CLIP sites containing genes is statistically significantly greater
than for other genes (p < 10−14, Kolmogorov-Smirnov test, see Figure 5.6c), and the more
HITS-CLIP targets sites are found for a gene, the more pronounced is its positive change.
5.4.4 Determining differential microRNA targets
In order to find differential microRNA targets, experiments of different conditions must be
compared, i.e. genes must be identified, that are more enriched in one condition in comparison to
the other. Obviously, a similar problem as in the summarization of replicates plays a role: How
can we account for differing IP efficiencies if we compare four replicates of the EBV infected
cell line Jijoye to the two replicates of the control cell line DG75-eGFP?
We can extend our method for summarizing replicates to the differential problem: The first
principal component corresponds to the direction of greatest variance, which is the direction
of common targets under the assumption that there are enough common targets (both are B
cell lines). Differential microRNA targets exclusive to Jijoye should have positive enrichment
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Figure 5.6: Differing IP efficiencies require normalization before computing summary values.
In contrast to replicates one and two of the Jijoye RIP-chip experiments, where IP efficiencies
are very similar (see Figure 5.6a), replicate three is different (see Figure 5.6b). Normalizing
replicates using the first principal component (PC1) significantly improves the summary z-
score with respect to HITS-CLIP data as reference: The difference of the normalized score to
the unnormalized score is significantly greater for genes with HITS-CLIP target sites (colored
distributions) in comparison to all differences (black distribution). The improvement is even more
pronounced for genes with multiple HITS-CLIP target sites (see Figure 5.6c).
values in the Jijoye RIP-chip replicates and smaller values in DG75-eGFP. These targets induce
variance into the corresponding direction of the six-dimensional space, such that the second
principal component corresponds to the IP efficiency normalized direction of differential targets
(see Figure 5.7a).
In order to compare the PC2 normalized differential enrichment values to the unnormalized
differential enrichment (i.e. subtract the enrichment mean of DG75-eGFP from the mean of
Jijoye), we exploit the fact that microRNAs are able to downregulate expression of target mRNAs
[Bartel, 2009; Guo et al., 2010] and that mRNA levels were measured as well in the RIP-chip
experiment: x fold downregulated genes get consistently and significantly higher scores after
normalization as compared to all other genes, independent on the choice of x (see Figure 5.7).
Thus, after normalization, significantly more RIP-chip targets are downregulated than without
normalization (independent on the particular threshold used to define RIP-chip targets and
downregulated genes).
5.5 Discussion
A similar approach to our gaussian mixture modelling (GMM) has already been used in
[Mukherjee et al., 2009], however, GMM was applied to summarized enrichment values and
log odds ratios (LOD scores) were computed as the ratio of the two scaled mixture components.
LOD scores were then used in two different ways: First, they were directly subjected to gene
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Figure 5.7: Differing IP efficiencies require normalization before computing differential targets.
The second principal component in Figure 5.7a is able to discover the experimental structure. Its
loadings can be used as weights to compute a differential enrichment value that is normalized for
different IP efficiencies, in contrast to the standard way of subtracting the mean log enrichment
in DG75-eGFP from the mean log enrichment in Jijoye (corresponding to weights indicated
in red). The difference distribution of the normalized differential enrichment values and the
unnormalized ones is shown in Figure 5.7b. Differential targets are expected to be downregulated,
and indeed, the difference is significantly greater than background for downregulated genes. As
illustrated in Figure 5.7c, this effect is more pronounced the higher the downregulation is.
set enrichment analysis (GSEA) [Subramanian et al., 2005], where they have no advantage over
directly using enrichment values (since the weighted Kolmogorov-Smirnov statistic used for
GSEA is non-parametric and only sensitive to the ranking of the genes). Second, the authors
used a cutoff of LOD>0 in order to define a set of targets. However, choosing a cutoff based
on the LOD is still arbitrary and not statistically meaningful in contrast to our false discovery
rates. If we used the LOD to define a cutoff, we would get FDRs ranging from 5% to 15% in our
experimental dataset.
We could show that our refined mixture modelling approach has several advantages: First, it
allows us to filter unexpressed genes. When comparing two conditions (e.g. virus infected cells
expressing viral microRNAs vs. non-infected cells) expression of a gene targeted by cellular
microRNAs below the detection limit of the microarray in one but not the other cell line
would result in the misinterpretation of this to be a target of the viral microRNAs. Second, for
experiments with poor IP efficiency, we observed extremely poor distance and asymmetry scores
over the whole intensity range and could remove these bad replicates from further analyses.
Third, it helps to compare experiments to each other (see Figure 5.3c) and finally, we can compute
valid FDRs.
Furthermore, the comparison of the RIP-chip FDRs to HITS-CLIP data revealed important
properties of both the RIP-chip and HITS-CLIP techniques: Both are designed to identify
microRNA targets and naturally, they agree significantly (p < 2.2×10−16, Kolmogorov-Smirnov
test), a fact that is also reflected in the negative slope of the linear fit to the FDR against sites
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per gene plot. However, the agreement is not perfect and we estimate an average number of
≈ 0.8 HITS-CLIP target sites per RIP-chip target gene and of ≈ 0.2 per RIP-chip nontarget
gene. Even if HITS-CLIP target sites may be erroneous and the CLIP techniques may implicate
additional bias [Ko¨nig et al., 2010; Kishore et al., 2011], we expect that not all of the ≈ 0.2 sites
per background gene are true errors: Such inconsistencies may be due to differing experimental
steps (e.g. different antibodies used for IP) or due to differences the Jijoye cell cultures have
accumulated in the two laboratories since the cell line has been established. Also, since HITS-
CLIP does not control for target mRNA abundance, it may find several weak sites on highly
expressed genes that are biologically irrelevant (i.e. not contributing significantly to regulation
of its expression). Such a gene should not be enriched in a RIP-chip experiment and could explain
many cases of HITS-CLIP sites on background genes. Thus, even if CLIP techniques have several
advantages (e.g. they are able to identify target sites instead of target genes), RIP-chip is still a
useful complementary method.
The second, novel method introduced in this paper is to use principal components to normalize
for different IP efficiencies. Evaluation using HITS-CLIP data or the differential expression
of target genes shows that the normalization improves results significantly. The normalization
proposed can only account for linear bias between experiments. This very lenient normalization
appears to be sufficient, since affine offsets are already removed by the mixture model approach
and nonlinear effects are not recognizable in a visual inspection.
Our proposed methods do not include a way to compute statistical significance, e.g. like a t-test
for standard differential gene expression experiment. However, this can be accomplished in a
straight-forward way, since all available tests could directly be used after our linear normalization
has been applied to a dataset.
5.6 Conclusion
In this paper we presented methods we developed to analyze RIP-chip data. In comparison
to standard differential gene expression experiments, the additional immunoprecipitation step
introduces special requirements for the data analyis. First, we use gaussian mixture modelling
(GMM) to determine biologically significant target genes, and second, we use a linear nor-
malization technique based on principal component analysis to remove bias introduced by
the immunoprecipitation. The evaluation of both methods using independent data showed a
significant improvement in comparison to standard approaches: The background of not enriched
genes can be removed, valid FDRs can be calculated and the comparability of both replicates and
differential experiments is improved.
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Chapter 6
Widespread context-dependency of
microRNA-mediated regulation
Motivation: In the previous two chapters, I introduced two methods for raw data analysis
of PAR-CLIP and RIP-Chip data, respectively. As indicated in the introduction (see section
1.1.1), raw data analysis is an important step in systems biology and converts raw data from
an experiment to biological information. However, in order to understand a biological system as
a whole, this information must be interpreted. In this chapter, I describe how microRNA related
data can be interpreted with respect to different cellular contexts. There were two specific reasons
that lead me to consider this specific aspect of microRNA-mediated regulation: First, one of the
first questions that came up when the PAR-CLIP data from our collaboration partners became
aVvailable was how big the overlap between our dataset and another already published KSHV
related PAR-CLIP dataset is [Gottwein et al., 2011]. This question originally was about data
quality and sounds quite easy to answer at first. However, in fact it is not, which has to do with
the way how an overlap should be defined for PAR-CLIP datasets and what the implications are
of any size of overlap. Second, during that time, the main phase of the ENCODE project was
published in several papers in Nature, Genome Research and Genome Biology and one of the
most intriguing results was that transcriptional regulation is heavily dependent on the cellular
context. So the main question was, whether and to which extent this is also true for microRNA-
mediated regulation. Importantly, in our project, various datasets have been generated that
allowed me to investigate and resolve this question.
Publication: This chapter has been submitted for publication [Erhard et al., 2013c]. Here,
I adapted the layout and restructured parts of the text to incorporate important parts of the
Supplementary material of the submitted manuscript into this chapter.
My contribution: I analyzed PAR-CLIP, RIP-Chip and mass spectrometry data and came up
with the idea of context-dependency of PAR-CLIP target sites. I carried out all computational
and statistical analyses, produced plots and wrote the paper.
Contribution of co-authors: Lukasz Jaskiewicz and Mihaela Zavolan performed PAR-CLIP
experiments, Georg Malterer, Diana Lieber and Ju¨rgen Haas provided SILAC measurements,
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Lars Do¨lken provided RIP-Chip and 4sU-tagging datasets and helped to revise the manuscript.
Ralf Zimmer supervised the work and helped to revise the manuscript.
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6.1 Abstract
Gene expression is regulated in a context-dependent, cell-type specific manner. Condition-
specific transcription is dependent on the presence of transcription factors (TFs) that can activate
or inhibit its target genes (global context). Additional factors such as chromatin structure,
histone or DNA modifications also influence the activity of individual target genes (individual
context). The role of the global and individual context for post-transcriptional regulation has
not systematically been investigated on a large-scale and is poorly understood. Here we show
that global and individual context-dependency is a pervasive feature of microRNA-mediated
regulation. Our comprehensive and highly consistent dataset from several high-throughput
technologies (PAR-CLIP, RIP-Chip, 4sU-tagging and SILAC) provides strong evidence that
context-dependent microRNA target sites (CDTS) are as frequent and functionally relevant as
constitutive target sites (CTS). Furthermore, we found the global context to be insufficient to
explain the CDTS and that RNA binding proteins provide individual context that is an equally
important factor. Our results demonstrate that similar to TF-mediated regulation, global and
individual context-dependency are prevalent in microRNA-mediated gene regulation implying
a much more complex post-transcriptional regulatory network than currently known. The
necessary tools to unravel post-transcriptional regulations and mechanisms need to be much more
involved and much more data will be needed for particular cell types and cellular conditions
to understand microRNA-mediated regulation and the context-dependent post-transcriptional
regulatory network.
6.2 Introduction
Regulation of gene expression is highly context-specific. The ENCODE project [Consortium,
2012b] provided convincing evidence that whether or not a specific transcription factor (TF)
binds to a specific binding site (TFBS) is not only dependent on the sequence of the binding site
but also on its chromatin state [Wang et al., 2012b], on DNA methylation [Wang et al., 2012a],
on other DNA binding factors [Yanez-Cuna et al., 2012] and numerous additional factors, which
are difficult to measure and predict. All these factors form the so-called cellular context that
influences the expression level of genes.
Gene expression is not only regulated at the level of transcription but also post-transcriptionally
in various ways of which regulation mediated by microRNAs is one of the most prevalent [He
and Hannon, 2004]. MicroRNAs are 20-24 nt long non-coding RNAs that have been found in
animals and plants. They play a pivotal role in development, tumorigenesis, the immune system
and during viral infections (for a review see Bartel [2004]). Within the RNA induced silencing
complex (RISC), microRNAs are responsible for target recognition by binding to target sites,
often located in the 3’-UTR of mRNAs. This is predominantly mediated by the so-called seed
region (nucleotides 2-8 of the microRNA). In general, RISC causes downregulation of the target
mRNA either by inhibiting translation or promoting degradation [Bartel, 2009]. Neither the exact
mode of binding nor the mechanisms of downregulation are completely understood [Djuranovic
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et al., 2011; Eulalio et al., 2008; Guo et al., 2010; Kozak, 2008; Mishima et al., 2012; Meijer
et al., 2013].
Computational prediction of microRNA targets is a difficult task [Thomas et al., 2010;
Sethupathy et al., 2006; Ritchie et al., 2009]. This is a consequence of the low specificity of seed
matches alone: There are several lines of evidence suggesting that additional factors such as target
site location [Grimson et al., 2007], additional basepairing at the microRNA 3’ end [Brennecke
et al., 2005], target site accessibility [Kertesz et al., 2007], other RNA binding proteins [Jacobsen
et al., 2010], microRNA and mRNA copy numbers [Ben-Moshe et al., 2012], additional unknown
factors or interplay between any of these play important roles in distinguishing functional from
non-functional target sites. Interestingly, several of these additional factors are not static but may
change dynamically: For instance, dependent on which RNA binding proteins are expressed at
what level in a given cell-type, RISC may or may not bind at a certain binding site. Similarly
to transcription factors, microRNAs are therefore likely to exhibit their regulatory function in a
context-dependent manner.
Several examples of context-specific microRNA-mediated regulation can be found in the
literature (for a review see Pasquinelli [2012]). Bhattacharyya et al. [2006] identified the RNA
binding protein HuR as a derepressor for miR-122 regulation of the CAT-1 mRNA. In normal
hepatocarcinoma cells CAT-1 is repressed by a miR-122 target site in its 3’-UTR. Under different
stress conditions, HuR is released from the nucleus into the cytoplasm which abolishes CAT-1
repression. The exact mechanism however remains unclear. Intriguingly, HuR has also been
implicated in activating a target site of the microRNA let-7 in the 3’-UTR of MYC [Kim et al.,
2009a] which indicates that HuR can both induce and prevent microRNA-mediated regulation.
In addition to HuR, DND1 [Kedde et al., 2007] and Pumilio-1 [Kedde et al., 2010] have also
been identified to influence microRNA regulation. There may be other RNA binding proteins
that interfere with or facilitate microRNA/target interactions.
These examples illustrate that the presence of a functional target site is not sufficient for
regulation. It may be active under certain conditions but non-functional in a different context.
Presently, our knowledge about context-dependent microRNA-mediated regulation is based on
few examples and the underlying molecular mechanisms are poorly understood.
By immunoprecipitation of microRNA/target complexes using monoclonal antibodies to RISC
components followed by high-throughput sequencing of the protein-protected microRNA target
sites, the complete targetome of cellular and viral microRNAs has become accessible. More than
10,000 putative microRNA binding sites, so called clusters, are obtained in a single HITS-CLIP
(high-throughput sequencing of RNA isolated by crosslinking immunoprecipitation) or PAR-
CLIP (photoactivated ribonucleotide-enhanced crosslinking immunoprecipitation) experiment.
Although the annotation of the responsible microRNA to an identified cluster still leaves room
for improvement, more than 75% of microRNA target interactions can be correctly annotated
thereby allowing in-depth analyses of microRNA regulatory networks [Gottwein et al., 2011;
Skalsky et al., 2012; Haecker et al., 2012; Riley et al., 2012b].
To study context specific microRNA-mediated regulation, we generated Ago2-PAR-CLIP data
from two human B-cell lines. In addition, we re-analyzed two recently published sets of Ago2-
PAR-CLIP data from two different human B-cell lines [Gottwein et al., 2011]. These four
cell lines represent different stages of B-cell development and are either infected by Kaposi’s
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sarcoma-associated herpesvirus (KSHV), co-infected by both KSHV and Epstein-Barr-Virus
(EBV) or not infected. Thus, each cell line provides a distinct context for microRNA-mediated
regulation. All datasets were re-analyzed using a new algorithm called PARma [Erhard et al.,
2013a]. PARma considers the topology of the microRNA/target interaction and the position of
UV-light induced cross-links in more detail than state-of-the-art methods and provides quality
control scores for both, the identification of microRNA target site clusters and for the annotation
of the interacting microRNA to these sites. For two of these four cell lines, we generated three
additional data sets including RIP-Chip, 4sU-tagging-derived RNA half-lives and large-scale
SILAC-based proteomics. This allowed us to comprehensively analyze the effect of context-
dependent microRNA/target interactions on the recruitment of the target mRNAs to Argonaute-2
complexes, on target RNA stability and on target protein levels. By considering viral as well
as host microRNAs, we investigated both microRNA/target interactions that coevolved within
a species as well as interactions of an exogenous microRNA with endogenous target sites. The
results provide compelling evidence that context-dependency of microRNA-mediated regulation
is not restricted to a few examples but is a widespread and general feature of post-transcriptional
regulation mediated by both cellular and viral microRNAs.
6.3 Results
6.3.1 Differential analysis of PAR-CLIP data
To comprehensively study regulation of cellular gene expression by both cellular and Kaposi’s
sarcoma-associated herpesvirus (KSHV)-encoded microRNAs, we applied Ago2-PAR-CLIP to
two human B-cell lines, the body cavity based lymphoma cell line BCBL1, which is latently
infected with KSHV, and the Burkitt lymphoma cell line DG75, which is KSHV negative.
Applying PARma [Erhard et al., 2013a] with stringent criteria (see the Methods), we identified
15,577 clusters, 12,333 of which mapped to known transcripts (Ensembl v60).
In order to assess the quality of the PAR-CLIP datasets, we first computed the positional
distribution of all target sites in mRNAs (Figure 6.1a). Target sites of viral microRNAs shared
the well described features of cellular microRNA target sites: They preferentially bind to the
3’ untranslated region (3’-UTR) and rarely to the 5’-UTR of transcripts [Grimson et al., 2007;
Hafner et al., 2010]. Within the 3’-UTR, target sites tend to accumulate at the very beginning,
i.e. immediately after the stop codon, and at the transcript end, i.e. immediately upstream of
the poly-A tail [Grimson et al., 2007]. We furthermore checked the accuracy of the microRNA
assignment to target sites by confirming that virtually no reads mapped to KSHV microRNA
target sites in the KSHV negative cell line DG75 (a feature that is not used by PARma to
assign microRNAs; see Figure 6.1b). The few instances with random reads in DG75 may
nevertheless be bona-fide KSHV microRNA target sites: As we observed random reads spread
across a multitude of transcripts at low frequency, these reads presumably result from infrequent
unspecific immunoprecipitates or insufficient removal of background total RNA rather than
microRNA-specific signatures. This is further supported by a significantly lower frequency of
T to C conversions and lower consistency across replicates for these reads (Figure 6.1b).
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Figure 6.1: Validation of PAR-CLIP experiments. In Figure 6.1a, the distribution of relative
positions of target sites on mRNAs is shown. The x-axis represents the average length of 5’
untranslated regions (5’UTR), of the coding regions (CDS) and of the 3’ untranslated regions of
all transcripts with at least one PAR-CLIP cluster. Each transcript was divided into 60 bins and
the relative frequency of target sites falling into each bin is shown on the y-axis. The data clearly
illustrate the preferences of target site in the 3’UTR as compared to CDS and 5’UTR. Viral
microRNAs have the same preferences as cellular microRNAs. In Figure 6.1b the normalized
number of reads in each cluster (rows) for each of the independent PAR-CLIP experiments
(columns) is shown for KSHV microRNA target sites in the four PAR-CLIP libraries. KSHV
negative cell lines (columns 1 and 2) almost exclusively have no reads, whereas for KSHV
positive cell lines, dozens to hundreds of reads are observed per target site. Replicates are highly
correlated indicating high reproducibility. The additional annotations on the left side indicate
the part of the transcript, where a cluster is located (orange: 5’-UTR; yellow: coding; green: 3’-
UTR; gray: not located on known mRNA) and the expression of the transcript in all experiments
(red, at least 2-fold lower expression than the mean expression value for this transcript across
all experiments; light red, at least 1.4-fold lower expression than the mean; light blue, at least
1.4-fold higher expression; blue, at least 2-fold higher expression).
We further validated our PAR-CLIP dataset using published data for the same cell lines: (i) PAR-
CLIP targets are highly consistent with RIP-Chip data (Do¨lken et al. [2010], Figures 6.2a and b),
(ii) KSHV microRNA targets are selectively enriched in BCBL1 and not DG75 in the RIP-Chip
experiments (compare Figures 6.2a and b) and (iii) PAR-CLIP target sites lead to a measurable
reduction of target mRNA half-lives (Figure 6.2c).
To be able to perform a more in-depth analysis on KSHV microRNA targets in human B-cells, we
also included recently published PAR-CLIP data from two additional B-cell lines, namely BC1
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Figure 6.2: Comparison of PAR-CLIP experiments with available datasets. Figures 6.2a and
6.2b show the log2 RIP-Chip enrichment distributions of mRNAs only containing target sites
of cellular microRNAs, only containing KSHV microRNA target sites and containing target
sites from both cellular and KSHV microRNAs in the uninfected cell line DG75 and the KSHV
positive cell line BCBL1, respectively. KSHV targets are enriched in BCBL1 but not in DG75.
In Figure 6.2c, the mRNA half-life ratios are shown for the same sets of genes as in Figure 6.2a
and b. The half-life of mRNAs with KSHV target sites is significantly reduced in BCBL1.
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Figure 6.3: Comparison of PAR-CLIP datasets. Figure 6.3a illustrates the number of target sites
observed only in individual cell lines (outermost labeled circles), in two cell lines (circles on
the edges between cell lines) and in all three cell lines (center circle), for KSHV microRNA
target sites. Relatively few target sites appear to be active in multiple cell lines. Figure 6.3b
summarizes all pairwise overlaps for all clusters in all datasets. The Jaccard index (J) is the
number of clusters in the intersection divided by the total number of clusters in any of the
two experiments. Jaccard indices of about 70% for all replicate measurements indicate high
reproducibility, whereas comparisons across cell lines show relatively low overlap (J < 40%)
(see also Figure 6.4).
and BC3 [Gottwein et al., 2011]. We re-analyzed all datasets using PARma, which yielded 21,628
clusters, 16,425 of which mapped to known transcripts. Intriguingly, the overlaps of targets sites
of both ubiquitously expressed cellular and KSHV microRNAs were surprisingly small (Figure
6.3b and 6.3a). Such extreme differences of called target sites may be due to experimental bias
or context-dependency, i.e. a major fraction of microRNA target sites is only active in some of
the cell lines considered.
6.3.2 Technical bias
When analyzing high-throughput data obtained from experiments performed in different lab-
oratories a certain extent of differences in between given data sets can be expected. In
our case, distinct clusters of target sites may also be consequences of erroneously assigned
microRNAs, bias introduced by differing sample preparation methods or insufficient sequencing
depth/sequencing library complexity.
Differing sample preparation methods are the most likely cause of bias and differences in
microRNA targets obtained by PAR-CLIP data. As such, the RNase used to trim the Argonaute-
2 protected microRNA target sequences has recently been shown to be a major source of bias
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Figure 6.4: Correlations of PAR-CLIP cluster quantifications. Figure 6.4a shows the normalized
quantifications of all target sites of kshv-miR-K12-4-3p as a scatter plot. Quantifications are
highly correlated. In Figure 6.4b, the distributions for all microRNAs of Spearman’s ρ (non-
parametric correlation coefficient) are shown for each possible comparison of KSHV positive
cell lines. Replicate correlations are drastically higher than between experiment correlations,
indicating context specific microRNA targeting.
[Kishore et al., 2011]. Other sources may include differing immunoprecipitation efficiencies,
RNAse treatment times, sequencing adapters or any other slight variation in the PAR-CLIP
protocol which may all result in a target site to be identified in one experiment but not in another.
Such bias could be controlled for, if PAR-CLIP data for one or more cell lines were available
that haven been measured in multiple labs. And only considering the high correlation of replicate
measurements does exclude such technical bias. Nevertheless, we can, to some extent, use the
inverse argument: BC1 and BC3 were analyzed in the same lab using the same protocol. Thus,
if technical bias was responsible for poor correlation and exclusive sites and not context-specific
microRNA targeting, the correlation between BC1 and BC3 should be as high as for replicate
experiments of either cell line. As illustrated in Figure 6.4b, this is not the case. However, the
correlations between BCBL1 and BC3 are even lower than between BC1 and BC3, for instance.
There may be two reasons for that: Either BC1 and BC3 are more similar to each other than
BCBL1 and BC3 with respect to their cellular context for microRNA-mediated regulation or
between-lab comparison of PAR-CLIP target sites is indeed influenced by technical bias to some
extent. But nevertheless, technical bias cannot explain the relatively low correlations between
BC1 and BC3 which provides first evidence that the observed differences may indeed not only
be due to technical bias.
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Insufficient saturation of PAR-CLIP libraries or sequencing depth may result in seemingly cell-
type specific and thus context dependent microRNA/target interactions may also be a reason
for our observations: If only a small fraction of target sites was detected (either due to poor
immunoprecipitation efficiency or insufficient sequencing depth), sampling effects would play
a severe role: Only due to limited sampling, a cluster may get very few or no reads in one
sample and many reads in another, even if the target site is strongly associated with a microRNA
in both experiments. Considering only a single experiment, this cannot be excluded by simply
counting reads and computing statistical significance under a naive probabilistic model: There
are many sequences that are identified multiple times, which may have two reasons: Either there
was only a single RNA molecule of this sequence in the library and the amplification before
sequencing gave rise to these multiply sequenced reads (indicating insufficient saturation), or
there were multiple copies of such an RNA already in the library. Particularly for PAR-CLIP data,
the latter is highly probable, since RNase T1, which is used in the PAR-CLIP protocol, cleaves in
a sequence-specific way downstream of guanosines [Pace et al., 1991]. Since the target mRNA
seems highly accessible for cleavage outside of the microRNA target site, the number of possible
distinct sequencing reads for a cluster is highly constrained. However, when we consider replicate
measurements of targets sites for a specific microRNA, e.g. for BC3 (see Figure 6.4a), we observe
that they are highly correlated (median ρ > 0.77 across all microRNAs for all replicate pairs,
see Figure 6.4b). Therefore, all sequencing data utilized in this meta-analysis were found to be
of sufficient saturation not to inflict major bias to our analysis.
6.3.3 Context-dependent target sites of KSHV microRNAs
Since technical bias cannot explain the differences of identified target sites across cell lines, we
analyzed the possibility of context-dependency in microRNA-mediated regulation. Intriguingly,
when we considered all target sites of a single microRNA, there was no clear correlation of target
sites across cell lines (Figures 6.4 and 6.5). Instead, distinct clusters of target sites emerged, for
instance several kshv-miR-K12-4-3p target sites that appear to be active in BCBL1 only and not
in BC1 or BC3. This suggests that context-dependent microRNA-mediated regulation may be
substantially more important than generally expected. Interestingly, the cellular context leading
to these clusters of target sites is not solely determined by mRNA levels, which are indicated
on the left side of the heatmap in Figure 6.5. Otherwise, one would expect significantly higher
mRNA levels for BCBL1 specific target sites in BCBL1 than in BC1 and BC3, for instance.
Additionally, there are target sites that are missing in BCBL1 and active in BC1 or BC3. Thus,
not all target sites exclusively active in BCBL1 can be explained by a higher expression or activity
of the respective microRNA or mRNA.
Taken together, our differential analysis of PAR-CLIP data suggests that microRNA-mediated
regulation is substantially and generally dependent on the cellular context. To experimentally
test this hypothesis, we employed three sets of additional high-throughput methods to investigate
the consequences of context-dependent microRNA-mediated regulation. First, using RIP-Chip
we tested whether context-dependent microRNA/target interactions, as found in the PAR-CLIP
data, had a measurable impact on the recruitment of the target mRNA to RISC in their specific
context only. And second, using microarray-based transcriptomics, including metabolic labeling
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Figure 6.5: miR-K12-4-3p heatmap.The PAR-CLIP read heatmap for target sites of the KSHV
microRNA miR-K12-4-3p is shown (see Figure 6.1b for more information about PAR-CLIP
read heatmaps). Between KSHV positive cell lines, there is no correlation but there are distinct
clusters of target sites. No obvious dependency between clusters and mRNA expression level is
observable.
of RNA, and SILAC-based proteomics experiments, we tested whether such context-dependent
microRNA/target interactions also have a measurable impact on mRNA half-lives and on mRNA
as well as protein levels of their targets in their specific context only. All these experiments were
performed by comparing DG75 to BCBL1. We selected all KSHV microRNAs that showed a
KSHV specific activity pattern, i.e. where the set of target sites was depleted of reads in DG75
and included reproducible target sites of all three KSHV positive cell lines (Figure 6.6).
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Figure 6.6: Context dependent target sites of KSHV microRNAs. The differential analysis of all
sets of considered KSHV microRNAs is shown. None of the target sites has a significant amount
of reads in the uninfected control cell line DG75. The top third corresponds to constitutive target
sites that are active in all three KHSV positive cell line (n = 162), the middle third are target
sites exclusively active in BC1 or BC3 and not in BCBL1 (n = 151) and the bottom third shows
BCBL1 exclusive active target sites (n = 151).
Context-dependent microRNA targets are associated with RISC in a context-dependent
manner
First, we looked at the recruitment of the mRNA targets of these KSHV microRNAs to Ago2-
complexes. We recently employed RIP-Chip to identify KSHV and EBV microRNA targets
in human B-cells [Do¨lken et al., 2010]. Since then, we performed two additional RIP-Chip
replicates of the KSHV-positive cell line BCBL1 to perform a more solid statistical analysis
[Erhard et al., 2013b].
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Figure 6.7: KSHV PAR-CLIP targets in RIP-Chip data. Figure 6.7a shows differential RIP-Chip
enrichment scores (PC2 scores; positive values indicate higher enrichment in BCBL1 than in
DG75). Generally, KSHV microRNA targets active in BCBL1 are significantly shifted towards
higher values as compared to all other genes with any PAR-CLIP target site, in contrast to KSHV
target sites exclusively active in BC1 or BC3 and not in BCBL1. Figure 6.7b illustrates this
further: The enrichment of genes with any KSHV site, with a constitutive or a BCBL1 exclusive
site over genes with BC1/BC3 exclusive sites among all genes with PC2 score > 2 is about 2-fold
in all cases.
Data were normalized using principal component analysis as described [Erhard et al., 2013b]
and differential enrichment values were computed for BCBL1 and DG75 as the second principal
component (PC2), indicating whether an mRNA is stronger associated with RISC in BCBL1
in comparison to DG75. All PAR-CLIP target sites were mapped to genes and genes with any
KSHV target site in BCBL1, with a constitutive target site in all KSHV positive cell lines and
with exclusive sites in BCBL1 or BC1/BC3 were compared to all other genes with any PAR-CLIP
target site as background (Figures 6.7,6.8 and 6.9).
The differential RIP-Chip enrichment was significantly shifted towards higher values for genes
with BCBL1 exclusive sites in comparison to the background (p < 0.0007, Kolmogorov-
Smirnov test), indicating that BCBL1 exclusive target sites indeed lead to a stronger association
of the target mRNA in BCBL1 to RISC. This was also true for constitutive KSHV target sites
(p < 0.009) as well as for all KSHV target sites active in BCBL1 (p < 3 · 10−8). Moreover,
BC1/BC3 specific target sites, which were not active in BCBL1, were indistinguishable from
the background (Figure 6.7a). In particular, all genes with active KSHV microRNA target sites
in BCBL1 showed a 2-fold enrichment of genes that are significantly (PC2 score > 2) more
associated with RISC in BCBL1 than in DG75 over background genes. In contrast, genes with
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KSHV microRNA target sites that are exclusively active in BC1 or BC3 and not in BCBL1 are
indistinguishable from background genes (Figure 6.7b).
This provides strong evidence that a major fraction of the KSHV microRNA target sites identified
by PAR-CLIP exclusively in BC1/BC3 and not in BCBL1 do not mediate a strong recruitment
of their target mRNA to RISC in BCBL1, i.e. are indeed context-dependent target sites. Context-
dependent microRNA/target interactions as defined by differential analysis of PAR-CLIP data
can thus be confirmed using an independent RIP-Chip experiment.
Target mRNA stability is affected in a context-dependent manner
Next, we analyzed context-dependent effects of the KSHV microRNAs on target RNA stability.
Since microRNAs can induce destabilization of the mRNA transcripts [Bartel, 2009], microR-
NA/target interactions that are active in BCBL1 should decrease the target mRNA half-life in
BCBL1 as compared to DG75. Target sites inactive in BCBL1 (and only active in BC1/BC3) in
contrast should not decrease mRNA half-life.
Previously, we applied metabolic labeling of newly transcribed RNA followed by microarray
analysis to separate newly synthesized and pre-existing RNA [Do¨lken et al., 2008]. We computed
RNA half-lives based on the ratios of newly synthesized to total RNA for both DG75 and BCBL1
[Do¨lken et al., 2010] and considered the differences in target mRNA half-lives in between
BCBL1 and DG75.
Intriguingly, the mRNA half-life of KSHV microRNA targets in BCBL1 was decreased by about
20 minutes (p < 3·10−5) on average, whereas for KSHV microRNA targets not active in BCBL1,
no significant decrease was observed (Figure 6.8a). Furthermore, the half-life difference values
of BCBL1 exclusive target genes were significantly smaller than half-life difference values of
BC1 or BC3 exclusive target genes (p < 0.008, Wilcoxon rank sum test; Figure 6.8b). Thus,
context-dependent microRNA/target interactions have an impact on mRNA stability in a context-
dependent manner.
Interestingly, constitutive KSHV microRNA target sites showed an even stronger decrease in the
mRNA half-life than for context-dependent target sites (> 35 minutes on average, p < 10−5).
A possible explanation is that constitutive microRNA/target interactions are less susceptible
to the cellular context resulting in more substantial target suppression. Therefore, constitutive
interactions likely represent the most important targets for the virus.
Protein levels are differentially regulated for context-dependent microRNA targets
We now asked whether context-dependent microRNA targets are also reflected in steady-state
mRNA or protein levels in two different contexts. It is important to note that protein levels
in a cell depend on multiple factors, including protein half-lives and microRNA independent
post-transcriptional regulation, most of which are well described to have a substantially greater
impact on protein levels than generally exerted by microRNAs. Therefore, targets of the viral
microRNAs may not necessarily show differential expression between DG75 and BCBL1
on protein or mRNA levels [Do¨lken et al., 2010]. Especially viral microRNAs are likely to
6.3 Results 101
−400 −300 −200 −100 0 100 200 300
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
Half−life difference (BCBL1−DG75)
Half−life difference (BCBL1−DG75)
cu
m
u
la
tiv
e
 fr
eq
ue
nc
y
all p=NA
BC1/BC3 exclusive p=0.647
BCBL1 target p=2.81e−05
constitutive p=9.75e−06
BCBL1 exclusive p=0.126
M
ea
n 
ha
lf−
life
 d
iff
e
re
n
ce
−
35
−
25
−
15
−
5
0
(a)
0.0 0.2 0.4 0.6 0.8 1.0
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
Half−life difference
Half−life difference rank
cu
m
u
la
tiv
e
 n
u
m
be
r o
f t
ar
ge
t s
ite
s 
(no
rm
a
liz
e
d)
expected
BC1/BC3 exclusive
BCBL1 target
constitutive
BCBL1 exclusive
BC1/BC3 exclusive sites − BCBL1 exclusive sites
p = 0.0071 (Wilcoxon’s test)
(b)
Figure 6.8: KSHV PAR-CLIP targets in mRNA half-life data. Figure 6.8a shows the distributions
of half-life differences between BCBL1 and DG75 for all genes with PAR-CLIP target sites.
Thus, positive values indicate a longer mRNA half-life in BCBL1 than in DG75. Genes with
KSHV microRNA targets active in BCBL1 tend to have shorter half-lives in BCBL1 than in
DG75. This is highly significant for all BCBL1 target genes as well as the constitutive targets
but not for BCBL1 specific targets, even if their half-life is on average about 20 minutes shorter
in BCBL1 than in DG75. However, KSHV microRNA targets that are inactive in BCBL1 do not
show any shift in their half-lives. As illustrated in Figure 6.8b, the difference between targets
active exclusively in BCBL1 is statistically significantly different from targets active exclusively
in BC1 or BC3, when their ranks among all PAR-CLIP targets are considered.
counteract the cellular response to infection [Cullen, 2011; Kincaid and Sullivan, 2012] which is
reflected by the fact that KSHV microRNAs target several induced genes [Do¨lken et al., 2010].
Indeed, when mRNA or protein levels were considered individually, no significant shift in
expression fold changes was observed for any set of microRNA targets (Figures 6.9). Thus,
in spite of the fact that mRNA half-lives are significantly decreased by KSHV microRNAs, there
is no observable effect on steady-state levels of neither mRNAs nor proteins. However, if protein
fold changes are normalized to mRNA fold changes, a small but statistically significant difference
can be observed between BCBL1 specific targets and BC1/BC3 specific targets (p < 0.01,
Wilcoxon rank sum test; Figure 6.9d). Since this normalization effectively removes all effects
of mRNA levels and half-lives, this indicates that KSHV microRNAs not only have an impact on
mRNA half-life in a context-dependent manner, but also on how many proteins are produced
per mRNA molecule. Constitutive targets of KSHV microRNAs did not show this pattern,
presumably because of their strong impact on mRNA half-lives (Figure 6.8).
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Figure 6.9: KSHV PAR-CLIP targets in expression data. Figures 6.9a and 6.9b show the fold
change distributions of mRNAs and proteins between BCBL1 and DG75, respectively. When
the log fold changes of mRNAs and proteins are considered individually, no significant shift
for any set of context-specific microRNA targets is observed. In Figure 6.9c, genes are scattered
according to their mRNA log2 fold changes between BCBL1 and DG75 on the x-axis and to their
protein log2 fold changes on the y-axis. Target sites active in BCBL1 appear to be shifted towards
the bottom-right. These sites correspond to genes whose protein level fold change between
BCBL1 and DG75 is lower than expected from the mRNA level. Figure 6.9d shows the ranks of
protein fold changes normalized to their mRNA levels for all gene sets considered. Normalized
protein fold changes are significantly lower for genes with BCBL1 specific target sites than for
genes with target sites inactive in BCBL1 (p < 0.01, Wilcoxon rank sum test).
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Figure 6.10: Context-dependent target interactions of human microRNAs. The differential PAR-
CLIP analysis for all target sits of cellular microRNAs is visualized. The top part corresponds to
BCBL1 specific target sites of constitutively expressed cellular microRNAs (n = 184) whereas
the bottom half represents target sites exclusively active in DG75 and not in BCBL1 (n = 137).
Importantly, all these patterns of context-dependency are highly reproducible across replicates.
Taken together, RIP-Chip data, RNA half-life data as well as mRNA and protein expression
data provides good evidence that a substantial amount of KSHV microRNA target sites as
found by differential analysis of PAR-CLIP data is indeed context-dependent which leads to
a differential association with RISC and results in context-dependent functional impact on target
gene expression.
6.3.4 Context-dependent target sites of cellular microRNAs
We next selected context-dependent microRNA/target interactions that are either active in
BCBL1 or DG75 but not in both. Thus, we first selected all microRNAs that are not differentially
expressed between BCBL1 and DG75 (< 2-fold) and are reliably detected in the PAR-CLIP
experiments (at least 100 reads in all four datasets). Furthermore, all microRNAs had to have at
least 20 target sites as identified by a 7-mer seed by PARma. All identified microRNAs showed a
clear pattern of context-dependency in their target sites. Using the same criteria as in the analysis
of KSHV microRNAs, context-dependent target sites were defined (Figure 6.10).
Again, context-dependent microRNA/target interactions as defined by the differential PAR-
CLIP analysis resulted in highly significant differential association with RISC (Figure 6.11a).
Specifically, context-dependent targets are more than 2-fold enriched in significantly differ-
entially RISC-associated mRNAs (PC2 score > 2) for both cellular contexts. Furthermore,
target mRNA half-lives are again significantly lowered by the context-dependent activity of the
microRNA/target interactions (p < 0.0002, Wilcoxon rank sum test; Figure 6.11b). Thus, as in
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Figure 6.11: Cellular PAR-CLIP targets in RIP-Chip and mRNA half-life data. Figure 6.11a
shows the distributions of the differential RIP-Chip scores as compared to all genes with any
PAR-CLIP target sites (see also Figure 6.7a). Both, targets exclusively active in DG75 as well
as in BCBL1 are significantly shifted towards stronger association with RISC in their respective
context. The vertical lines indicate a threshold for strongly differentially RISC-associated genes.
In both cases, the respective context-dependent targets are more than 2-fold enriched over the
background genes (about 10% of background genes in comparison to > 20% of the target
genes in both cases. In Figure 6.11b, the rank distribution of half-life differences for both
sets of context-dependent targets is shown (see also Figure 6.8b). BCBL1 specific targets are
significantly shifted towards lower half-life difference ranks in comparison to DG75 specific
targets indicative for effects of context-dependent microRNA/target interactions in the respective
context only.
the analysis of KSHV microRNAs, context-dependent target sites of cellular microRNAs also
lead to differential RISC-association and have functional impact on target mRNA half-lives in a
context-dependent manner.
The analysis of steady-state expression levels revealed a clear pattern of context-dependent tar-
gets: Both sets of context-dependent targets are clearly shifted in comparison to the background
with respect to both mRNA and protein fold changes (Figures 6.12a and 6.12b). Specifically,
genes tend to have higher expression in the context where the microRNA/target interactions are
active.
Importantly, this is not solely due to a completely abrogated expression in the non-active context,
since proteins are detected for almost half of all context-dependent targets in both cell lines and
in more than two thirds of the cases, the fold change is smaller than 2-fold (Figure 6.12c). Thus,
it is not the absence or presence of target mRNAs that lead to context-dependency of target sites.
Rather, this indicates a complex dependency of the target site activity on the exact target mRNA
expression levels. However, there may be a subpopulation within both sets of context-dependent
6.3 Results 105
−5 0 5
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
log2 mRNA BCBL1/DG75
log2 mRNA BCBL1/DG75
cu
m
u
la
tiv
e
 fr
eq
ue
nc
y
all p=NA
DG75 exclusive p=0
BCBL1 exclusive p=6.42e−12
(a)
−6 −4 −2 0 2 4 6
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
log2 protein BCBL1/DG75
log2 protein BCBL1/DG75
cu
m
u
la
tiv
e
 fr
eq
ue
nc
y
all p=NA
DG75 exclusive p=7.63e−08
BCBL1 exclusive p=4.36e−08
(b)
protein,constitutive
protein,differential
no protein,differential
no protein,constitutive
(c)
2 4 6 8 10 12
2
4
6
8
10
12
PAR−CLIP sites on genes
expression data
mRNA BCBL1
m
R
N
A 
D
G
75
all n=4620
DG75 exclusive n=133
BCBL1 exclusive n=183
(d)
Figure 6.12: Cellular PAR-CLIP targets in expression data. Here the distributions of mRNA
and protein fold changes between BCBL1 and DG75 for context-dependent targets of cellular
microRNAs are shown, as compared to the background of all genes with any PAR-CLIP
target site. Clearly, based on mRNA as well as on protein levels, context-dependent targets are
higher expressed in their target context. This indicates that the target mRNA expression directly
contributes to the cellular context of microRNA-mediated regulation. As depicted in Figure
6.12c, this is not solely due to a complete absence of gene expression in the non-target context,
as proteins are detected for all these genes in half of the cases and more than two thirds are only
slightly differentially regulated (< 2-fold). Figure 6.12d shows a scatterplot of the microarray
intensity measurements for all genes with a PAR-CLIP target site.
targets, where a missing activity of a target site may be explained by the complete absence of the
target mRNA (Figure 6.12d).
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Table 6.1: Identified motifs by MERCI. We searched for motifs in flanking sequences (+/- 80
bp) of context-dependent seed sites not explained by differential mRNA levels. These motif
searches were done in a discriminative manner, i.e. by comparing a positive set to a negative set of
sequences. E.g. BCBL1 exclusive sites of cellular microRNAs (Cellular BCBL1) were compared
to DG75 exclusive target sites of cellular microRNAs (Cellular DG75). For each comparison, the
identified motifs only occurred in the positive set and not in the negative set.
Positive set with motif Negative set with motif Min occurrences Motif count
Cellular BCBL1 94/107 Cellular DG75 0/76 7 29
Cellular DG75 65/76 Cellular BCBL1 0/107 5 25
Viral BCBL1 83/100 Viral BC1/BC3 0/99 6 29
Viral BC1/BC3 74/99 Viral BCBL1 0/100 6 20
6.3.5 mRNA levels and flanking sequence motifs explain context-dependent
microRNA/target interactions
Thus, we analyzed to which extent mRNA expression levels contribute to the cellular context and
whether there are other factors that are necessary to explain the widespread context-dependency
of target sites. First, we tested whether the target mRNA level is the only contributor that
constitutes the cellular context for microRNA-mediated gene regulation.
Read counts are not only subject to biological variance but also to a substantial amount of
sampling noise since many clusters only have a few dozen reads. To compare PAR-CLIP read
count fold changes with mRNA fold changes in a more robust manner, it is therefore important
to estimate the extent of this sampling noise. We used a population based estimate of variance
using a conditional gamma distribution (see Methods). This approach is similar to recent methods
to estimate significance of differential expression in RNA-seq data [Anders and Huber, 2010;
Robinson et al., 2010].
If this noise model is applied to the comparison of mRNA fold change corrected PAR-CLIP
target sites, more than 50% of all context-dependent target sites, i.e. at least 14% of all target
sites of the selected set of cellular microRNAs, cannot be explained as judged by the P-value
distribution (Figure 6.13). This means that in these cases, the PAR-CLIP read count fold change is
significantly higher than expected from the corresponding mRNA fold change and this difference
also cannot be explained by sampling noise inherent to low-count data such as PAR-CLIP. Thus,
target site activities are not simply linearly dependent on mRNA levels.
Furthermore, as illustrated in Figure 6.13b, there are several instances where the target gene is not
differentially expressed (i.e. datapoints around 0 on the mRNA log2 fold change axis) but where
the target sites show a > 16-fold elevated activity. In these cases, mRNA expression alone clearly
cannot explain target site activity. Thus, other factors contribute to context-specific microRNA
function.
RNA binding proteins (RBPs) likely constitute such additional contributors. Thus, we performed
a motif search in regions flanking context-dependent target sites (seed site +/- 80 bp). For motif
discovery we used MERCI [Vens et al., 2011], which is based on efficiently enumerating all
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Figure 6.13: Comparison of mRNA fold changes to PAR-CLIP read count fold changes. Figure
6.13a shows a scatterplot comparing mRNA fold changes to PAR-CLIP read count fold changes
of all target sites of the cellular microRNAs analyzed. For the PAR-CLIP data, a pseudocount
of 1 was used. Green dots represent target sites that can be explained by the mRNA fold change
while respecting sampling noise of the read counts, whereas orange and red dots correspond to
significant outliers (p < 0.05 and p < 0.01, respectively). The P-value distribution in Figure
6.13c of all these target sites suggests that at least 14.9% (363 instances with p < 0.01 of overall
2436 target sites after subtraction of baseline indicated by the horizontal line) of all differential
target site activities cannot be explained by the mRNA fold change and sampling noise. Figures
6.13b and 6.13d illustrate this for the context-dependent microRNA/target interactions only.
Here, more than 50% of all sites cannot be explained by mRNA levels.
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Figure 6.14: Role of sequence motifs for context-dependent target sites. Figure 6.14a shows the
fraction of context-dependent target sites that contain a certain number of discriminative k-mers.
Only target sites that cannot be explained by mRNA levels were used. A k-mer is discriminative
if it occurs n times in the positive set (e.g. cellular BCBL1 exclusive sites in red) and does
not occur in the corresponding negative set (e.g. cellular DG75 exclusive sites, see Table 6.1).
We sorted discriminative k-mers according to their number of occurrences in decreasing order
and chose a cutoff for n based on our randomization experiments (Figure 6.15). In all cases,
between 75% and 90% of all context-dependent target sites can be explained by a discriminative
k-mer. In Figure 6.14b, putative explanations for the full sets of context-dependent target sites
are illustrated. On average, more than 90% can be explained by either differential mRNA levels
or the presence of a discriminative k-mer.
discriminative k-mers of two sets of sequences. Specifically, we searched for k-mers that do not
occur in the negative set and occur at least n times in the positive set and we only considered
target sites from mRNAs that are not differentially expressed. n was chosen according to the total
number of sequences in the positive set. MERCI identified 20-30 k-mers when we compared
target sites of cellular microRNAs exclusively present in BCBL1 to those exclusively present in
DG75 and target sites of viral microRNAs exclusively present in BCBL1 to those in BC1/BC3 or
vice versa (Table 6.1 and Figure 6.14a). These discriminative k-mers occur in 75%-90% percent
of all context-dependent target sites that cannot be explained by the mRNA level and as few
as 5 motifs already can explain 30%-40% of all sites. In contrast, discriminative k-mers found
by chance in randomized sequences only occur in a considerably lower number of sequences
(Figure 6.15). Thus, these motifs are likely candidates of binding sites for RBPs contributing to
context-dependent recognition of target sites by microRNAs.
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Figure 6.15: Motif randomization results. For each comparison, positive and negative labels were
randomly permuted 1000 times. MERCI was run on each randomized instance and the number
of sequences containing an n-discriminative k-mer was counted for n between 5 and 10. A k-mer
is n-discriminative, if it occurs in at least n sequences in the positive set and does not occur in the
negative set. We plotted the distributions of the fractions of explained sequences and compared
them to the actual fractions in the true positive and negative sets (points in the plots).
In summary, from all context-dependent target sites identified by PAR-CLIP and validated by
RIP-Chip experiments, 4sU tagging based mRNA half-lives and mRNA and protein expression
measurements, more than 90% can either be explained by differential mRNA levels or by the
presence of a putative RBP binding motif (Figure 6.14b).
110 6. Widespread context-dependency of microRNA-mediated regulation
0 2 4 6 8 10 12
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
Evolutionary conservation of seed sites in 3’−UTRs
branch length 7mer
cu
m
u
la
tiv
e
 fr
eq
ue
nc
y
cellular microRNA, context−dependent
cellular microRNA, constitutive
viral microRNA, context−dependent
viral microRNA, constitutive
p=0.00304
p=0.964
primates + rodents + other mammals + other vertebrates
(a)
0.0 0.2 0.4 0.6 0.8 1.0
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
Evolutionary conservation of seed sites in 3’−UTRs
branch length 7mer rank in 3’−UTR
cu
m
u
la
tiv
e
 fr
eq
ue
nc
y
cellular microRNA, context−dependent
cellular microRNA, constitutive
viral microRNA, context−dependent
viral microRNA, constitutive
p=0.0259
p=0.941
(b)
Figure 6.16: Conservation of target sites. Distributions of branch lengths of target sites are
illustrated in Figure 6.16a (see main text for a definition of branch lengths). Shaded regions
indicate the maximal branch lengths of target sites conserved in primates, in primates and
rodents, in mammals and in vertebrates. All cellular microRNAs considered here are conserved in
vertebrates. Constitutive target sites of these microRNAs are significantly more conserved (p <
0.00304, two-sided Kolmogorov-Smirnov test) than context-dependent target sites. Moreover,
neither context-dependent nor constitutive target sites of viral microRNAs show evidence for
evolutionary conservation. Figure 6.16b shows that these patterns are not due to different overall
3’-UTR conservation levels of target mRNAs. Branch lengths were computed for all 7-mers in
each 3’-UTR and the distribution of the rank of the seed (normalized between 0 and 1) among
all corresponding 3’-UTR branch lengths was considered.
6.3.6 Context-dependent target sites are less conserved than constitutive
sites
Finally, we asked whether context-dependent target sites have distinct evolutionary conservation
patterns as compared to constitutive target sites. Following the approach of Friedman et al.
[2009], for each target site we computed the branch length along the phylogenetic tree of 46
vertebrates by summing all branches where the seed of a cluster is fully conserved in the genome-
wide multiple alignment of 46 vertebrate species. The branch length thus incorporates both the
evolutionary age as well as the loss of a target site in specific lineages. Specifically, a target site
that emerged in the last common ancestor of primates and rodents, and has not been lost in any
primate or rodent lineage has a branch length of 2.342 (shaded areas in Figure 6.16).
Intriguingly, constitutive target sites of conserved cellular microRNAs are significantly stronger
conserved than context-dependent sites (p < 0.003, two-sided Kolmogorov-Smirnov test). For
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instance, while more than 80% of constitutive sites are conserved beyond the last common
ancestor of primates and rodents, only about 65% of context-dependent sites are conserved
beyond this clade. 20% of context-dependent sites even show a signature of recent evolution
within the primate lineage. Importantly, this does not reflect the overall conservation level of the
respective 3’-UTRs, but is specific to the seed sites (Figure 6.16b).
Target sites of viral microRNAs, independent whether they are context-dependent or constitutive,
show patterns of much weaker conservation. This can be expected, as there are no conserved viral
microRNAs and as pathogenicity of KSHV may rather induce positive selection of its microRNA
target sites on host mRNAs.
6.4 Discussion
In this study, we analyzed PAR-CLIP data from four human B-cell lines, three of which are
infected with Kaposi’s sarcoma-associated herpesvirus (KSHV), using an improved computa-
tional approach to identify target sites of both cellular and viral microRNAs (PARma, Erhard
et al. [2013a]). The overlap in target sites between the four cell lines was surprisingly low
(about 40%), indicating a large set of context-dependent microRNA/target interactions. Three
additional sets of high-throughput data (RIP-Chip, 4sU-tagging-derived RNA half-lives and
SILAC proteomics data) supported this observation: Context-dependent microRNA targets are
associated with RISC in a context-dependent manner and have a measurable functional impact on
their targets in a context-dependent manner. This was observed for the targets of both, cellular and
viral microRNAs. The latter offered an important control as they were exclusively observed in the
cells expressing the viral microRNAs. Thus, we propose a new layer of complexity in microRNA
targeting: Depending on the cellular context, specific microRNA/target interactions may be active
or not, even if both microRNA and target mRNA are expressed. Furthermore, we could show that
the evolutionary conservation differs between context-dependent and constitutive target sites,
indicating that selective pressure may be different for context-dependent and constitutive target
sites or that they have different evolutionary ages.
6.4.1 Contributors to the cellular context
Cellular context may be formed directly by the quantities of microRNAs and mRNAs: Dependent
on the exact copy numbers of microRNAs and mRNAs in each cell, intricate regulatory
mechanisms may emerge leading to highly complex patterns of regulation [Mukherji et al., 2011].
Furthermore, due to the many-to-many relationship of regulators and targets, microRNAs and
mRNAs are embedded in a highly complex regulatory network [Hobert, 2008]. Our analyses
indicate that the quantities of microRNAs and target mRNA are direct contributors to the cellular
context. However, based on our results, more than 50% of all observed context-dependent
microRNA/target interactions cannot be explained by microRNA or mRNA levels and, therefore,
are likely dependent on indirect factors.
The presence of RNA binding proteins (RBPs) may prevent microRNA binding to nearby sites
[Bhattacharyya et al., 2006] or also induce binding [Kim et al., 2009a]. In a recent study the
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whole RNA binding proteome of a cell line was examined by PAR-CLIP coupled to high
resolution mass spectrometry [Baltz et al., 2012]. This study revealed two important aspects of
RBPs: First, in a single cell type, about 800 different RBPs can be identified. This unexpectedly
high number of RBPs allows for highly complex combinatorics of competitive or activating
RBP-microRNA interactions. And second, crosslinking events were observed for almost 30%
of all uridines in 3’-UTRs, suggesting that mRNAs are broadly covered by RBPs. Indeed, we
could identify a handful of sequence motifs that are able to explain a large fraction of context-
dependent target sites, indicating that RBPs may play important roles in shaping the cellular
context for microRNA-mediated regulation.
Thus, there is an intriguing analogy of the transcriptional and post-transcriptional layer of
regulation: DNA, which is the material for transcriptional regulation, is covered by histones,
transcription factors and other DNA binding proteins and the composition and dynamics of
these proteins contribute to the cellular context [Consortium, 2012b]. This cellular context
determines to which extent a certain transcription factor can bind to a specific target site
and exert its regulatory role. Context-dependent regulatory networks may differ dramatically
across different cell types or conditions [Neph et al., 2012a]. Similarly, mRNAs, which are
the units for post-transcriptional regulation, are covered by RBPs, and we argue that their
composition and dynamics contribute to a cellular context for microRNA-mediated regulation.
Additionally, factors other than these covering proteins may further shape the cellular context for
both, transcriptional and post-transcriptional regulation: For transcriptional regulation, distinct
modifications of chromatin or the DNA may also determine context. Furthermore, chromosomal
conformations may place distal binding sites of transcription factors to promotors of different
genes in three-dimensional space and may therefore also be important.
6.4.2 Other contributors
mRNAs may even provide more opportunities for context-dependent regulation: While DNA
usually is restricted to a single cellular compartment, the nucleus, the life cycle of mRNAs
may span multiple compartments and subcompartments. This cellular localization may itself
be regulated and depending on the localization, mRNAs may be translated or not. For instance,
sequestering of mRNAs to P-bodies by microRNAs leads to a reduced translation and mRNA
decay [Pasquinelli, 2012]. Furthermore, the single stranded mRNA gives rise to complex
secondary and tertiary structures, and it has been shown that the accessibility of target sites
determines whether microRNAs can bind to the mRNA or not [Kertesz et al., 2007]. Interestingly,
the conformation of RNAs is highly flexible and may be reshaped in a context-dependent way:
Kedde et al. [2010] have shown that the activation of the RNA binding protein Pumilio-1 induces
a local change in a hairpin structure of the 3’-UTR of the p27 tumour suppressor mRNA. Upon
Pumilio-1 activation, an inaccessible binding site of miR-221/miR-222 is opened for binding,
leading to an efficient repression of p27.
In addition, RISC is a highly modular protein complex [Frohn et al., 2012]. Therefore, proteins
that interact with RISC may influence the effects of microRNA/target interactions: For instance,
the NHL family protein LIN41 has been found to suppress let-7 and miR-124 activity by
ubiquitilation of AGO2 [Rybak et al., 2009] and several other NHL proteins have been implicated
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in the regulation of RISC activity [Pasquinelli, 2012]. In addition to ubiquitilation, AGO2 is
susceptible for several other types of modification including hydroxylation [Qi et al., 2008],
phosphorylation [Ru¨del et al., 2011] and poly(ADP)-ribosylation [Leung et al., 2011].
Another layer of complexity in microRNA-mediated regulation is induced by mutual microRNA-
target regulation. Very strong microRNA binding sites in an mRNA [Franco-Zorrilla et al.,
2007], a pseudogene [Cazalla et al., 2010], a non-coding RNA [Cesana et al., 2011] or viral
RNAs [Marcinowski et al., 2012] may sequester RISCs containing a specific microRNA acting
as a microRNA sponge. It has also been hypothesized that the microRNA target sites in a cell
as a whole allow for crosstalk between expressed transcripts giving rise to an intricate post-
transcriptional regulatory network based on mutually competing microRNA/target interactions
[Salmena et al., 2011]. The complexity of such a regulatory network is further underlined by
the nonlinearity of the regulatory outcome of a microRNA/target interaction [Mukherji et al.,
2011]: Depending on the exact copy numbers of microRNA and mRNA and the affinity of the
microRNA for the target site, protein expression may be either completely abolished or only
fine-tuned.
It has been suggested that sequestering of RISCs by the expression of transcripts containing one
or multiple strong target sites for a specific microRNA may derepress its targets [Franco-Zorrilla
et al., 2007; Cazalla et al., 2010; Cesana et al., 2011; Marcinowski et al., 2012]. Thus, such
microRNA sponges may also be important contributors to the cellular context for microRNA-
mediated regulation. In such a setting, weak target sites should disappear first. By comparing
binding energies for our set of context-dependent target sites, we tested whether such effects play
a role in our datasets. However, we could not identify any microRNA where exclusive binding
sites had significantly different binding energies than constitutive target sites (data not shown).
This may be due to deficiencies of the current RNA energy model to describe microRNA/target
duplexes, or because microRNA sponges do not play an important role for our cell lines. And
indeed, all of the selected cellular microRNAs exhibit target sites that are exclusive in DG75 and
other target sites exclusively present in BCBL1, which would not be expected if a microRNA
sponge is active in one of these cell lines.
6.4.3 Functional considerations of context-dependent regulation
Based on results from concurrent research on transcriptional regulation [Consortium, 2012b;
Wang et al., 2012b,a; Yanez-Cuna et al., 2012], context-dependency in post-transcriptional
regulation should not come as a surprise: It is known that transcription factors bind to their target
sites in a context-dependent manner. Therefore, context-dependency of regulatory mechanisms
presumably is beneficial in an evolutionary sense, and this is a widespread phenomenon for
transcriptional regulation. Here, we argue that evolution also has invented this additional layer of
complexity for microRNA-mediated regulation as well.
One evolutionary benefit of the additional layer of complexity by context-dependent microRNA/-
target interaction may be the greater flexibility in regulation: Modulating the expression level of
a microRNA would alter the regulation of hundreds of targets and therefore potentially influence
a multitude of cellular processes. In contrast, using context-dependent regulation, for instance
by activating or inactivating an RNA binding protein (RBP), smaller groups of targets could be
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activated or inactived in a much more focused manner. The combinatorics that unfolds when
multiple RBPs, multiple target sites or other factors contribute to the overall regulation provides
opportunities for evolutionary forces to achieve the desired expression levels for individual genes.
Our analysis of target sites of constitutively expressed cellular microRNAs revealed that a large
fraction of context-dependent targets may be due to induced mRNA levels. For instance, a gene
may get transcribed at high rates in BCBL1 as compared to DG75, leading to elevated mRNA
levels. At the same time, microRNA target sites are more active in BCBL1 than in DG75,
leading to an induced degradation as compared to DG75. Importantly, this dependency between
microRNA and mRNA is not necessarily linear, as pointed out above. Thus, these constitutive
microRNAs seem to limit the expression levels of their target mRNAs: If targets have high
enough expression levels, they become subject to microRNA-mediated regulation thus providing
an upper bound for the target mRNA levels.
6.4.4 Consequences of context-dependency
The differential analysis of a collection of high-quality large-scale experiments for microRNA
target site discovery indicates that context-dependent microRNA targeting is not restricted
to a few examples, but is a widespread phenomenon and a general feature of microRNA
mediated regulation. This has significant consequences for both computational and experimental
approaches for microRNA target discovery.
MicroRNA target prediction algorithms may not as bad as their reputation [Thomas et al., 2010;
Sethupathy et al., 2006; Ritchie et al., 2009]: False positive as well as false negative predictions
simply may be due to a wrong context used when evaluating the predictions. Thus, none of the
apparently inconsistent evaluations of microRNA target prediction algorithms may be wrong:
Each of these was evaluated on a different cellular context and, consequently, differing prediction
methods seemed more accurate than others. However, the problem of microRNA target prediction
may be defined in an incorrect way and as long as prediction methods do not incorporate the
cellular context, predicted targets are of limited use. Thus, we expect that future development
of microRNA target prediction methods will mainly depend on integrating features of cellular
context into the prediction algorithms. Such an approach is obviously heavily dependent on
progress in unraveling contributing factors to the cellular context.
Another consequence of a general context-dependency of microRNA targeting is that experi-
mental assays for microRNA target discovery and validation must be interpreted with care. In
various studies, either a single or a pool of microRNAs has been transfected into a cell line and
gene expression has been measured genome-wide either on the mRNA level using microarrays
or RNA-seq [Lim et al., 2005; Linsley et al., 2007; Grimson et al., 2007; He et al., 2007; Xu
et al., 2010] or on the protein level using mass spectrometry [Selbach et al., 2008; Baek et al.,
2008] differentially for transfected and control cells. In addition to the well-known problem
of secondary regulation [Tu et al., 2009; Naeem et al., 2011], there are several reasons why
downregulated genes should not generally be taken as the set of targets for the transfected
microRNA: First, they may be targets exclusively active in the cell line investigated in the
study. Second, the transfected microRNA may have copy numbers at levels never occurring
in physiological conditions. And third, the transfection itself may lead to an altered cellular
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context, e.g. by the induction of cellular stress pathways. Also, further conclusions drawn from
such experiments, e.g. that microRNAs generally lead to widespread but only modest regulation
should be revisited: This may only be true in the context of the experiment, which is not a cellular
context that evolved naturally but has been forced onto a cell line artificially. Furthermore, later
studies revealed that the particular outcome or strength of regulation is dependent on the exact
mRNA and microRNA copy numbers [Mukherji et al., 2011].
Also, the most widely used validation assay for microRNA targets is based on fluorescence
reporter genes that are fused to target 3’-UTRs and co-transfected with the microRNA into a
particular cell line usually lacking this microRNA [Kiriakidou et al., 2004; Gottwein et al.,
2011]. Obviously, not only is the microRNA-target pair introduced into a non-natural context
and probably expressed at non-physiological conditions, but also the microRNA target site itself
is expressed in a non-natural context, i.e. the 3’-UTR of a fusion gene. Thus, both outcomes of
such an experiment may not hold for the microRNA target pair under different conditions, i.e. if
the reporter assay does not confirm regulation, the target site may still be highly functional in the
right context and if the reporter assay validates regulation, this may not be true for the context
under consideration. In conclusion, while luciferase assays provide good evidence that a certain
gene can be regulated by a given microRNA it does not allow any claims about whether this
interaction is of relevance in the biological context of interest.
Consortium-driven endeavors to unravel context-dependent transcriptional regulation have been
started years ago, as soon as the human genome project has been finished [Consortium, 2012b].
Context-dependent transcription factor binding sites have been determined in an overwhelming
variety of conditions and it is one of the most intriguing results of the ENCODE project that
context-dependency is one of the key features of transcriptional regulation.
Here, we show that context-dependency is also an important factor in post-transcriptional
regulation. We propose that a similar approach as for transcriptional regulation must also be
taken for microRNA-mediated regulation and that a lot of additional experiments are necessary
to further investigate both, microRNA targets specific to certain contexts and key contributors
that determine cellular context.
6.5 Methods
6.5.1 Cell lines
DG75-eGFP and BCBL1 were cultured in RPMI medium supplemented with 10% fetal calf
serum and pen/strep.
6.5.2 PAR-CLIP and sequencing
PAR-CLIP on DG75 and BCBL1 were performed by the Zavolan laboratory as described
[Kishore et al., 2011; Jaskiewicz et al., 2012]. Briefly, a total of 3 ∗ 108 cells per replicate were
grown and treated with 4-thiouridine (Sigma) for 14 hours (final concentration 100 uM). Cells
were pelleted and washed in cold PBS. Aliquots of 5 ∗ 107 cells were resuspended in 5 ml of
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cold PBS, placed in a 15 cm petri dish and irradiated at 365 nm with 100 mJ twice on ice, with
30 s break in between. Cross-linked cells were collected, pelleted and snap-frozen. PAR-CLIP
was performed using 11A9 anti-Ago2 monoclonal antibody [Ru¨del et al., 2008]. The PAR-CLIP
sequencing data for BC1 and BC3 from [Gottwein et al., 2011] have been downloaded from
GEO (accession number: GSE32113). We applied PARma [Erhard et al., 2013a] to the whole
collection of all PAR-CLIP datasets as described.
6.5.3 SILAC-based proteomics
SILAC and LC-MS/MS were performed as described in the Mann laboratory at MPI for
Biochemistry in Munich. The raw files from the mass spectrometer have been analyzed using
MaxQuant (version 1.2.2.5) [Cox and Mann, 2008] using standard parameters against all human
proteins from Ensembl (v60).
6.5.4 RIP-Chip analysis
For the RISC-IPs, 5 × 108 cells were taken for each replicate and processed as previously
described [Do¨lken et al., 2010] using 6µg of purified monoclonal hAgo2 antibody (α-hAgo2;
11A9) or monoclonal BrdU-antibody (Abcam; used as control).
6.5.5 RNA half-life measurements by 4sU-tagging
The RNA half-life data for DG75 and BCBL1 have been published previously [Do¨lken et al.,
2010]. In brief, newly transcribed RNA was labeled for 1h by adding 100µM 4sU to the cell
culture medium. Total RNA was prepared using Trizol and newly transcribed RNA was purified
as described [Do¨lken et al., 2008]. Three replicates of newly transcribed, total and preexisting
RNA were measured.
6.5.6 PARma
PARma is specifically designed to accurately determine target sites and to determine which
microRNA is responsible for each target site and is described in a separate paper [Erhard et al.,
2013a]. Briefly, it estimates seed activity probabilities and the parameters of a generative model
for the PAR-CLIP data simultaneously in an iterative manner. The model and probabilities
are then used to accurately determine the seed position within each PAR-CLIP cluster, and to
compute a cluster confidence score (C-score) and a microRNA assignment confidence score
(MA-score). The C-score can be used to exclude false positive clusters (i.e. clusters that do
not correspond to a target site of any microRNA), whereas the MA-score can be used to judge
whether the assigned microRNA is indeed targeting a given site.
The PAR-CLIP expression value for each cluster is computed for each experiment by counting
the reads overlapping the main crosslinking site [Erhard et al., 2013a]. For proper comparison
across experiments, the expression values for all clusters are normalized using the same strategy
as in Anders and Huber [2010], i.e. by dividing each count value by the geometric mean
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Figure 6.17: PAR-CLIP read count correlation with expression; The mRNA expression fold
change is scattered against the PAR-CLIP read count fold change. Replicate counts were
summed and a pseudocount of 1 was used to circumvent division by zero. In red and blue,
context-dependent target sites of cellular microRNAs are shown.
across experiment and taking the median of all these values from a specific experiment as the
normalization factor for this experiment.
To analyze the positional distribution, we subdivided each transcript into 60 bins and counted the
number of target sites of cellular, EBV and KSHV microRNA, respectively, belonging to each
bin. In order to compare cellular and viral frequencies, the number of target sites within each bin
was divided by the total number of cellular, EBV or KSHV target sites, respectively.
Context-dependent target sites were determined by applying stringent cutoffs: More than 10
normalized reads in all replicates in the active context and less than 5 in all other experiments.
6.5.7 Correcting for sampling noise
In order to estimate the contribution of mRNA levels to the cellular context for microRNA-
mediated regulation, we first inspected the correlation between the mRNA fold changes and PAR-
CLIP read fold changes (see Figure 6.17). Replicate counts were summed and a pseudocount of
1 was used to circumvent division by zero. These fold changes were correlated to some extent,
but there were also many exclusive (i.e. context-dependent) target sites present, that did not show
any or only a very modest mRNA fold change. In order to properly estimate the fraction of non-
correlated target sites and to handle the sampling noise of the low-count data and pseudocounts,
we took the following approach:
First, we estimated the variance of PAR-CLIP fold changes based on replicate experiments.
Because the number of replicates was extremely low (n = 2), no reliable estimates can be
compute in a target site-wise manner, and, thus, we took a population based approach similar
to methods that estimate significance of differential expression in RNA-seq data [Anders and
Huber, 2010; Robinson et al., 2010]. Since the variance is not equal for strong target sites and
weak target site (as measured by the number of PAR-CLIP reads) due to sampling noise, variance
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was estimated conditional on the target site strength. Then, for each target site, we checked,
whether the mRNA fold change was within a critical region as defined by significance levels of
1% and 5%.
To estimate read count fold change variances, we considered the absolute difference of read
counts from replicate measurements (see Figure 6.18). For a given target site strength (as
measured by the geometric mean of read counts across replicates), the distribution of these
absolute differences resembled a gamma distribution by visual inspection. Thus, by using a
running window approach, we estimated the distribution of absolute read count differences by
fitting a gamma distribution to each window of 1000 target sites along the target site strength
(i.e. the red line in Figure 6.18) using the fitdistr function from the R package MASS. We plotted
the rate and shape parameters of the gamma distribution as fitted for different windows along
the target site strength (see Figure 6.18c) and noticed that the shape parameter was relatively
constant and the rate parameter increased linearly in log space with the target site strength. For
robustness of the fits, we therefore computed the median shape parameter S across all windows
and computed a robust linear fit for the rate parameters R(s) against the logarithmized target
sites strengths s. Thus, our model describes the absolute read count difference of a target site
with strength s (i.e. the geometric mean of read counts across all experiments) by a gamma
distribution with rate and shape parameters R(s) and S.
This conditional gamma distribution allows us to compute the distribution of absolute read count
differences for a given target site strength. As illustrated in Figure 6.18d, this conditional gamma
distribution nicely reflects the variances for replicate measurements.
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Figure 6.18: Conditional gamma distribution fit. In Figures 6.18a and 6.18b, the correlation of
replicate PAR-CLIP read counts are shown in log scale for the DG75 and BCBL1 experiments,
respectively (using a pseudocount of 1). The red line indicates the main diagonal. Deviations
from the diagonal are obviously larger for weak targets sites (bottom left), indicative for sampling
noise inherent to low count data such as PAR-CLIP. Figure 6.18c shows the fitted gamma
distribution parameters against the target site strength. Outliers from the conditional model are
indicated in gray (see Methods). In Figure 6.18d the p-value distribution of the gamma model
applied to replicate measurements is shown. It closely resembles a uniform distribution, which
indicates that our model accurately resembles the observed deviations in replicate measurements.
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Chapter 7
Detection of outlier peptides
Motivation: While the previous chapters mainly focussed on viral microRNAs, their classi-
fication and targets, this chapter concentrates on possible effect of viruses and potentially
of microRNAs, their impact on splicing patterns. To investigate alternative splicing patterns
on large-scale, several methods have been proposed for RNA-seq data [Richard et al., 2010;
Trapnell et al., 2013]. However, the effect of splicing only plays a role on protein level and
considering the mRNA is only a proxy to proteins. Thus, I investigated whether and to which
extent shotgun mass spectrometry data can be used for the identification of splicing patterns.
In particular, I focussed on differential splicing, i.e. on splicing patterns that are different
between two conditions. In order to develop a method to identify differential splicing and for
its evaluation, I considered a publicly available high-quality dataset which I preprocessed using
MaxQuant, which is a recent and widely used analysis software for raw LC-MS/MS data [Cox
and Mann, 2008]. This is described in this chapter. I also applied this methods to the mass
spectrometry data generated by our collaboration partners, which, however, did not yield any
promising candidates for further experiments (see section 2.2.1).
Publication: An abstract of this chapter has been presented and published at the German
Conference on Bioinformatics (GCB) 2011 in Weihenstephan, Germany [Erhard and Zimmer,
2011]. Subsequently, a full paper has been published in the Journal of Proteomics [Erhard and
Zimmer, 2012]. Here, I adapted the layout and made minor corrections to the text.
My contribution: I came up with the method and the evaluations, implemented the method,
carried out evaluations and wrote the paper.
Contribution of co-authors: Ralf Zimmer supervised the work and helped to revise the
manuscript
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7.1 Abstract
Quantitative high-throughput mass spectrometry has become an established tool to measure
relative gene expression proteome-wide. The output of such an experiment usually consists of
a list of expression ratios (fold changes) for several thousand proteins between two conditions.
However, we observed that individual peptide fold changes may show a significantly different
behavior than other peptides from the same protein and that these differences cannot be explained
by imprecise measurements.
Such outlier peptides can be the consequence of several technical (misidentifications, misquan-
tifications) or biological (post-translational modifications, differential regulation of isoforms)
reasons. We developed a method to detect outlier peptides in mass spectrometry data which is
able to delineate imprecise measurements from real outlier peptides with high accuracy when the
true difference is as small as 1.4 fold.
We applied our method to experimental data and investigated the different technical and
biological effects that result in outlier peptides. Our method will assist future research to reduce
technical bias and can help to identify genes with differentially regulated protein isoforms in
high throughput mass spectrometry data.
7.2 Introduction
Mass spectrometry (MS) based proteomics has become a common tool for a wide range
of biological research areas [Baek et al., 2008; Cox and Mann, 2007; Huttlin et al., 2010;
Schwanhausser et al., 2011; Selbach et al., 2008]. In a shotgun experiment, proteins from a
complex sample are digested into peptides (e.g. using Trypsin) whose mass-to-charge ratios are
then measured in a first round of MS after ionization. Metabolically (e.g. SILAC) or chemically
(e.g. iCAT) introduced heavy amino acids can be used as labels to distinguish peptides in a
mixture of samples in the same MS run [Ong and Mann, 2005]. Measurement intensities are
related to peptide abundances and can therefore be used for quantification. These MS spectra
alone do not provide a reliable way to identify peptide sequences in a complex sample since mass
alone is not a reliable discriminator for peptides [Colinge and Bennett, 2007]. Therefore, tandem
mass spectrometers are able to select one or several peaks per MS scan for further fragmentation
followed by a second round of MS (MS2 spectra). The most abundant fragments produced are
so-called b and y ions, which are the result of fragmentation between the amino and hydroxy
groups of two consecutive amino acids and correspond thus to prefixes and suffixes of the original
peptide. It has been shown that these MS2 spectra provide enough information to identify peptide
sequences.
Primary data analysis is usually done by integrated analysis pipelines, e.g. TPP [Keller et al.,
2005], TOPP [Bertsch et al., 2011] or MaxQuant [Cox and Mann, 2008]. In modern high-
resolution LC-MS/MS settings, data analysis generally consists of the two crucial steps peptide
identification and quantification.
For peptide identification, experimental MS2 spectra are compared to theoretically computed
spectra from peptides derived from a protein sequence database. Several methods to score
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experimental to theoretical spectra have been developed and are available either as commercial
software such as Mascot [Perkins et al., 1999] or Sequest [Yates et al., 1995] or as open source
tools such as X!Tandem [Craig and Beavis, 2004] or Andromeda [Cox et al., 2011]. Such
methods typically report a candidate list of possible sequences for each MS2 spectrum with
one or several associated scores. False discovery rates (FDR) can be calculated using a decoy
database approach: For each protein in the database, a (pseudo-) reversed protein is created and
also used for database search. For a given score cutoff, the FDR then is equal to the fraction of
decoy identifications above this cutoff [Gupta and Pevzner, 2009; Ka¨ll et al., 2008].
Generally, there are two types of quantification: For an absolute quantification, the concentrations
of all proteins within a single sample must be determined, whereas for relative quantification the
concentration ratio (the fold change) between two or more samples is the quantity of interest.
We concentrate on relative quantification here, since it is deemed much more accurate than
absolute quantification [Ong and Mann, 2005]. The most widely used relative quantification
techniques rely on the intensities in the MS spectra. This can either be done within a single MS
run after samples have been labeled or across runs in a label-free experiment and involves finding
intensities that belong to the same peptide in the two samples, a proper way to compute the ratio
of all corresponding intensities and normalization. After peptide fold changes are available, they
are assembled into protein quantifications. This is usually done for so called protein groups that
contain those proteins from the database that share the majority of their peptides [Nesvizhskii
and Aebersold, 2005]. The output of such workflows therefore consists of a list of protein groups
together with identification statistics and a summarized relative quantification.
When looking at individual peptide fold changes of typical high-throughput mass spectrometry
experiments, it becomes clear that in several cases, peptides seem to exhibit a different fold
change than other peptides from the same protein (see for instance Figure 7.1). There are several
possible explanations for such situations, including:
1. Measurement imprecision: Repeated independent measurements of the same quantity
(i.e. peptide fold change) are subject to noise. The variance of the seven independent
measurements of the left most peptide in Figure 7.1 for instance are most likely the effect
of noise.
2. Ambiguous peptides: The sequence of the left most peptide may not be unique to this
protein and its true fold change in the sample should be intermediate between all matching
proteins.
3. Wrong identification: An MS2 spectrum may erroneously be assigned to a given peptide
and the measured fold change therefore belongs to a peptide from a different protein.
4. Wrong quantification: There may be certain properties of peptides that introduce bias into
quantification and the normalization of the quantification algorithm may not have corrected
for that. For instance, if a peptide of an abundant protein can be ionized easily, saturation
effects may lead to underestimated fold changes.
5. Differentially regulated post-translational modifications (PTMs): It is known that post-
translational modifications such as phosphorylations are highly regulated and may be
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Figure 7.1: Example MS peptide quantifications for a gene with several isoforms. Shown
are quantitative mass spectrometry measurements for the gene HN1 in a SILAC experiment
as produced by MaxQuant using standard parameters. On the top, log2 fold changes of all
quantifications for this gene are shown. For each event, a dot is drawn on top of the respective
peptide and multiple measurements for the same peptide are shown in increasing order. For the
left most peptide, that spans an exon-exon junction, its seven measurements are shown twice
(above both exons). On the bottom the gene structure according to Ensembl is shown: The first
line corresponds to the gene with all its exons and alternative splice donors and acceptors (black
lines) and the remaining lines represent the four transcripts with coding parts in dark gray. For
clarity, exons are shown in scale whereas introns are shrunken to a fixed size. All shown peptides
uniquely map to these locations.
differential in the conditions under consideration. If only the unmodified version of a
peptide has been identified and the modification has been upregulated, the unmodified
peptide will have a fold change that is different from the gene fold change.
6. Differential regulation of isoforms: Most eukaryotic genes can give rise to multiple
isoforms, either by alternative splicing, alternative transcription start sites or combinations
of these. Alternative peptides, i.e. peptides that are not part of all isoforms of a gene are
expected to show different fold changes, if respective isoforms are differentially regulated.
Depending on the summarization strategy the protein fold change for the gene in Figure 7.1
would either be around 2-fold down regulated or not regulated (when using the median of all
measurements or the median of all peptide medians, respectively). In either case, defining a
protein fold change may not be appropriate since the situation is obviously more complex. Thus,
a method to detect such situations would be of great benefit and would allow to investigate such
situations further.
A first attempt into that direction was made in [Forshed et al., 2011], where the correlation
coefficient of intensities of peptide from the same gene across multiple conditions was used as
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a distance measure for peptides. Hierarchical clustering was then used to either exclude outlier
peptides (that are uncorrelated to all other peptides) or to group genes in order to infer isoforms.
However, the correlation coefficient is useless when only two conditions are investigated as
in standard SILAC experiments. Also, since it directly compares the XIC of peptides between
conditions to compute the correlation coefficient, it cannot make use of more sophisticated ways
to compute intensity ratios as for instance implemented in MaxQuant [Cox and Mann, 2008].
Furthermore, excluding peptides that are uncorrelated to all other peptides from the same gene
may not always be appropriate, since such a peptide may be the only one specific to an isoform
(e.g. if it is located on a cassette exon).
Our goal in this study was to provide a method that is able to detect outlier peptides in standard
SILAC experiments. The proposed method was rigorously tested on in-silico simulated data,
where it could detect outlier peptides with high performance (as measured by an AUC > 0.8)
when the true difference was as small as 1.4 fold. The second goal was to investigate reasons for
outlier peptides in experimental data: Given we have identfied a set of genes like in Figure 7.1,
determine which of the reasons from above play a role in this set.
7.3 Materials and methods
7.3.1 Data processing
Experimental data taken from [Cox and Mann, 2008] has been downloaded from ProteomeCom-
mons Tranche, where EGF stimulated HeLa cells were compared to control cells using SILAC.
Data has been analyzed using MaxQuant [Cox and Mann, 2008] version 1.2.0.18 (June 2011)
against all proteins downloaded from Ensembl v60 (November 2010). Default parameters
have been used: Oxidatation (M) and Acetylation (N-term) as variable modifications and
Carbamidomethylation(C) as fixed modification, reverse peptides as decoy database, matching
between runs in a 2min rt window. For all further analyses, we use all unique peptides from
evidence.txt (produced by MaxQuant) that contains quantification events of all identified (and
matched) SILAC pairs at a FDR of 1% (according to a decoy database approach). To determine
uniquely matching peptides, peptide sequences from evidence.txt have been mapped to the
human genome using position information obtained via Ensembl Biomart, and only uniquely
matching peptides have been retained. Gene definitions also have been taken from Ensembl,
with the modification that overlapping genes have been clustered to gene clusters using single
linkage (i.e. a peptide mapped to the genome always belongs to a single gene cluster). We will
refer to these gene clusters as genes in the following. In order to perform statistical tests on
quantifications, we furthermore discard all peptides if less than 3 independent measurements are
available.
7.3.2 Detecting outlier peptides
The goal of our method is to distinguish measurement noise from other reasons that lead to
peptide fold changes that are different from other measurements from the same gene. This
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is based on an important property of typical mass spectrometry experiments: Many peptides
are identified and quantified multiple times because experiments have been done in replicates,
because peptides may have been measured in multiple gel slices (which may have been used
for a fractionation step before mass spectrometry) or in multiple charge states. Since all these
quantifications are technically independent from each other, we can use them to estimate the
quantitive precision. The goal then is to determine peptides that are different from other peptides
from the same gene and where this difference cannot be explained by a high quantification
variance.
The most basic algorithm first computes all peptide and gene fold changes pi and gk by taking
the mean or median of all corresponding measured fold changes. Then, genes are ranked by their
maximal absolute peptide-from-gene deviation
dk = max{|gk − pi| | peptide i uniquely belongs to gene k}
Unfortunately, there are two caveats in such a procedure: First, it is difficult to determine a
reasonable cutoff without performing permutation tests and second, it inherently assumes that
variance due to noise is equal for all peptides in the dataset. This is certainly not true, since the
signal-to-noise ratio depends on the expression level of a gene.
Therefore, we also adapted a classical ANOVA procedure: For each gene, we fit the linar model
Fij = g + pi + ǫij to all log2 fold changes of a given gene, where Fij is the jth log2 fold change
of a repeatedly measured peptide of the gene, g is the gene fold change, pi is the residual peptide
fold change and ǫij is the noise in measurement i, j. Residual peptide fold changes that are
significantly different from 0 indicate that this peptide behaves differently from other peptides
from the same gene. Therefore, genes can be ranked using the p-value from an F test or by
η2 = SSp
SSg
from ANOVA (where SSp is the within peptide sum-of-squares and SSg is the within
gene sum-of-squares), a classical measure for effect size [Cortina and Nouri, 2000].
The ANOVA model estimates noise levels gene-by-gene and, therefore, deals with different
signal-to-noise ratios across genes. Unfortunately, the signal-to-noise ratio could not only
depend on expression levels of genes, but also on properties specific to peptides (e.g. ionization
efficiency). The ANOVA model however assumes equal variance across peptides. We therefore
also adapted the heteroscedastic ANOVA from [Krishnamoorthy et al., 2007], which can deal
with different variances.
Thus, we propose five methods to rank genes: Mean distance and Median distance corresponding
to ranking by the maximal peptide-from-gene deviation, ANOVA F test p-value and ANOVA
η2 using the classical ANOVA approach and the heteroscedastic ANOVA p-value. For further
analyses, we define the outlier peptide of a significant gene as the peptide that has the greatest
absolute difference between its log2 fold change median and the log2 fold change median of the
gene. Note that there may be multiple peptides that have fold changes differing from the gene
fold change but for simplicity we only used a single peptide per gene.
7.3.3 In-silico data generation
For the experimental data, no standard of thruth is known, i.e. there is no knowledge about
differentially regulated isoforms between stimulated and control HeLa cells. Therefore, we
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simulated mass spectrometry data in-silico which allowed us to provide a controlled environment
for a rigorous evaluation of our method. Instead of attempting to simulate the physical events in
a mass spectrometer, we chose to directly generate peptide quantifications, which is the type of
measurement our method works on. We use experimental data (see Data processing) to estimate
model parameters for the simulation and, therefore, the simulated data has the same properties
as experimental data. As a consequence, evaluation results for simulated data should also apply
to experimental data.
We proceed as follows: We consider each Ensembl gene with at least two isoforms. First we draw
the number of measured peptides for a gene and distribute these peptides across all isoforms. We
discard these peptides and repeat this step if there is no specific peptide, i.e. a peptide that is not
present in at least one isoform. Then we set the isoform log2 fold changes f0 and f1 depending
on whether we want to generate a positive or a negative example. For positive examples, we set
f0 = 0 and f1 = f > 0, for negative ones we set f0 = f1 = 0. Then, for each peptide p, we
draw the number of measurements n and the variance σ2 based on the empirical distributions
obtained from the experimental data. n log2 fold changes for p are drawn according to N(µ, σ2),
where µ = I0·f0+I1·f1
I0+I1
, where Ii is an indicator variable for peptide p to be contained in isoform
i. Therefore, µ is either f0,f1 or their arithmetic mean, depending on the location of the peptide
(unique to isoform 0, unique to isoform 1 or on a shared exon).
Thus, we can generate N positive examples for a defined fold change value f and N negative
examples. Each positive example represents a gene that is not regulated transcriptionally but
have isoform proportions differing by a factor of f (e.g. by differential regulation of alternative
splicing). Negative examples represent genes that are not regulated at all. Our methods are
able to compute a score for each gene and therefore, we can use these N positive and N
negative examples to evaluate their accuracy using ROC curves. Since the number of peptides
and measurements per peptide and the quanification noise is drawn according to distributions
from experimental data, and only the isoform fold change difference is set by hand, results from
this in-silico evaluation can be expected to apply to experimental data also.
7.4 Results and Discussion
In a typical high-throughput quantitative mass spectrometry experiment, hundreds of thousands
of precursor ion measurements can be used for peptide quantification. Usually, a single peptide
is detected and quantified multiple times either due to biological or technical replicates or to
repeated measurements within a single replicate in different charge states, different gel slices etc.
(see Figure 7.2 for the SILAC data from [Cox and Mann, 2008]). As introduced above, there are
several reasons why peptides may have been measured with differing fold changes even if they
are products of tryptic digestion of the same protein.
If we assume a complete protein database, excluding ambiguous peptides is straight-forward (see
Methods). And even if the database is not complete, the likelihood that an outlier peptide also
occurs in another unknown but expressed protein is negligible. We want to emphasize that we
only treat peptides matching to multiple genomic locations as ambiguous. For instance, peptides
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Figure 7.2: Number of measurements per peptide. The figure shows a histogram for uniquely
matching peptides for a dataset taken from [Cox and Mann, 2008] and processed using MaxQuant
with default parameters (see Materials and Methods for details). Overall, 265000 peptide
meausurements out of 344000 are shown in the histogram. For clarity, all counts > 100 have
been set to 100.
coming from constitutive exons of an alternatively spliced gene (which occur multiple times in
our protein database) are still unique by our definition.
Thus, the main focus of our algorithm is to distinguish noise from other reasons for outlier
peptides. In order to rigorously test the accuracy of the proposed methods, we applied them on
in-silico generated data for which we know the true situation. This allowed us to circumvent the
problem of missing gold standards. We furthermore applied our algorithm to real data in order to
delineate which reasons other than noise can lead to outlier peptides.
7.4.1 Test on in-silico generated data
We simulated peptide quantification datasets for several true fold change differences f (see
Methods) and for all methods proposed and evaluated them using ROC curves and the AUROC
(see Figure 7.3). According to the AUROC scores in Figure 7.3a, all methods seem to behave
very similar across the whole range of true fold changes. When looking at individual ROC curves
however, we note that their performance at different score cutoffs is quite different: Gene-wise
variance estimation seems to perform much better at high specificity score cutoffs, whereas
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experiment-wide variance estimation has higher sensitivity at lower cutoffs (see also Figures
7.3c and 7.3d). For all further analyses, high specificity is important, and we will therefore use an
ANOVA procedure in the following, which also allows us to compute a statistically sound cutoff.
As can be seen in Figure 7.3d, for a p-value cutoff of 0.01, the heteroscedastic ANOVA performs
superior independent of the true fold change difference and thus we propose this method as the
method of choice.
We note that the fold changes reported in Figure 7.3a already account for the fact that the fold
change difference between a specific peptide and a constitutive peptide is expected to be smaller
than the isoform fold change, so the peptide fold change that is enough to detect significant
differences between peptides is actually even lower than 0.5 on log2 scale.
We acknowledge that testing a method on in-silico generated data can lead to overoptimistic
conclusions: If the model that generates the data is oversimplified, an oversimplified method’s
performance would be overestimated. One main goal of our model is to test for influence of
in-gene heteroscedasticity of quantifications. Since our model generates unequal variances in
a realistic way by using the variance distribution obtained by real data, our generated data is
affected by heteroscedasticity to the same extent as experimental data. There are two possible
outcomes of our evaluation: If the standard ANOVA would perform equal or even superior to the
heteroscedastic ANOVA, then heteroscedasticity is not an important factor and respecting it is
not justified due to a greater power of the standard ANOVA in a homoscedastic situtation.
However, we observe that a test that respects possible unequal variances performs better than
tests that assumes homoscedasticity and thus we can conclude that heteroscedasticity indeed
plays an important role in such kind of data and that it is beneficial to use our heteroscedastic
ANOVA for real data. Furthermore, we observe that we are able to detect differentially regulated
isoforms reasonably well (as judged by an AUC > 0.8) if their fold change is as small as ∼1.4
fold (i.e. the log2 fold change is 0.5), if we observe at least one specific peptide (i.e. a peptide
that is not part of one of the differential isoforms).
7.4.2 Outlier peptides in real data
We applied our method based on the heteroscedastic ANOVA on experimental data taken
from [Cox and Mann, 2008]. As can be seen in Figure 7.4, there are several genes that have
significantly different peptides and their fold change distribution is as expected by our in-
silico data analysis: The majority of genes shows a ≥ 0.3 log2 fold change which matches the
performance measured by our ROC analysis (see Figure 7.3).
We next made an attempt to reveal why these peptides show a fold change that is different from
the gene fold change. For the following analyses, we used an (uncorrected) p-value cutoff of
1% in order to get a reasonable large set of peptides that is still enriched with real differential
peptides. By setting this cutoff, from the 3314 genes, we extracted 257 peptides (we will refer
to them as outlier peptides). We extracted a background set of 1850 peptides from genes with a
p-value of > 0.5.
First, we checked whether there is an indication of misidentifications within our outlier peptides.
To this end, we checked whether there was a second best candidate in the list of identifications for
the corresponding MS2 spectrum and extracted its score if another candidate peptide was found.
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Figure 7.3: Evaluation on in-silico generated data. For several true fold changes f ranging from
0.1 to 2, 1000 positive and 1000 negative examples have been generated (see Methods). Genes
were then ranked according to the five proposed methods and ROC curves together with their
area under the ROC curve (AUROC) were computed. Shown in 7.3a is the AUROC value for
all computed ROC curves and all proposed methods. In 7.3b the ROC curve for f = 0.5 is
shown. Figures 7.3c and 7.3d show the true positive rates for a fixed false positive rate of 0.1 and
0.01, respectively, and emphasize the superiority of the ANOVA procedures in comparison to the
simple methods at high specificity cutoffs.
This revealed that the outlier peptides have statistically significantly more additional candidate
peptides than expected by our background peptides (p = 0.0073, Fisher’s exact test on the
number of peptides that have only single candidate spectra; p = 0.0018, Kolmogorov-Smirnov
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Figure 7.4: Heteroscedastic ANOVA applied to the experimental data. Shown is the distribution
of all p-values in 7.4a and in 7.4b the log2 distribution of all significant peptides. For clarity, in
7.4b, all values > 1 have been set to 1.
test on the fraction of quantification events for a peptide having additional candidates; see also
Figure 7.5a).
This means that even if all these peptides have been independently identified multiple times, there
is evidence that in several cases, all these independent quantifications erroneously are assigned to
the same peptide. A reason for that could be that some peptides in the proteome are very similar
to each other, either directly in their sequence or with respect to additional unknown properties
that lead to a similar fragmentation pattern. This is also directly reflected in the scores of the
peptide candidates: An Andromeda score is − log10(p) of a p-value p testing the Null hypothesis
that a peptide does not belong to a given MS2 spectrum. There are several cases where multiple
candidates have a score > 10 and if we assume that only a single peptide species has been chosen
for fragmentation, all but one of these scores are overestimated. It is a-priori not clear, if the top
candidate necessarily is always the correct one.
We also noted that sometimes there were extreme outliers within the independent quantification
events of a peptide as judged by an interquartile range (IQR) distance of > 1.5. When we
performed similar tests on these IQR outliers compared to all quantifications within the IQR,
we also observe statistically significant more additional candidates than expected by background
(p < 10−26, Fisher’s exact test on the number of quantification events that have additional
candidates; p < 10−11, Kolmogorov-Smirnov test on the ratio of second score to the best score,
see also Figure 7.5b).
Then, we tested whether there is bias with respect to several physico-chemical properties. These
properties have been taken from [Mallick et al., 2007], where they have been used to predict
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Figure 7.5: Evidence for misidentifications in outlier peptides. Figure 7.5a shows the distributions
of the fraction of spectra that have multiple candidates for outlier and background peptides. E.g.
a peptide where 5 out of 10 measurements have additional candidate peptides would be counted
with the value 0.5. For instance, about 55% of the background peptides have a value of ≤ 0.5
in comparison to about 45% for outlier peptides, which is a statistically significant difference
according to a Kolmogorov-Smirnov test. In Figure 7.5b the distributions of the fraction of
second to best candidate score for outlier measurements and background measurements. Here,
outliers are not defined by the ANOVA but by an interquartile range distance of > 1.5. E.g.
if there is a peptide with 10 measurements, we can calculate the interquartile range r as the
difference between (sorted) measurements 2 and 9. If the difference between measurements 1
and 2 or 9 and 10 are ≥ 1.5r then they are deemed outliers, respectively. Such outliers have
better second candidates than all other measurements.
proteotypic peptides. Each of these properties allows to compute a score for a given peptide
sequence. For each property, we computed scores for all outlier peptides and all background
peptides and compared the score distributions by a Wilcoxon-Mann-Whitney test. The p-value
distribution of these tests shown in Figure 7.6 clearly shows that most of these physico-chemical
properties are significantly different between outlier peptides and background peptides. This
means that the normalization used by MaxQuant is not able to correct for bias introduced by
these properties. It should however be noted, that several of these properties are not independent,
for instance there are several properties that try to measure hydrophobicity. One interesting
example (which is directly related to hydrophobicity) is the striking difference in retention times
(p < 10−5, Wilcoxon test). This analysis shows that there are more outlier peptides with short
retention time than expected, which is probably only due to technical bias that should be removed
by further normalization.
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Figure 7.6: Evidence for misquantifications in outlier peptides. Shown is an histogram of the
p-values of all physico-chemical properties tested in 7.6a and the cumulative distributions of
retention times for outlier peptides and background peptides in 7.6b. See text for details.
Another possible explanation for misquantification is saturation, which means that for extremely
abundant peptides, reported intensities may be underestimated. When, for instance, two peptides
from the same protein have differing ionization efficiencies, computed fold changes may be
different due to this saturation effect. And indeed, outlier peptides have higher intensities than
expected by background (p < 10−13, Kolmogorov-Smirnov test), which indicates that saturation
is another effect that should be removed by proper normalization.
We also made an attempt to test for differential post-translational modifications. Allowing
phosphorylation as a variable modification during peptide identification in Andromeda yielded
only very few results and the correctness of these identifications should be doubted (data not
shown). This however was expected since in the dataset we used, phosphopeptides have not been
enriched experimentally. However, the absence of reliably identifiable phosphopeptides does not
prove their absence in the sample: If without enrichment the phosphopeptides abundance in the
mass spectrometer is lower than the unmodified peptide, it will not be selected for fragmentation
and MS2. Thus, we downloaded known phosphopeptides from a publicly available database
[Bodenmiller et al., 2008] and tested whether there is an overlap of these peptides with our outlier
peptides. Even if there was only a small number of phosphopeptides detected in our experiment
and it is not clear if they are also phosphorylated here, there was a weak but statistically
significant overlap (p = 0.034, Fisher’s exact test). This means that differential PTMs indeed
seem to be present in our dataset and that they can be detected using our method.
Finally, we tried to find evidence for differentially regulated isoforms in our dataset. To this end,
we classified each peptide location as alternative or constitutive location. Due to the sparseness
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Figure 7.7: Evidence for saturation in our dataset. The distributions for summed intensities for
all detected peaks is shown for outlier peptides and for background peptides.
of the identified peptides, it is impossible to infer which isoforms are expressed in our data and
therefore we cannot restrict the transcripts to expressed transcripts. Thus, we classify based on
the full Ensembl annotations: A constitutive peptide is contained in all Ensembl transcripts of the
corresponding gene and an peptide is characterized alternative if there is at least one transcript
that does not contain the peptide. Surprisingly, we found a small but statistically significant
enrichment of outlier peptides among constitutive locations (p = 0.0086, Fisher’s exact test),
which supposedly suggests that background and not outlier peptides are parts of differentially
regulated isoforms. However, we noted that the exon length (defined as the number of nucleotides
in a gene, that is part of at least one Ensembl exon) is significantly larger for our outlier peptides
than for our background peptides (p < 10−16, Kolmogorov-Smirnov test). Thus, we removed
this bias from the analysis by sampling peptides from our background set according to the exon
length distribution of our outlier peptides. When we apply the same test as without sampling,
outlier peptides are now enriched among alternative location. This enrichment is however not
statistically significant (p = 0.3, Fisher’s exact test), which is either a consequence of the small
numbers or indeed true: Probably in our dataset, differential regulation of isoforms is not as
widespread as all the other effects, in which case a statistic over the whole set of outliers is not
expected to yield significant results.
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7.4.3 Discussion
Our results demonstrate that all effects introduced before may be present in the set of outlier
peptides. Our main future goal is to be able to distinguish between these effects: Errors
(misidentifications and misquantifications) could be reduced by improving both identification
algorithms and normalization methods. Detecting outlier peptides can help to do that: For
instance, if an identification algorithm has to choose between multiple candidate peptides for
a spectrum, it could use the outlier score as an additional criterion to do so. It also seems as if the
normalization in MaxQuant, that accounts for intensity, labeled amino acids and different protein
load [Cox and Mann, 2008], is not able to remove all bias from the data.
Post transcriptional modifications (PTMs) have received increasing interest in recent years
[Huttlin et al., 2010; Olsen et al., 2010]. Usually, specific steps during sample preparation are
made to enrich modified peptides such that they can readily be detected and identified. We have
shown that even without these enrichment steps, differential PTMs are in principle detectable in
a standard MS experiment, even if peaks corresponding to the modified version of a peptide are
not selected for fragmentation. Our outlier peptide score can be used to generate hypotheses for
finding differential PTMs.
Alternative isoforms, which are consequences of alternative transcription start sites, alternative
splicing or alternative end-of-transcription sites (or combinations of these), are widespread in
higher organisms [Pan et al., 2008] and it is known that they are highly regulated in development
[Chawla et al., 2009; Cooper, 2005; Lynch, 2004], between different tissues [Wang et al., 2008]
and in diseases [Cooper et al., 2009; Grosso et al., 2008]. Experimental techniques to detect
differentially regulated isoforms usually only consider isoforms on the mRNA level [Pan et al.,
2008; Wang et al., 2008]. However, it is known that not all produced transcripts give rise to
an equal number of proteins, so the ultimate test for differential regulation of isoforms must be
performed on the protein level.
Finding differentially regulated isoforms is thus probably the most interesting application of
our method, even if we were not able to reliably find cases in the dataset we used. To our
knowledge, there is no established method available that has the ability to detect differential
isoforms on proteome level in a high-throughput manner. Once other effects can be excluded for
an outlier peptide, quantitative mass spectrometry could serve this purpose: The only explanation
that remains for outlier peptides then is indeed differential regulation of isoforms. Furthermore,
we can expect that in the future, the number of identified peptides will increase due to technical
progress and due to improved computational methods [Cox and Mann, 2008]. Even if there
certainly are peptides that are not detectable in mass spectrometers, the number of peptides
that can nowadays be identifed is orders of magnitude lower than what is actually quantifiable
in modern mass spectrometers [Michalski et al., 2011]. Due to technical and computational
advances, we expect that in the near future, the protein coverage by peptides will provide a more
complete picture. This will also help to distinguish differentially regulated isoforms from the
other effects, since then, regularly more than one quantified peptide will be specific for isoforms.
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7.5 Conclusion
In modern quantitative high throughput mass spectrometry data, the final analysis step is
to compute protein fold changes for all identified proteins. In most cases, this seems to be
straight-forward as long as a robust statistic is used to compute the protein fold change
from all individual quantifications. However, when having a closer look at individual peptide
quantifications, it becomes evident that protein fold changes are not always a proper way to
summarize measurements. In many cases there are peptides that are significantly different from
other peptides of the same gene. This could be because the peptides stem from alternative
isoforms of a gene and because respective isoforms are differentially regulated in the conditions
under consideration. We propose a method that is able to detect such differential regulation of
isoforms.
However, we found several effects that could confound this explanation of the quantifica-
tions in real data: misidentifications, misquantifications and post-translational modifications.
Unfortunately, it is a-priori not clear which of these effects plays a role for a gene. Thus, in
order to reliably detect differentially regulated isoforms and distinguish it from these effects,
additional data is necessary. If for instance RNA-seq data is available for the same cells used for
mass spectrometry, it could provide additional evidence for differentially regulated isoforms by
sequencing reads that support these isoforms either qualitatively or even quantitatively.
This study also revealed that the normalization currently used is not sufficient to remove all
technical bias. For instance, we have shown that the retention time (either directly or something
that is correlated with it) affects quantification and further normalization is necessary to remove
this bias. Our method is able to provide peptides that are probably affected by such a bias which
can help in the development of further normalization steps.
In a modern mass spectrometer, only a limited number of all the peptides detectable in MS spectra
is selected for fragmentation and MS2 [Michalski et al., 2011]. In order to find differentially
regulated isoforms, it would be beneficial to increase the number of identified peptides: Usually
there is more than one peptide specific to a single isoform. If multiple specific peptides are
detected and measured, all other effects as described above become less probable. Due to the
increasing throughput and decreasing scan times, we expect that such kind of data will be
available soon and our method could then even better be used to systematically search for
differentially regulated isoforms.
Chapter 8
FERN - Stochastic Simulation and
Evaluation of Reaction Networks
Motivation: The previous chapters were either about raw data analysis (chapters 3-5) or the
interpretation of systems biology data with respect to specific research questions, namely context-
dependence of microRNA-mediated regulation in chapter 6 and differential splicing in chapter
7. In this chapter, I complete the workflow described in the introduction (see section 1.1.1) by
describing a software package for stochastic simulation of biological networks. In my diploma
thesis, I developed the Petri Net Modelling application (PNMA), a comprehensive modelling
platform for biological networks, which provides a highly flexible system for simulations of such
networks and originally provided methods to simulate networks using Fuzzy logic systems that
are powerful when experimental data is sparse and noisy. When detailed experimental data is
available, a system can be modeled in more detail and more detailed simulations are possible.
A widely used, highly detailed model is based on stochastic simulation, where reactions of
individual molecules are considered. Thus, I developed a Java library for stochastic simulation,
which I integrated into PNMA, but which is also available for the widely used software packages
Cytoscape and Celldesigner.
Publication: FERN has been published in BMC Bioinformatics [Erhard et al., 2008] and in this
extended form as a book chapter by Springer [Erhard et al., 2010]. Here, I adapted the layout
and made minor corrections to the text of the book chapter.
My contribution: I developed and implemented the software, carried out evaluations, drafted
the paper and wrote the extensions for the book chapter text.
Contribution of co-authors: Caroline Friedel helped to draft the original manuscript. Ralf
Zimmer supervised the work and helped to revise the manuscript.
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8.1 Abstract
Stochastic simulation can be used to analyze the development of biological systems over time
and the stochastic nature of these processes. Most available programs for stochastic simulation,
however, are limited in that they either a) do not provide the most efficient simulation algorithms
and are difficult to extend, b) cannot be easily integrated into other applications or c) do not
allow to monitor and intervene during the simulation process in an easy and intuitive way. Thus,
in order to use stochastic simulation in innovative high-level modeling and analysis approaches
more flexible tools are necessary. FERN (Framework for Evaluation of Reaction Networks) is a
Java framework for the efficient simulation of chemical reaction networks. It is subdivided into
three layers for network representation, stochastic simulation and visualization of the simulation
results each of which can be easily extended. It provides efficient and accurate state-of-the-
art stochastic simulation algorithms for well-mixed chemical systems and a powerful observer
system, which makes it possible to track and control the simulation progress on every level. To
illustrate how FERN can be easily integrated into other systems biology applications, plugins to
Cytoscape and CellDesigner are included. These plugins make it possible to run simulations
and to observe the simulation progress in a reaction network in real-time from within the
Cytoscape or CellDesigner environment. FERN addresses shortcomings of currently available
stochastic simulation programs in several ways. First, it provides a broad range of efficient and
accurate algorithms both for exact and approximate stochastic simulation and a simple interface
for extending to new algorithms. FERN’s implementations are considerably faster than the C
implementations of gillespie2 or the Java implementations of ISBJava. Second, it can be used in a
straightforward way both as a stand-alone program and within new systems biology applications.
Finally, complex scenarios requiring intervention during the simulation progress can be modelled
easily with FERN.
8.2 Background
Traditionally, wet-lab experiments were focused on describing the function of individual genes or
proteins. With the advent of high-throughput technologies, system-level approaches have become
common, which make it possible to identify the interactions between the individual elements of
the cell. Here, mathematical models are crucial in understanding these biological systems. In
particular, the simulation of the dynamics of these can visualize and predict quantitative aspects
of the system such as gene expression in regulatory networks or signal amplification in signal
transduction networks [Szallasi et al., 2006].
The most common approach to modeling dynamics is via ordinary differential equations (ODEs)
which describe deterministically how the system evolves with time (see e.g. [Clodong et al.,
2007; Shimoni et al., 2007; Calzone et al., 2007]). Since the simulation of ODEs is deterministic,
successive simulations starting from the same initial conditions lead to the same results. Many
aspects of biological systems are not deterministic, which can lead to quite different outcomes
for the same initial conditions. In addition, when small numbers of molecules are involved,
concentrations of the involved molecules cannot be considered to be continuous, which is one of
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the fundamental assumptions for ODE models. To address these problems, stochastic simulation
algorithms (SSAs) have been developed.
SSAs operate on reaction networks, graph structures containing the molecular species and
reactions as vertices and their wiring as edges. These reaction networks are introduced in the
following in terms of the more general framework of Petri nets.
8.2.1 Petri nets
Petri nets [Murata, 1989] are a well-established framework for modeling concurrent systems.
They do not only provide a variety of analysis tools for biological networks [Reddy et al.,
1993] but are also able to simulate their dynamic behaviour in an intuitive way. Furthermore,
they provide a straight-forward graphical representation, which makes it possible to model
biological networks interactively and to observe or even control simulations. The reaction
networks proposed by Gillespie in his original work [Gillespie, 1976] are a special case of Petri
nets and are also often called Stochastic Petri nets (SPN). As Gillespie did not use the Petri net
nomenclature, his original notations are given in parentheses in the following definition:
Definition 1. A Petri net (reaction network) is a 5-tuple PN = (P, T, F,W,M0) :
• P is a finite set of places (molecular species)
• T is a finite set of transitions (reactions)
• P ∩ T = ∅
• F ⊆ (P × T ) ∪ (T × P ) is a set of arcs
• W : (P × T ) ∪ (T × P )→ {0, 1, 2, 3, ...} is a weight function (stoichiometry)
• M0 : P → {0, 1, 2, 3, ...} is the initial marking of tokens (molecule population)
Thus, a Petri net is a bipartite graph composed of two types of nodes: places (P ) and transitions
(T ), connected by directed edges called arcs (F ). Arcs from a place p to a transition t are called
input arcs of t. p is than called input place of t. Arcs from transition t to place p are output
arcs of t and p is an output place of t. Places are marked with a number of tokens according
to the marking M and each arc f has an associated positive integer weight W (f). Note that
W (f) = 0⇔ f /∈ F .
A transition t is enabled, if M(p) ≥ W (p, t) for each input arc, i.e. each input place is marked
with at least as many tokens as the input arc weight requires. The firing of an enabled transition
t updates markings of connected places: The marking of each input place pi is set to M(pi) −
W (pi, t) and each output place po is updated with the value M(po) +W (t, po). This means that
a firing transition removes tokens from each input place and adds tokens to each output place.
The graphical representation of a Petri net is shown in Figure 8.1. Places are depicted as circles,
transitions as rectangles. Furthermore, the firing of the transition and the update of tokens is
shown.
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From this intuitive definition, a simple mathematical description of the state and of a firing
transition can be derived: If the ordering of P = {p1, p2, ..., pn} is clear, the current state of
a Petri net can be described by a vector S = (s1, ..., sn) where si = M(pi). Furthermore, each
transition ti can be described by a state change vector vi with components
vij = W (ti, pj)−W (pj, ti) (8.1)
Hence, S+vi is the state after firing transition ti. In Figure 8.1, the places are P =(H2,O2,Water)
and the initial state vector is S = (3, 1, 1). Firing of the transition with state change vector
v = (−2,−1, 2) results in the state S + v = (1, 0, 3).
A simulation of a Petri net is a sequence of firing N arbitrary transitions. Each firing updates
the state vector Sk tj−→ Sk+1 according to the state change vector of the firing transition tj. The
resulting sequence of state vectors S0, ..., SN is called trajectory. The order of firing transitions
is determined by a firing rule. A generic simulation algorithm is given in Listing 8.1.
while (there is an enabled transition) {
t = choose an enabled transition according to firing rule
fire t
}
Listing 8.1: Generic Petri net simulation
As indicated above, a single token on a place p represents a single molecule of the molecular
species p. A firing transition represents the occurrence of a chemical reaction. As a consequence,
a trajectory fully describes the temporal dynamics of a molecular model. Thus, to simulate a
biological system according to stochastic chemical kinetics, an appropriate firing rule must be
derived.
8.2.2 Stochastic chemical kinetics
For our purpose, we assume a well-mixed system with a homogeneous distribution of molecules
in a fixed volume at a constant temperature. In this case, many nonreactive molecular collisions
will occur until eventually some colliding molecules react. Since we assume a well-mixed
system, it is not necessary to track positions and velocities of individual molecules and only the
amount of each molecular species and their reactive collisions in the system must be considered.
The amount of each molecule is stored as the number of tokens on the respective place in the
model and a reactive collision corresponds to a firing transition.
Each state Sl of a trajectory is thus considered as random variable and assigned a time tl. Hence,
P (Sl, tl) is the probability of having state Sl at time tl. For each reaction ri there exists a
propensity function ai such that ai(S)dt is the probability that there occurs a reactive molecular
collision of input molecules of reaction ri in the next infinitesimal time interval [t, t + dt)
[Gillespie, 1992]. Then the probability of having state S at time t given the initial state S0 at
t0 is given by the chemial master equation (CME):
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Table 8.1: Mass action propensity functions for basic reactions. c is the respective reaction rate
constant. Note, that the propensity function only depends on its input places and not on its output
places.
Reaction Propensity function
s 1
p 1
p k
2
w 1
w k
c
s 1
p 1
p k
1
w 1
w k
c× s1
s 1
p 1
p k
1 w 1
w ks 2 1
c× s1 × s2
s 1
p 1
p k
2
w 1
w k
c× s1×(s1−1)
2
∂
∂t
P (S, t|S0, t0) =
|T |∑
j=1
aj(S − vj)P (S − vj , t|S0, t0)−
|T |∑
j=1
aj(S)P (S, t|S0, t0) (8.2)
This equation describes the time evolution of the probability of having state S at time t for
fixed initial conditions. In order to get to S, either one of the |T | reactions has to fire in the last
infinitesimal time interval or none. If reaction j fires, the system must be in state S − vj before
the firing (this is the first sum in the CME). If none of the |T | reactions fires, the system must
already be in state S (second sum). For a more elaborate description of the CME, see [Gillespie,
1992].
The CME fully describes the stochastic dynamics of a system if the propensity functions for
each transition in the model is given. The most prominent form of propensity function comes
from mass action kinetics [Gillespie, 1976]. See Table 8.1.
Note that any higher order reaction can be built by composing these zero-, first- and second-order
functions. For example, the mass reaction propensity function a of the reaction in Figure 8.1 is
a(S) = c× S(H2)×(S(H2)−1)
2
× S(O2).
From the definition of the propensity function, the next-reaction density function can be derived,
which gives the probability that a specific reaction is the next to occur in an infinitesimal time
interval τ :
pi(τ, j|S, t) = aj(S) exp(−a(S)τ) (8.3)
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Figure 8.1: A Petri net and the firing of a transition. The Petri net represents the chemical formula
2H2 +O2 → 2H2O. Tokens are shown as filled circles and arc markings as numbers.
where S is the current state vector, τ the time interval and a(S) =
∑|T |
j=1 aj(S) the sum of all
propensity functions in the system.
A stochastic firing rule which fires transitions according to this density function generates
trajectories that have the same probability distribution as the chemical master equation [Gibson
and Bruck, 2000]. Usually the CME cannot be solved analytically or numerically, but by
sampling a large enough number of SSA trajectories, it can be approximated to an arbitrary
precision.
The previous assumptions of constant volume and temperature can be relaxed in this framework.
To incorporate changing volume or temperature, the propensity functions are not only dependent
on the current state S but also on the current temperature and volume (see [Gibson and Bruck,
2000] for details).
If many reactions can fire without changing propensity functions significantly, the Langevin
method [Gillespie, 2001] can be used to describe the stochastic process in a continuous manner
in contrast to the discrete form of SSAs. If infinitely large molecular populations are assumed,
the Langevin method can in turn be approximated by reaction rate equations, which are a kind of
ODEs. Since a trajectory from an SSA run is a sample of the CME, the average of a large sample
of stochastic trajectories resembles the solution of the respective ODE.
8.2.3 Stochastic simulation methods
The firing rule introduced in the previous section can be implemented in various ways. Exact
methods generate random pairs (τ, j) according to equation (8.3), adjust the state vector by the
respective state change vector vj and advance the time t to t+ τ . Then the propensity functions
are recalculated to allow generating the next random pair (see Figure 8.2).
First reaction method
The most basic method for drawing random pairs (τ, j) according to equation (8.3) is to
generate tentative reaction times τi for each reaction ri according to an exponential distribution
with parameter ai(S) [Gillespie, 1976]. This can be done by using the inversion method, i.e.
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Draw time τ until next reaction:
Draw next reaction µ:
Fire reaction: 
Update product and substrate numbers
Update all propensity functions ai
Tau-Leaping:
Fire several reactions
before updating
propensity functions
Gibson-Bruck:
Find next reaction
with priority queue; 
Recycle unused
random numbers
Enhanced Gillespie, 
Gibson-Bruck:
Update only changed
propensity functions
Figure 8.2: This figure shows the flow of one simulation step. On the left-hand side the flow
for the original Gillespie algorithm can be seen. On the right-hand side, we illustrate how the
different steps are modified by the Gibson-Bruck, enhanced Gillespie and tau-leaping algorithms.
Here, U(0, 1) denotes the uniform distribution on the range of 0 to 1 and aµ the reaction
propensity for reaction µ.
generate a uniformly distributed number ui between 0 and 1 for each reaction and calculate
τi = ai(S)
−1 ln(u−1i ). Then the first reaction i = argminj τj is determined and (τi, i) is taken
as next pair (for a proof that this generates trajectories according to the CME, see [Gillespie,
1976]). Each firing thus requires generating |T | exponentially distributed random numbers and a
linear search to determine the first reaction.
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Direct method
In order to draw the pair (τ, j) by the direct method [Gillespie, 1976], the joint probability (8.3)
is rewritted to
pi(τ, j|S, t) = p
′
i(τ |S, t)× p
′′
i (j|τ, S, t) (8.4)
p′i(τ |S, t) = a(S) exp(−a(S)τ) (8.5)
p′′i (j|τ, S, t) =
aj(S)
a(S)
(8.6)
where a(S) =
∑|T |
j=1 aj(S) is defined as above. Hence, τ is exponentially distributed with param-
eter a(S), while j is distributed according to the discrete probabilities aj(S)
a(S)
and independent of
τ . The reaction j can be determined by generating a uniformly distributed random number u
between 0 and 1 and then computing the smallest j such that
∑j
j′=1 aj′(S) > ua(S). Thus,
each firing requires the generation of a single exponentially distributed random number and one
uniformly distributed number, which is a substantial improvement compared to the first reaction
method. Efficiently finding the smallest j is crucial to the performance of this method. Gillespie
originally proposed a linear search method, which was later improved by [Cao et al., 2004] to a
binary search method using a reordering of the propensities.
Next reaction method
24 years after the publication of the original SSA, Gibson and Bruck proposed some clever
improvements of the first reaction method. It uses a priority queue to reuse previously unused
tentative reaction times and a dependency graph for efficiently updating only those propensity
functions, that have changed since the last firing. By using these additional data structures, it is
possible to (assymptotically) generate only a single exponentially distributed number per firing
[Gibson and Bruck, 2000]. However, it has been suggested that the next reaction method is
actually less efficient than improved versions of the direct method [Cao et al., 2004] due to
the cost of mainting the data structures.
Composition/Rejection method
Generating a random number from a discrete probability distribution is not only a problem for
SSAs but have also been encountered in other fields. Slepoy et al. [Slepoy et al., 2008] used a
method previously described in [Devroye, 1986] to improve the direct method. If the minimum
and maximum of the propensity funtions is bounded (which is a valid assumption in biological
networks), it is possible to generate j in expected constant time. This means that finding the next
firing reaction does not depend on the number of reactions anymore. If the reaction network is
sparse (not too many propensity functions have to be updated after firing a reaction), it becomes
possible to simulate networks with tens of thousands of reactions.
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Tau-leaping methods
The direct and next-reaction methods are exact methods. This means reaction propensities are
updated after each reaction. Recently, Gillespie [Gillespie, 2001] proposed an approximative
method, tau-leaping, which performs all reactions in a certain interval τ before updating the
propensity functions (they ’leap’ over a time interval). The interval size τ is chosen such that the
propensity functions remain almost constant in this interval and reactions may fire multiple times.
This, however, can sometimes lead to negative populations and as a consequence, this method has
been improved later by Cao et al. [Cao et al., 2005a, 2006] to avoid this problem. The modified
tau-leaping algorithm automatically switches to the exact SSA for a few steps if the choice of
τ becomes too small. This allows for efficient simulation, especially when huge quantities of
molecules are present in the system. If the interval is chosen such that the propensity function
remain almost constant, the CME can accurately be approximated by the tau-leaping method.
Hybrid methods
Both exact and tau-leaping methods cannot be used to efficiently simulate models with multiple
scales in molecule numbers or reaction rates. Exact methods are too inefficient to simulate many
fast reactions and high molecule concentrations. On the other hand, the presence of low molecule
concentrations and slow reactions in the systems will effectively lead to small τ values for the
tau-leaping methods and thus make them behave as the exact methods. To circumvent these
problems, hybrid methods have been developed, which partition the system into fast and slow
reactions. The slow reactions are then generally simulated using the exact SSA. The fast reactions
are solved either deterministically or with the Langevin equation [Cao et al., 2005b; Chiam et al.,
2006; Harris and Clancy, 2006] or simulated with tau-leaping methods [Harris and Clancy, 2006;
Puchalka and Kierzek, 2004]. Alternatively, the model is simplified such that the effect of the fast
reactions is incorporated in the simulation of the slow reactions, e.g. using quasi-steady-state
assumptions, without actually firing the fast reactions [Rao and Arkin, 2003; Cao et al., 2005b;
Salis and Kaznessis, 2005; Cao et al., 2005c; Goutsias, 2005; Samant and Vlachos, 2005; Samant
et al., 2007].
8.3 Implementation
The early implementations of SSAs (e.g. the one Gillespie proposed in [Gillespie, 1976]) in the
late 70’s were quite inflexible, since they used hardcoded reaction networks, i.e. the source code
itself contained the definitions of S and V = {v1, ..., vn} and it was not possible to change it
without editing the source code and recompiling it. With the advent of modern programming
languages like C++ or Java, more flexible implementations have been developed.
Flexible in this context has several meanings. First, it is absolutely necessary to allow loading of
reaction networks, i.e. the implementation should be able to load a reaction network stored in a
file and simulate it. Second, the user should be able to observe or even control the simulation
process in various ways. As indicated above, there are different methods for different fields
of applications and using the best suited algorithm is crucial for simulation efficiency. As a
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consequence, implementations have to include the various algorithms and should provide an
easy way to add new methods, since even 32 years after the first SSA paper, there is still room
for improvement [Slepoy et al., 2008].
8.3.1 Other implementations
Several implementations of stochastic simulation algorithms are available, e.g. COPASI [Hoops
et al., 2006], Dizzy [Ramsey et al., 2005] using the SSA implementations of the ISBJava
library, gillespie2 [Gillespie et al., 2006], STOCKS [Kierzek, 2002], StochKit [Li et al., 2007],
and BioNetS [Adalsteinsson et al., 2004]. In general, these programs were designed as stand-
alone programs and, as a consequence, the user is limited to the functionalities of the user
interface. This makes it difficult to use the implementations of the SSAs within other programs.
Furthermore, most of these programs provide only one implementation of an exact SSA method,
which is not always fast enough for the specific needs of practical systems biology applications.
Users cannot easily add faster SSAs such as e.g. the approximative tau-leaping procedure or new
hybrid algorithms to the programs.
The StochKit software and ISBJava library provide these faster tau-leaping algorithms and the
latter was also designed to be used within other systems biology programs. The output of the
corresponding SSA implementations, however, is limited to the molecule concentrations. More
flexible implementations are necessary to simulate complex high-level models and integrate
stochastic simulation algorithms in new and innovative analysis and modeling tools. Two
examples which illustrate the need for more flexible tools are the visualization of the simulation
progress directly in a network and the simulation of cell growth and division. With current
simulation tools, it is not possible to implement these two examples without having to change
the code of the actual simulation algorithms considerably.
8.3.2 FERN
FERN [Erhard et al., 2008] is a Java framework for modeling and simulating biological systems,
which provides all types of state–of-the-art simulation algorithms (exact, approximate and
hybrid) and has been designed to be easily extendable to new ones. With the help of the observer
programming pattern [Gamma et al., 2004], the simulation progress can be monitored on every
level and modifications to the systems can be introduced during simulations in an intuitive
way. Even with these additional functionalities, the implementation is faster than the respective
ISBJava implementation. Results can be visualized easily and networks can be loaded from
different sources. Contrary to ISBJava, FERN supports the most current version of SBML, a
widely used file format for exchanging biological networks [Hucka et al., 2003], and allows
arbitrary rate law definitions. FERN is primarily intended as a library which can be included in
other Java applications to simulate reaction networks. However, various user interfaces are also
provided by the FERN distribution, which allow to use it without writing a single line of Java
code. The most basic user interface included in the FERN distribution is a command-line tool,
which can be used to generate time courses for given species in a given reaction network from
the unix shell or windows terminal. Additionally, by exploiting the plugin architectures of the
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Figure 8.3: The figure illustrates the overall design of FERN into three layers. Each layer is
represented by one interface or abstract class: Interface Network and abstract classes Simulator
and Observer.
systems biology programs Cytoscape [Shannon et al., 2003] and CellDesigner [Funahashi et al.,
2003], graphical interfaces to FERN are provided as well, which make it possible for the user
to design reaction networks visually, simulate them, create time courses and even to observe the
simulation process in real time on the graphical representation.
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8.3.3 Implementation details
FERN is an object oriented library implemented in Java (see UML diagram in Figure 8.3).
Although it consists of more than 100 classes and interfaces, most classes are implementations
of one of three major interfaces and abstract classes:
1. The interface Network provides the network structure of the model.
2. The abstract class Simulator performs simulations on a Network. It additionally calls the
registered observers during the simulation run.
3. The abstract class Observer traces the simulation progress and creates the simulation
output.
A simple simulation can be performed in only five lines of code, one line for each of: loading a
network file, creating a simulator, creating and registering an observer, running the simulations
and printing the results. More complex examples for using FERN can be found in the FERN
distribution. In the following, the three layers of FERN are described in more detail.
Networks
The interface Network describes the network’s structure, i.e. the reactions and species in the
networks. Furthermore, the network stores basic information like species names and their initial
molecule numbers. For the simulation more information is necessary, which is stored in three
additional classes:
• The AmountManager controls the amount of each molecular species during the course of
a simulation.
• The AnnotationManager can store additional annotations for the network, its species and
reactions.
• The PropensityCalculator calculates the propensity functions for the reactions by the
specified kinetic laws.
There are three types of implementations of the Network interface:
• Readers which can read network data from files (e.g. FernMLNetwork, SBMLNetwork)
• Decorators which redirect method calls to existing network classes (e.g. CytoscapeNet-
workWrapper)
• Evolution algorithms which generate networks according to certain network models (e.g.
AutocatalyticNetwork)
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For each network, stochastic simulations can be performed with all implemented simulation
algorithms using all implemented observers.
An interesting example of network decorators and a perfect showcase for the flexibility
of the FERN architecture are the modification networks. These are implementations of the
Network interface, take an existing network instance and create a modified version of it.
For instance, the ReversibleNetwork class creates a reverse reaction for each reaction of the
input network. Here, the power of object oriented software design is exploited in two ways:
First, the ReversibleNetwork can take any instance implementing the Network interface, e.g.
a network loaded from the file system (FernMLNetwork), a network obtained from Cytoscape
(CytoscapeNetworkWrapper) or even another modifier network. Second, the modifier network
itself is an implementation of Network and can hence be used like every other network, e.g. for
simulation. This scheme is often called decorator pattern [Gamma et al., 2004].
Import and export of networks
FERN supports two formats for loading and exporting networks: the SBML format [Hucka
et al., 2003] as well as the simpler but also XML based FernML format. For reading and
writing the SBML format, FERN uses the Java bindings of the C library (libSBML) available at
http://www.sbml.org. Thus, it can be easily adapted to new developments of the SBML format.
From the model loaded by libSBML from the SBML file, a FERN SBMLNetwork is created
using the list of compartments, species, reactions, parameters and events in the model. Events
have to be registered with a simulator by the SBMLNetwork if they are to be triggered during the
simulation. Triggering of events is handled by specific observers.
Currently, the SBMLNetwork class uses only the features of SBML necessary for the simulation
of the network. It supports MathML to define complex reaction mechanisms but not rules,
constraints or function definitions. If these features are required they can be incorporated
easily by extending the SBMLNetwork class and loading these features from the SBML model
created by libSBML. Since many systems biology applications support SBML (e.g. CellDesigner
[Funahashi et al., 2003]), the SBML format can be used as an interchange format between FERN
and these other applications.
SBML is a powerful format which can provide lots of information about a model. In contrast,
FernML stores only the topology of the reaction network, optional annotations and the simulation
parameters. This results in a much more simplified input format. More complex aspects, such as
volume change due to cell growth and division, can then be modeled in Java using the FERN
library in a straightforward way. As a consequence, arbitrarily complex models can be designed
on the level of Java code.
Since FernML supports only the mass action reaction rate equations used by Gillespie[Gillespie,
1976], the propensities can be recalculated at each step efficiently by a few arithmetic operations.
SBML uses MathML to store the kinetics of a reaction. This allows for more complex reaction
mechanisms and is particularly useful if the model cannot be formulated exclusively with first
or higher order rate equations. To evaluate MathML expressions, FERN creates expression trees
from them, which have to be evaluated every time a propensity is calculated. Since this is one of
the essential steps of SSAs, the simulation of an SBML network in FERN can be significantly
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slower than the simulation of the same network as a FernML network. Thus, if only simple
reaction rate equations are used, an SBML network should be converted to a FernML network
using the provided conversion methods before performing the simulation.
FERN is not restricted to the input formats currently available. Any new input format can be
easily included by implementing the Network interface or extending the AbstractNetworkImpl
class.
Simulation algorithms
FERN provides implementations for four exact stochastic simulation algorithms, three state-of-
the-art tau leaping procedures (see [Gillespie, 2001; Cao et al., 2006]) and a hybrid method
combining SSA and tau-leaping [Puchalka and Kierzek, 2004]. The exact SSAs implemented
include the original direct method of Gillespie [Gillespie, 1976], the next reaction method of
Gibson and Bruck [Gibson and Bruck, 2000], the Composition/Reaction method [Slepoy et al.,
2008] and an enhanced version of the direct method. This enhanced method uses the dependency
graph technique of the next reaction method to only update the propensity functions that are
affected by the firing of a reaction. Apart from this improvement, it is identical to the direct
method. As indicated in [Cao et al., 2004], this simple enhancement is sufficient to make the
direct method faster than the next reaction method in most cases.
The tau-leaping algorithms are all based on the modified tau-leaping procedure proposed by Cao
et al. [Cao et al., 2005a], which avoids the problem of negative populations observed for the
original tau-leaping procedure. This method switches to an exact SSA (in our implementations
the enhanced Gillespie) for a few steps if the selected τ becomes too small. The three implemen-
tations differ only in the way the error is bounded (see [Cao et al., 2006] for details). The error
is bounded either by the sum of all propensity functions (TauLeapingAbsoluteBoundSimulator),
the relative changes in the individual propensity functions (TauLeapingRelativeBoundSimulator)
or the relative changes in the molecular populations (TauLeapingSpeciesPopulationBoundSimu-
lator).
Furthermore, FERN implements the hybrid method by Puchalka and Kierzek [Puchalka and
Kierzek, 2004], which partitions the system during the simulation into slow reactions, which
involve only small molecule numbers, and fast reactions, which involve large molecule numbers.
The slow reactions are then simulated using an exact SSA while the fast reactions are simulated
with tau-leaping. This algorithm was chosen over other hybrid methods for two reasons. First,
it uses only stochastic simulation algorithms, i.e. exact SSA and tau-leaping, and no further
assumptions such as quasi-steady state. Second, the partitioning of the system is performed
dynamically according to the state of the system and updated after each reaction step. Our
implementation of the hybrid method uses our more efficient enhanced Gillespie algorithm
instead of the Gibson and Bruck algorithm used by Puchalka and Kierzek. On the model of
LacZ and LacY gene expression by Kierzek [Kierzek, 2002], the hybrid method speeds up the
runtime by a factor of about 100 compared to the enhanced Gillespie algorithm.
Future developments of the algorithms can easily be included into FERN by extending one of the
SSA implementations or the original Simulator class. In the same way, ODE solvers or simulators
for spatial models, which are not provided by FERN, can be integrated.
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Observer system
FERN uses observers [Gamma et al., 2004] to trace the simulation progress and react to events.
For this purpose, each observer has to implement functions which describe its response at specific
time points of the simulations. Such responses may occur either at the beginning or the end of a
simulation, before each step, after a reaction is fired or when a certain time is reached. In order
to be notified of these events, observers have to be registered with the simulator.
Observer implementations are provided for tracing the molecule numbers for some species in
arbitrary intervals, for recording the firings of reactions, for computing distributions of molecule
numbers at a certain time over many simulation runs as well as for many other purposes. Several
observers can be registered for a simulation at the same time and most of them can also handle
repeated simulation runs, e.g. to create average curves or curves containing all trajectories for
the individual simulation runs.
In general, the observers use gnuplot to present their results. Once gnuplot is installed on a system
and accessible e.g. via the path variable, the Gnuplot class makes it possible to easily create plots
and retrieve them as Image objects, save them as files or present and update them online in a
window. Plots can be customized using appropriate gnuplot commands.
Stochastics
An important feature of FERN is that random number generation is handled by the singleton
class Stochastics. Accordingly, only one instance of this class is instantiated during a FERN
run and all calls for random numbers are referred to this instance. This has several advantages.
First, the underlying random number generator can easily be replaced if faster and better random
number generators are developed. Currently, the Mersenne Twister implementation of the Colt
Project is used (http://dsd.lbl.gov/∼hoschek/colt/). Second, by setting the seed value for the
random number generator explicitly, the simulation can be made deterministic and e.g. interesting
trajectories can be reproduced. Third, it is possible to count the number of random number
generations necessary for different implementations of SSAs, which is particularly interesting
to figure out why some algorithm is inefficient for some application.
8.3.4 Accuracy and runtime performance of FERN
To test the accuracy of the implemented stochastic simulation algorithms we used the Discrete
Stochastic Models Test Suite (DSMTS) [Evans et al., 2007]. This test suite provides 36 stochastic
models in the SBML format which have been solved either analytically or numerically. To test
the implementation of a stochastic simulation algorithm, simulations have to be performed a
large number of times (in general 10,000 times) for each individual model. The test is failed for
a model if the distribution of the results is statistically significantly different from the known
underlying distribution.
The exact simulation algorithms passed 94.4% of the DSMTS models [Erhard et al., 2008],
which is significantly better than the performance of other implementations. The reference
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implementation of one of the authors of DSMTS, gillespie2 [Gillespie et al., 2006] for instance
passes only 80.6% of the tests.
Even though FERN is implemented in Java, which is often claimed to be less efficient than
C, FERN’s original gillespie algorithm is significantly faster than the C implementation of
gillespie2. FERN was also compared to the SSA implementation of ISBJava using the EGF
signaling pathway by Lee et al. [Lee et al., 2006], which contains 39 molecular species and 19
reversible and 12 irreversible reactions. Our results show that the implementations of the original
Gillespie and Gibson-Bruck algorithm of FERN are always more efficient for the FernML
network than the implementations provided by ISBJava (for details about runtime performance,
see to [Erhard et al., 2008]).
Furthermore, the enhanced implementation of the Gillespie algorithm provided by FERN
outperforms any of the exact methods provided by ISBJava. This shows that the powerful
observer system of FERN does not come at the cost of a reduced runtime performance. In
contrast, observers may rather help to avoid the execution of unnecessary code. Accordingly,
FERN is a useful library for stochastic simulation even if the observer tools are not used.
8.4 Using FERN
8.4.1 Command line tool
FERN can directly be used from command line by calling one of the start scripts. This is currently
supported for windows (start.bat), linux/unix/mac os (start.sh) and cygwin (start cygwin.sh).
They all call the main method of the class fern.Start, which is able to simulate networks with
different algorithms and record time courses of molecular species. Usually, these time courses are
written to stdout in tab separated format, to enable an easy processing by downstream programs.
In addition, the command line tool of FERN is able to directly create plots of time courses using
the freely available software gnuplot.
In the following, some examples are shown for using the command line tool to simulate the EGF
signaling pathway by Lee et al. [Lee et al., 2006], which is included in the FERN distribution as
a FernML network (examples/mapk.xml) and an SBML network (examples/mapk sbml.xml).
The most basic simulation run can be started by typing
start.sh examples/mapk.xml 800 10
This will simulate the pathway for a time of 800 seconds and record the amount of each of the 39
molecular species every 10 seconds. The recorded time course is written to stdout, which gives
a total of 81 lines of 40 columns each containing the time in the first column and the molecule
number of the i’th molecule in the i’th column (the molecular species are numbered according to
their occurrence in the xml file):
0.0 680.0 100.0 0.0 0.0 0.0 ...
...
800.0 580.0 0.0 2.0 0.0 12.0 ...
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In the model, the molecular species E0∗, E1∗, E2∗, E3∗, E4∗, E5∗ represent the receptor
signaling complex EGF.EGFR2Grb2.SOS (E0∗) and the phosphorylated forms of the kinases
Ras, Raf, MEK, ERK and Elk (E1 ∗ −E5∗). Since these are the constituent parts of the
phosphorylation cascade and therefore particularly interesting, it is possible to specify the
molecular species to observe using the -s parameter.
The output then will only have seven columns: the time and the amount of these six molecular
species (now the species are numbered according to their occurrence in the command). In order
to create a plot, the interactive flag can be used.
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Figure 8.4: Trajectories of the EGF signalling pathway by Lee et al. [Lee et al., 2006]. After 100
SSA runs, the average of all trajectories strongly resembles the time course of the ODE model.
A window containing the time course plot (see Figure 8.4) will pop up once the simulation has
finished. It is possible to save the plot in various formats by clicking onto the window. Lee et
al. used ODEs to model the pathway, so their plots looked a lot smoother than the time course
created by SSAs, which is a random sample according to the CME. In order to create muliple
time courses, use the -n parameter. The full command then is:
start.sh examples/mapk.xml 800 10 -i -n 100 \
-s E0* E1* E2* E3* E4* E5*
Now, the plot is updated after every simulation run. The more runs are averaged, the more similar
are the results to the ODE model in [Lee et al., 2006] as the CME is better approximated.
8.4.2 Basic usage of FERN
Apart from the the command line, Java programmers can use FERN’s advanced functionalities
by writing only a few lines of code. A network can be loaded in a single line of Java code (line 1
in Listing 8.2). Then it can be simulated using a Simulator instance (lines 4 and 9).
The parameter 800.0 is the time duration for simulation, i.e. the reaction network is simulated
from t0 = 0 with S0 =the initial amounts taken from mapk.xml to time tN = 800. Simulation
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results, however, are not reported yet (and not even recorded), since no Observer is registered
at the simulator. The AmountIntervalObserver can be used to create time courses of molecular
populations (lines 5 and 6).
When the simulation is started afterwards, the observer records the amounts of the phospho-
rylated kinases (see above) at time points t0 = 0, ti1 = 10, ti2 = 20, ..., ti81 = 800. If the line
sim.start(800.0) is placed inside a for loop (line 8), the observer will record all the runs. However,
these results are still not reported to the user.
This is done by lines 11-16. These create a plot of the averaged time courses as well as the tab
separated output known from the command line tool.
1 Network net = new FernMLNetwork(new File("mapk.xml"));
2 NetworkTools.dumpNetwork(net, new PrintWriter(System.out));
3
4 Simulator sim = new GillespieEnhanced(net);
5 AmountIntervalObserver amount = new AmountIntervalObserver(sim,10,"
E0*","E1*","E2*","E3*","E4*","E5*");
6 sim.addObserver(amount);
7
8 for (int i=0; i<100; i++)
9 sim.start(800.0);
10
11 GnuPlot gp = new GnuPlot();
12 gp.setVisible(true);
13 amount.toGnuplot(gp);
14 gp.plot();
15
16 System.out.println(gp.toString());
Listing 8.2: Complete listing of the example
Although this example only performs the same simulation as the command line tool, it illustrates
the structure and modularity of a FERN program for the use of even unexperienced Java
programmers.
Additional examples are included in the FERN distribution in the package fern.example, which
can be used as a starting point for own projects. Besides these single class examples, the FERN
distribution includes more sophisticated applications of its functionalities, which are described
in the following.
8.4.3 Cytoscape plugin for stochastic simulation
Cytoscape [Shannon et al., 2003] is a software platform for visualizing and integrating networks
with an emphasis on biological data. It provides a flexible plugin architecture, which can be used
to enrich the platform with additional methods. We used this functionality to create a plugin
which uses FERN to simulate networks loaded into Cytoscape (see Figure 8.5). This plugin
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makes it possible to track the simulation progress directly on the network. Furthermore, it shows
how FERN can be easily integrated into other applications and how the observer system can be
used to visualize more than just the changes in molecule numbers.
Figure 8.5: EGF signalling pathway loaded into Cytoscape. Currently, a simulation is performed
and visualized directly on the graphical representation of the network: The transition L+R→ C
(the dark colored diamond in the lower left corner) is currently firing.
Each network readable by Cytoscape can be used for simulation by the plugin if it consists of
two distinct types of nodes, namely reactions and molecular species. Furthermore, the initial
amount of each molecular species and the reaction rate coefficient for each reaction are required.
These parameters and the node type (species or reaction) can be read from arbitrary node
attributes specified in Cytoscape. Additionally, the plugin provides access to FernML files in
both directions. Thus every Cytoscape network can be saved as FernML, and every FernML file
can be loaded into Cytoscape.
Simulations can be performed with every stochastic simulation algorithm provided by FERN
and the simulation progress can be visualized directly on the network. Reaction nodes flash up
whenever the corresponding reaction is fired and the species nodes are colored according to their
molecule numbers. Furthermore, simulations can be run in real-time, which causes the algorithms
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to pause between two reaction events according to the simulated time. In addition, time series of
molecular species can be created using gnuplot.
The implementation of the Cytoscape plugin is straightforward. A central plugin class integrates
FERN into the Cytoscape platform by creating a menu item to start the plugin and to load the
user interface. Apart from the classes defining the user interface, only a few additional classes are
necessary. The most important ones are a wrapper class implementing the Network interface to
map the Cytoscape network structure to FERN and an Observer class to make the visualization
possible. Additionally, FERN provides its own Visual Style (which defines how nodes and edges
are colored and shaped in Cytoscape) to guarantee a proper display of the network and to handle
the flashing and recoloring of reaction and species nodes, respectively.
The Cytoscape plugin was also adapted as a plugin to CellDesigner [Funahashi et al., 2003],
which now offers a plugin functionality with the recent version 4.0 beta.
8.4.4 Simulation of cell growth and division using observers
The Cytoscape plugin is one example how observers can be used to track the simulation progress
at various levels. Another example which illustrates the potential of the observer system is the
simulation of the LacZ model described by Kierzek et al. [Kierzek et al., 2001; Kierzek, 2002]
and based on experimental results by Kennell and Riezman [Kennell and Riezman, 1977].
This model requires the simulation of cell division. After each cell division, the stochastic
simulation is continued with one promotor molecule and all other molecule numbers divided
by 2. RNA polymerase and ribosome molecules are assumed to remain approximately constant
with natural variations. For this purpose, the number of these molecules has to be adjusted after
each simulation step by drawing from normal distributions. Furthermore, cell growth leads to a
linear volume change.
With existing stochastic simulation programs, this model can, in general, only be simulated by
changing the code of the actual simulation algorithms. Contrary to that, the model can be easily
simulated with FERN by simply defining a cell growth observer. Before each simulation step,
the observer checks if a generation has been completed. If this is the case, all molecule numbers
are adjusted as described before. In any case, the volume size is adjusted to account for either
cell division or cell growth, and the RNA polymerase and ribosome molecule numbers are set
randomly.
This approximation was also used by Kierzek et al. and assumes that cell volume does not change
during a simulation step. To perform an exact simulation of volume change, propensity functions
would have to be defined which handle the cell volume as a function of time. However, since the
volume change during one reaction is extremely small, the differences between the approximate
and exact results should be negligible.
Using the cell growth observer, we simulated the LacZ model with the enhanced Gillespie
algorithm. Our results for the concentration of the LacZ protein clearly show the periodic
oscillation in the protein numbers due to cell growth and division (see Figure 8.6). From these
results, we can estimate the rate of LacZ protein synthesis via a linear fit to the increasing LacZ
concentrations during the first generation. Here, we obtained a rate of protein synthesis of 21s−1,
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Figure 8.6: Average results of 1,000 simulations are shown for the LacZ protein over ten bacterial
generations (black). After each generation ( 35 min) the number molecules for each species was
divided by 2 to simulate cell division. The gray line shows a linear fit to the increasing LacZ
concentration during the first generation. This yields a rate of protein synthesis of 21s−1.
which is close to the 22s−1 obtained by Kierzek et al. [Kierzek, 2002] and the 20s−1 reported by
Kennell and Riezman [Kennell and Riezman, 1977].
8.5 Discussion
In this chapter, we presented FERN, a Java framework for modeling and simulating biological
reaction networks. We showed, that FERN improves on implementations in terms of runtime
efficiency and flexibility and that it provides a comprehensive and easy to use framework for
fast, accurate and flexible stochastic simulation to Java developers. It provides state-of-the-art
stochastic simulation algorithms, efficient representations of networks with several input and
output options and various ways of tracing and visualizing simulation data.
It is possible to do reasonable simulations with FERN in just five lines of Java code. Each of the
five steps can be expanded to cover more complex scenarios and simulations can be controlled
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at different levels. For instance, to simulate cell growth, an observer can be modified to change
the volume of the simulation space. Alternatively, an interesting subnetwork can be selected on
which simulations can then be run.
Compared with the ISBJava library, FERN has several advantages. First, FERN is more flexible
than ISBJava and offers more functions for tracking and interacting with simulations. Second, in
contrast to ISBJava, it implements the composition/rejection method for large networks, a hybrid
algorithm as well as the most current tau-leaping methods which resolve the problem of negative
concentrations. Furthermore, its stochastic simulation algorithms are significantly faster than the
ISBJava implementations. Finally, it supports the current version of SBML and allows arbitrary
rate laws.
FERN can be easily integrated into other applications making its functionalities available within
different environments. We have illustrated this by implementing FERN plugins to Cytoscape
and CellDesigner. With only few additional classes, the Cytoscape plugin enables the users to
follow the simulation progress directly on the network. This was made possible by the powerful
observer system of FERN, which is one of its major advantages compared to other available
simulation programs. In addition, we currently develop PNMA (Petri Net Modeling Application),
a software platform for modeling, simulation and parameter optimization of biological networks
based on Petri nets (http://www.bio.ifi.lmu.de/PNMA). It also includes a FERN plugin for
stochastic simulation and offers many more specialized functionalities regegarding Petri nets
and their simulation than Cytoscape or CellDesigner.
Thus, the plugins and the command line tool make it possible to exploit FERN’s functionalities
without writing Java code. Although some available stochastic simulation programs offer a few
specialized features not yet supported by FERN such as e.g. time-delayed dynamics, none of
them offer such a wide range of features and can be extended to new features as easily as FERN.
Therefore we provide FERN as a useful tool for biochemical network analysis or the development
of new analysis methods or applications.
Chapter 9
Conclusion and outlook
In this work I developed several methods to analyze and interpret high-throughput data from
systems biology experiments. As pointed out in the previous chapters for specific examples,
it is highly important to properly analyze the raw data from such experiments. Otherwise,
interesting findings may be missed or, which is even worse, mistakes made in the raw data
analysis, e.g. not recognizing certain bias, may lead to wrong interpretations. Furthermore, it
becomes more and more apparent that the major bottleneck in genomics research is not the
generation of data but their computational analyis, interpretation, visualization and integration
[Green and Guyer, 2011]. For instance, the ENCODE project [Consortium, 2012b] has generated
and is still generating unprecedented and massive amounts of data. Even if various papers have
been published jointly in Nature, Genome Research and Genome Biology in September 2012,
there is probably still much to be found in the ENCODE data, and hypotheses published by the
participants of the ENCODE project must be challenged. Only computational methods and tools
give the opportunity to handle such data.
I applied the methods I developed to data that was obtained in the context of a project about
herpes viruses with a focus on post-transcriptional regulation by microRNAs. ALPS (see chapter
3 and Erhard and Zimmer [2010]), PARma (see chapter 4 and Erhard et al. [2013a]) and
REA (see chapter 5 and Erhard et al. [2013b]) are methods for the raw data analysis of short
RNA-seq, PAR-CLIP and RIP-Chip experiments, respectively. All of these experiment types
are widely used in biological research and implementations of ALPS, PARma and REA are
publicly available on the institute’s website and can be used by the research community to
identify regulatory RNA in short RNA-seq experiments or to find their targets by PAR-CLIP
or RIP-Chip experiments.
These methods or ideas thereof may also help to answer additional questions that have not been
addressed so far. For instance, since regulatory ncRNAs are also sequenced in a PAR-CLIP
experiment, it may be of interest to apply ALPS to PAR-CLIP data in order to identify novel
regulatory ncRNAs that is also utilized by RISC to recognize targets. Furthermore, the ALPS
scoring system could be extended to also consider PAR-CLIP characteristic features, i.e. T to C
conversions.
Furthermore, ideas from PARma could also be used to analyze other types of experiments, for
instance Digital genomic footprinting (DGF) [Neph et al., 2012b]. Roughly, in comparison to
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CLIP-seq, which measures data of microRNA-mediated regulation, DGF can be seen as the
equivalent experiment for data of transcription factor (TF)-mediated regulation. In DGF, binding
sites of all active TFs are obtained in a genome-wide manner, which is similar to CLIP-seq
experiments, where binding sites of microRNAs are measured in a genome-wide manner: In
both cases, there are two tasks for bioinformatics, the identification of the binding sites and of
the regulator that has bound to each of the sites. Importantly, while the characteristic features
of PAR-CLIP data are uniform for each microRNA [Erhard et al., 2013a], DGF target sites may
exhibit quite distinct but highly specific patterns in the DGF data depending on the TF that
has bound there [Neph et al., 2012b]. Thus, PARma cannot be directly applied to DGF data,
but extending PARma to respect these distint patterns may help to distinguish TFs with high
accuracy.
FERN (see chapter 8 and [Erhard et al., 2008]) is a software package for stochastic simulation
of Petri nets. The simulation of biological networks will become more and more important in the
future due to the massive amounts of data that is being produced and tools such as FERN will
be important to model and check the measurements by simulation. FERN is also freely available
on the internet as stand-alone library, as a plugin for Cytoscape and for CellDesigner, and also
embedded in our in-house modelling applications PNMA.
The detection of outlier peptides (see chapter 7 and Erhard and Zimmer [2012]) is a first step
towards finding differentially spliced genes in proteomics data. Considering transcript level
expression instead of gene level expression is a necessary step towards understanding eukaryotic
gene regulation and technological advances in mass spectrometry and their analysis methods
will help to uncover splicing patterns on proteins in a genome-wide manner. Furthermore,
ncRNAs have been implicated in the regulation of splicing and thus, integrating microRNA
related experimental data, e.g. target sites obtained by PAR-CLIP, and experiments measuring
splicing patterns will be an important topic in the future.
The most intriguing finding in this work is that microRNA-mediated regulation is dependent on
the context and that context-dependence is not restricted to a few examples but a widespread
feature for microRNAs. Future experiments and research must focus on the identification of
contributors to this context. For instance, there are already several studies available that try to
identify binding sites either of specific RNA binding proteins [Lebedeva et al., 2011] or of all
RNA binding proteins at once [Baltz et al., 2012]. However, such experiments must be conducted
for multiple contexts in conjunction with experiments that measure microRNA targets. Thus, not
only an Encyclopedia of DNA Elements is necessary to understand the human genome, but also
an Encyclopedia of RNA Elements.
So far, high-throughput data has mainly played a role in basic research. However, falling prices
are currently initiating a new age for high-throughput experiments such as NGS: They are more
and more applied in a clinical setting, opening up completely new opportunities for personalized
medicine [Biesecker et al., 2012]. Thus, the development of analysis software that cannot only
be used by specially trained bioinformaticians but also by clinical personal will also play an
important role in the future.
Currently, we may not yet be in the position to understand a complete system such as a single
cell or a whole organism in a quantitative manner, but high-throughput technologies give us
the opportunity for big steps towards a quantitative understanding. It is in the responsibility of
161
computational biology to take these steps by providing methods and tools for the analysis and
interpretation of high-throughput data.
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List of abreviations
nt nucleotides
NGS next generation sequencing
SNP single nucleotide polymorphism
CNV copy number variation
mRNA messenger RNA
ncRNA non-coding RNA
IP immunoprecipitation
4sU 4-thio-uridine
RBP RNA binding protein
FDR false discovery rate
DE differential expression
FDR false discovery rate
LC-MS/MS liquid chromatography tandem mass spectrometry
SILAC stable isotope labelling of amino acids in cell culture
UTR untranslated region
RISC RNA induced silencing complex
GRN gene regulatory network
TF transcription factor
RNAi RNA interference
AGO Argonaute
190 List of abreviations
kb kilobases
EBV Epstein-Barr virus
HSV1 Herpes Simplex virus 1
HSV2 Herpes Simplex virus 2
HCMV Human Cytomegalovirus
MCMV Murine Cytomegalovirus
KSHV Kaposi’s Sarcoma-associated Herpesvirus
VZV Varicella-Zoster Virus
rLCV Rhesus monkey Lymphocryptovirus
CLIP crosslinking and immunoprecipitation
PAR-CLIP Photoactivatable-Ribonucleoside-Enhanced Crosslinking and Immunoprecipitation
eGFP enhanced green fluoresent protein
DGF Digital genomic footprinting
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